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Dual functions of the Retinal Determination Gene Network member EYES ABSENT as a
transcription factor and protein phosphatase
Serena J. Silver Brown
submitted to the Biology Department on June 10, 2004 in partial fulfillment of the
Requirements for the degree of Doctor of Philosophy in Biology
Proper development of cell types and tissues requires the integration of extracellular
signals to provide context specific information that insures appropriate differentiation. The
Drosophila eye is an excellent model for the study of this signal integration, as its development is
orchestrated by the interactions of common signal transduction pathways in conjunction with
organ specific gene expression. Signaling through these pathways sets the stage for appropriate
deployment of the Retinal Determination (RD) gene network members to direct formation of the
eye and other organs.
Our studies have focused on the RD gene network member EYES ABSENT as a point of
signal integration necessary for the formation of the Drosophila eye. We have examined two
functions for EYA, the first as a transcriptional co-activator, and the second, more novel function
as a protein tyrosine phosphatase.
Previous work suggested that EYA functions as a transcriptional co-activator, particularly
in a complex with the DNA binding domain containing RD network member SINE OCULIS
(SO). In order to better understand RD network regulation, we performed a structure-function
analysis of the EYA protein, which defined the P/S/T rich region of EYA as crucial for EYA
transactivation potential. This region is also necessary for EYA mediated ectopic eye induction
and rescue of the eya2 mutant phenotype. We showed that RAS/MAPK signaling potentiates
EYA transactivation, providing a mechanism for previously described in vivo activation of EYA
by MAPK. We have also demonstrated roles for GROUCHO and DACHSHUND in negative
and positive regulation of the EYA-SO transcription factor, respectively.
Recently we have begun to study a novel function of EYA suggested by the homology of
the highly conserved EYA domain (ED) to the Haloacid dehalogenase (HAD) family. Using the
substrate analog para-nitrophenyl phosphate (pNPP), we showed that recombinant ED possesses
phosphatase activity, which is affected by tyrosine phosphatase inhibitors but not
serine/threonine phosphatase inhibitors. To determine whether this activity is important for EYA
function in vivo, mutants that reduce or abrogate phosphatase activity, as shown by lower
specific activity or higher Km in pNPP assays, were tested for their ability to induce ectopic eyes
or rescue the EYA mutant phenotype. These mutants, which we refer to collectively as EYA AD,
are unable to induce ectopic eyes or rescue the eya2 phenotype to the degree of wildtype EYA.
As the EYAHAD mutants are all within the ED, which is known to bind to SO, we tested whether
these mutants are competent transcriptional coactivators with SO, and found that they retain this
activity. Thus the phosphatase and transactivation functions of EYA may represent two distinct
essential functions of EYA.
As EYA represents one of the first transcription factors found to possess phosphatase
activity, and modulation of phosphorylation state represents a common mode of transcriptional
regulation, it will be of particular interest to elucidate the role of EYA phosphatase function in
vi'vo, studies which will require identification of transcriptional targets and phosphatase
substrates.
Thesis Advisor: Ilaria Rebay
Title: Associate Professor of Biology
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Chapter 1
The Retinal Determination Gene Network:
A Point of Signal Integration for
Specification and Proliferation
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Abstract
Proper development of cell types and tissues requires the integration of extracellular
signals to provide context specific information that ensures appropriate differentiation. The
Drosophila eye is an excellent model for the study of this signal integration, as its development is
orchestrated by the interactions of common signal transduction pathways in conjunction with
organ specific gene expression. Signaling through the NOTCH, DECAPENTAPLEGIC/
TRANSFORMING GROWTH FACTOR-P, WINGLESS, HEDGEHOG, and EPIDERMAL
GROWTH FACTOR RECEPTOR pathways sets the stage for appropriate deployment of the
Retinal Determination (RD) gene network members to direct formation of the eye and other
organs.
The RD gene network encodes a group of evolutionarily conserved transcription factors
and co-factors that are crucial for the formation of many organs including the eye. These nuclear
factors, which include proteins in the PAX6, EYA, SIX, and DACH families, are regulated by
their interactions with each other and by effectors of the signaling pathways mentioned above.
The mechanistic links between the RD gene network and signaling pathways are just beginning
to be understood, particularly at the level of phosphorylation and regulation of transcriptional
targets. One crucial role for the crosstalk between signaling pathways and this network of
transcription factors is to coordinate the processes of cell proliferation and cell differentiation so
that appropriate organ size and structure can be achieved.
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A CONSERVED REGULATORY NETWORK FOR EYE DEVELOPMENT
Eye development in different organisms produces strikingly different structures: the
primitive eye of planaria, the compound eye of insects, and the camera-like eye of vertebrates.
While these visual organs are morphologically distinct, the molecular mechanisms that lead to
these different eyes are remarkably conserved. Specification of the eye field in these diverse
organisms requires expression of homologous members of the Retinal Determination (RD) gene
network, a group of transcription factors and co-factors crucial for the development of the eye as
well as other organs. Much has been learned about these transcription factors, which include
members of the PAX6, EYA, SIX, and DACH families (Figure 1), from studies in Drosophila as
well as vertebrates.
A Master Regulator? - EYELESS/PAX6
The first RD gene network member to be identified molecularly was Drosophila eyeless
(ey), the homolog of vertebrate Pax6 (Quiring et al., 1994). The PAX6 family is a subgroup of
the large family of PAX proteins, each containing two DNA binding motifs; a PAIRED box
I)NA binding domain, and a HOMEOBOX type DNA binding motif (Figure 1; Quiring et al.,
1 994).
ey was first named due to eye specific alleles which result in loss of eye tissue (Quiring et
al., 1994). Subsequent cloning of this gene and isolation of null alleles, which are homozygous
lethal, revealed a broader role for EY in the embryo and brain (Kammermeier et al., 2001). This
pattern of discovery, where isolation of eye specific alleles is followed by recognition of broader
roles in development, would be repeated for many of the RD gene network members.
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Heterozygosity at the Pax6 locus is associated with aniridia and Peters' anomaly in
humans and the small eye phenotype in mouse (Hanson et al., 1994; Quiring et al., 1994),
indicating conservation of PAX6 family roles in eye and head development in addition to the
striking sequence conservation. Consistent with studies in Drosophila, homozygous mutant
vertebrates, including humans, do not survive due to broader requirements for PAX6 during
development (Hanson, 2001).
In addition to ey, the Drosophila melanogaster genome contains a second closely linked
PAX6 homolog, twin-of-eyeless (toy), thought to be the result of a duplication during insect
evolution, as two PAX6 homologs are also found in the closely related Drosophila virilis and the
more distantly related silkmoth Bombyx mori, but not in the grasshopper Schistocerca nitans nor
a primitive insect, the springtail Folsomia candida (Czerny et al., 1999). TOY and EY are
independently required for proper eye development (Kronhamn et al., 2002; Quiring et al., 1994)
and display distinct as well as overlapping embryonic and larval expression patterns
(Kammermeier et al., 2001; Kronhamn et al., 2002). Therefore these homologous genes are not
merely redundant, and insects have taken advantage of the presence of two PAX6 genes by
adapting them for different uses.
Both TOY and EY are highly homologous to human PAX6, with over 90% identity in the
PAIRED domain and 90% identity in the HOMEOBOX domain. TOY is more similar to PAX6
in length and in sequence outside of the two DNA binding domains, and also shows more similar
DNA binding specificity (Czerny et al., 1999). This distinction may play a role in the binding
specificities of TOY and EY in vivo, as the PAIRED domain of TOY binds to five sites in the
eye specific enhancer of their target gene sine oculis, while the PAIRED domain of EY binds
only to a subset of those sites (Niimi et al., 1999; Punzo et al., 2002).
12
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In the eye, TOY and EY are expressed in a regulatory hierarchy, whereby TOY acts
upstream to activate ey through binding to PAX6 consensus motifs in the ey intron (Czerny et al.,
1999; Hauck et al., 1999), and both are required for proper development of the head and eyes
(Kronhamn et al., 2002). Perhaps one of the most striking aspects of PAX6 family members is
their ability to act as "master regulators" of eye formation, by directing the formation of ectopic
eyes upon overexpression (Halder et al., 1998). Expression of either TOY or EY is sufficient to
induce ectopic eyes (Czerny et al., 1999; Halder et al., 1995), and even human PAX6 can induce
ectopic eyes when expressed in flies (Halder et al., 1995).
Although PAX6 proteins contain two DNA binding motifs, studies of Drosophila EY
suggest they may be used independently. For example, analyses of truncated EY proteins reveal
a requirement for the PAIRED domain but not the HOMEOBOX to rescue the eye specific ey2
mutant phenotype and also to induce ectopic eyes (Punzo et al., 2001). The PAIRED domain
may also be involved in cooperative interactions with other transcription factors, as is observed
for the PAIRED domain of a related protein, PAX5, in its interactions with the transcription
factor ETS-1 (Garvie et al., 2001). In contrast, the HOMEOBOX is required to downregulate
genes important for the development of appendages, such as distalless, suggesting a role for this
I)NA binding domain in repression (Punzo et al., 2001). It is interesting to note that these two
DNA binding domains appear to mediate opposite effects, activation versus repression, and
function in the development of discrete organs. It is likely that co-factor interactions, such as
those observed between PAX5 and ETS-1, may favor the use of one or the other DNA binding
domain, co-recruiting it to target sequences and giving PAX6-DNA complexes context
specificity.
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TOY and EY function at the top of a transcriptional hierarchy, where they are required
for the expression of downstream members of the RD gene network (Figure 2; Halder et al.,
1998). Like TOY and EY, members of the RD gene network have largely been characterized as
transcription factors, and include the PAX6-like gene eyegone (eyg), which is thought to act in
parallel to ey, and downstream components eyes absent (eya), sine oculis (so), and dachschund
(dac). EYA, SO, and DAC are all the founding members of families of proteins important for
organ development in both invertebrates and vertebrates, and are homologous to members of the
EYA, SIX, and DACH families, respectively. SO contains a HOMEOBOX DNA binding
domain (Cheyette et al., 1994; Serikaku and O'Tousa, 1994), while EYA and DAC are novel
nuclear proteins (Bonini et al., 1993; Mardon et al., 1994). However, the transcriptional
hierarchy observed in the eye is not linear, and EYA, SO, and DAC contribute to positive
feedback loops that ensure continued expression of EY (Figure 2; Halder et al., 1998). Another
SIX family member, optix, also appears to act in parallel to TOY and EY to direct eye growth
(Seimiya et al, 2000).
Despite study of the function of the PAX6 family in many organisms, few direct targets
of these transcription factors have been identified. Recently, microarray analysis of ectopic eyes
induced by eyeless was performed in order to understand the developmental program initiated
upon eye formation, identifying 371 genes induced by EY (Michaut et al., 2003). Of these,
many are already known to be involved in eye formation, others have been previously
characterized for roles in other developmental processes, while over half remain uncharacterized,
including 100 novel genes (Michaut et al., 2003). It still must be determined which of these
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The RD gene network is expressed in a transcriptional hierarch whereby TOY leads to
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network such as EYA and DAC operate in reiterative feedback loops to turn on EY.
Other RD members EYG and OPTIX are required independently for proper eye
development.

genes are direct targets of EY and which play roles further downstream in eye formation.
Performing similar microarray analysis of tissue expressing the closely related TOY might reveal
overlapping and distinct targets for these two PAX6 proteins.
It is of particular note that greater than one-fourth of the total enriched gene class encode
novel proteins, especially in light of two novel but now well studied members of the RD gene
network, EYA and DAC. EYA and DAC when cloned could not be categorized immediately as
transcription factors, enzymes, or DNA binding proteins based on amino acid sequence, but
indeed each perform some of these functions (Ikeda et al., 2002; Ohto et al., 1999; Silver et al.,
2003; Tootle et al., 2003). It will require more detailed study to the identify functions of these
100 novel proteins, through analysis of localization, mutant phenotype, structure, and
biochemistry. The study of the novel genes identified by this microarray screen may reveal new
paradigms for functional motifs as well as the mechanistic roles of individual genes in organ
development.
EYEGONE, a PAX6-like gene in Drosophila
In addition to the PAX6 orthologs TOY and EY, there are two Pax6-like genes in
Drosphila, eyegone (eyg), and its related gene, twin-of-eyegone (toe). Like most RD gene
network members, loss of function alleles of eyg result in loss of eye tissue, while
overexpression of EYG promotes ectopic eye formation (Jang et al., 2003). eyg and toe encode
Pax proteins which contain a truncated PAIRED domain and a complete HOMEOBOX (Figure
1; Jang et al., 2003; Jun et al., 1998). The PAIRED DNA binding domain contains two
separable motifs, PAI and RED, which can each bind DNA independently (Jun and Desplan,
1996); eyg and toe contain only the RED motif (Jun et al., 1998). eyg expression does not
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require the presence of ey, nor does ey expression require eyg function (Jang et al., 2003).
Furthermore, ectopic expression of neither ey nor eyg can induce the other, indicating that they
may act in parallel during eye formation (Jang et al., 2003).
While there are no homologs of eyg in mammals, it has been suggested that the functional
ortholog of this gene is the 5a splice isoform of Pax6 (Pax6(5a)) (Dominguez et al., 2004; Jun et
al., 1998), which also contains only the RED motif portion of the PD. In support of this theory,
the RED domain of EYG and the RED domain of PAX6(5A) can bind to similar sequences (Jun
et al., 1998), and overexpression of PAX6(5A) in Drosophila produces the same overgrowth
effects as overexpression of EYG (Dominguez et al., 2004). Therefore the functions of EYG are
likely to represent conserved processes in vertebrates.
In Drosophila, EY and EYG can function synergistically to induce larger ectopic eyes,
for which a mechanism has recently been suggested. Specifically, EY and EYG may play
discrete roles in eye development, where EY is important for eye specification while EYG is
crucial for eye growth (Dominguez et al., 2004). It is crucial to the development of a functional
organ that these two processes be coordinated during tissue formation, and EY and EYG may be
important in this coordination through their parallel roles in differentiation and growth.
In the animal, the discrete roles of EY and EYG can be observed by analysis of marker
gene expression in developing eye tissue mutant for either ey or eyg. ey mutant tissue, which can
be examined in eye specific ey alleles, develops into the larval eye primordia, the eye disc, but
lacks expression of retinal determination markers such as EYA and SO (Halder et al., 1998).
Due to the absence of differentiation, this tissue then undergoes programmed cell death, leading
to the "eyeless" phenotype (Halder et al., 1998).
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In contrast, growth defects in eyg mutant tissue can be observed using the FLP-FRT
system (Xu and Rubin, 1993) to induce specific, marked clonal patches of homozygous mutant
tissue wherever FLP is expressed. When this is done in the eye disc, eyg mutant clones display
clear growth disadvantages compared to wildtype tissue, but express the normal complement of
retinal determination markers such as ELAV and EYA (Dominguez et al., 2004). Thus the
"eyegone" phenotype is due to growth defects in the developing eye.
Thus two distinct proteins, encoded by different genes in Drosophila but a single gene in
vertebrates, separate the control of two essential processes for the development of an organ;
growth and differentiation. These processes must be coordinated precisely to generate
appropriate adult structures, coordination that relies upon members of the RD gene network to
communicate between multiple signaling pathways.
EYES ABSENT: a novel protein with two conserved functions
eyes absent (eya) was first identified in Drosophila as a gene important for cell survival
and differentiation in the Drosophila eye (Bonini et al., 1993). Further studies of Drosophila
EYA and of vertebrate homologs EYA 1-4 have revealed a wider role for EYA in organogenesis
(Bonini et al., 1998; Xu et al., 1999). In Drosophila, strong alleles of eya are lethal and affect
cell proliferation and apoptosis, most clearly resulting in defects in head morphology, but also
defects in gonad formation and body wall musculature (Bonini et al., 1998; Boyle et al., 1997).
Weaker alleles survive to adulthood but display defects in eye and ocelli as well as male and
female sterility (Bonini et al., 1998; Leiserson et al., 1998).
In humans, heterozygosity for mutations in the Eyal gene are associated with Branchio-
oto-renal (BOR) syndrome, as well as Branchio-oto (BO) syndrome and Ocular Defects (OD)
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(Abdelhak et al., 1997; Ozaki et al., 2002), while homozygotes display more severe defects and
do not survive. Eyal heterozygous mice display similar defects in ears and kidneys, as well as
more pleiotropic defects in organogenesis in homozogyotes (Xu et al., 1999; Xu et al., 2002).
The four vertebrate EYA homologs have both discrete and overlapping expression patterns,
suggesting that their functions may not be wholly redundant (Xu et al., 1997a; Zimmerman et al.,
1997). While knockout mice of Eya2, Eya3, and Eya4 have yet to be reported, in humans
mutations in the Eya4 locus are associated with familial hearing impairment (Pfister et al., 2002;
Wayne et al., 2001).
The EYA family is characterized by a highly conserved -250 amino acid C-terminal
domain called the EYA DOMAIN (ED), while the N-terminus of different EYA orthologs shows
little conservation aside from the tyrosine rich EYA DOMAIN2 (ED2; Figure 1; Xu et al.,
1997b; Zimmerman et al., 1997). The amount of EYA must be carefully titrated to maintain
viability, as broad overexpression in Drosophila is lethal (Hsiao et al., 2001), while in cell
culture overexpression of EYA triggers the programmed cell death pathway (Clark et al., 2002).
The ED was initially characterized as a protein-protein interaction domain, a point of
contact between EYA and other RD gene members SO (Pignoni et al., 1997), and DAC (Chen et
al., 1997), an observation that has been extended to interactions between vertebrate EYA and
SIX and DACH families (Ohto et al., 1999; Heanue et al., 1999).
EYA has been best characterized as a transcriptional co-activator which is recruited to the
DNA of target genes via interaction with the SO/SIX family. SIX proteins bind DNA through
their HOMEOBOX domain, recruiting the transactivation potential of EYA to the promoter of
target genes (Ohto et al., 1999). This transcriptional co-activator function of EYA requires the
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Proline/Serine/ Threonine (PST) rich region of EYA's N-terminus including the ED2, which is
also required for EYA function in vivo (Figure 1; Silver et al., 2003).
Recently a second function has been described for EYA, through the identification of the
ED as a catalytic motif belonging to the Haloacid dehalogenase family of enzymes (Tootle et al.,
2003). Recombinant EYA has been shown to dephosphorylate tyrosyl phosphorylated peptides
(Rayapureddi et al., 2003; Tootle et al., 2003) and serine/threonine phosphorylated peptides (Li
et al., 2003) suggesting it may be a dual-specificity protein phosphatase. Thus far there are only
two suggested substrates, both of which can be dephosphorylated by EYA in vitro: RNA
polymerase II (Li et al., 2003), and EYA itself (Tootle et al., 2003). The phosphatase function
of EYA is required for rescue of the eye specific eya 2 allele (Tootle et al., 2003), indicating that
this role is utilized in vivo during eye development.
EYA is the first identified transcription factor to posses intrinsic phosphatase function.
As phosphorylation plays a key role in modulation of transcription factor activity, and EYA is a
nuclear protein associated with DNA, it is likely that the targets of the EYA phosphatase may
play important roles in transcriptional regulation. The identification of in vivo substrates of the
EYA phosphatase, and targets of EYA transcriptional regulation, will help determine how the
phosphatase and transcription factor functions of EYA are coordinated to establish the
appropriate developmental program.
More insight as to EYA function may come from identification of co-factors other than
SO and DAC. Heterotrimeric G proteins are important components of cellular communication,
responding to extracellular cues through activation of the Gc subunit. They are known to
regulate the function of numerous transcription factors indirectly through second messengers, but
in the case of EYA may directly affect transcription factor function by competition for co-
23
factors. Activated Goc and Goq2 proteins have been shown to interact directly with the ED
using Yeast and Mammalian-two hybrid analysis as well as glutathione S-transferase (GST)
fusion protein pull-down assays, and may compete with SIX family members for EYA, thus
preventing target gene activation (Fan et al., 2000). This represents a novel mode of
transcriptional regulation through Goc subunits, and it is intriguing to ask if this interaction might
serve to direct EYA's phosphatase activity towards particular substrates, allowing EYA to
regulate other transcription factors or perhaps a different aspect of the cellular machinery.
The ED also contains a potential interaction motif for the GROUCHO (GRO) family of
corepressors, although GRO-EYA interactions are not observed by co-immunoprecipitation in
Drosophila cell culture (Silver et al., 2003). Recent genome wide yeast-two-hybrid screens of
Drosophila and C. elegans proteins have identified other potential EYA binding partners, 8 in
Drosophila and 51 in C. elegans, whose relevance remains to be determined through more
detailed experimental analysis (Giot et al., 2003; Li et al., 2004). Unfortunately, other than the
isolation of SO and its C. elegans homologs ceh-33 and ceh-35, there is no overlap between the
two screens, and more analysis will be needed to identify true binding partners.
Although it is best known for its role in eye development, EYA is found in organisms
which do not have eyes, including as mentioned above the nematode C. elegans and perhaps
more strikingly, plants such as Arabidopsis thaliana. Despite the absence of eyes, C. elegans
have many sensory neurons which interact with the environment to sense modalities such as
temperature and odor (for review see Mori and Ohshima, 1997), and homologs of RD gene
network members EY, SO, and DAC are expressed in the worm head in discrete and overlapping
domains (Chisholm and Horvitz, 1995; Dozier et al., 2001; Duncan et al., 1997; Zhang and
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Emmons, 1995; A. Brown, personal communication), while the EYA expression pattern has yet
to be reported. The presence of the RD gene network in these animals underscores their use in
early development of sensory organs, and ultimately the adaptation of this network to organize
multiple tissue and organ types in vertebrates (Wawersik and Maas, 2000).
EYA is thus far the only member of the RD gene network to be found in plants, in both
monocots and dicots (Takeda et al., 1999). EYA homologs in Oryza sativa (rice) and
,4rabidopsis consist solely of an EYA DOMAIN preceded by a short 18 amino acid peptide, and
Oryza EYA is highly expressed during embryogenesis (Takeda et al., 1999). As the Arabidopsis
genome is now complete and annotated, and searches do not reveal homologs of EY, SO, or
DAC, analysis of EYA function in plants may reveal independent and evolutionarily older
functions for this family of proteins.
Absence of transcriptional cofactors in addition to the absence of the N-terminal
transactivation domain suggests that EYA may not function as a transcription factor in plants.
However plant EYA contains all conserved residues necessary for HAD family phosphatase
activity, and indeed is the most active EYA of all orthologs tested (Rayapureddi et al., 2003).
Thus plant EYA may represent EYA's original role as a protein phosphatase which was later in
evolution brought into transcriptional regulation through interactions with "new" proteins such
as SO and DAC. This would then bring EYA's phosphatase activity to promoter complexes,
where it might act in the regulation of transcription factors through control of phosphorylation
state, a common mechanism of transcriptional regulation. It will be interesting to ask whether
plant EYA is localized to the nucleus, as constructs of the Drosophila EYA domain alone are
both nuclear and cytoplasmic (T. Tootle, personal communication), and whether plant and
animal EYA phosphatases will display similar substrate preferences.
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SO/SIX family members; crucial mediators between EYA, DAC, & DNA
The SIX family can be grouped into three subgroups, one member each in Drosophila
and two members each in vertebrates thought to result from the duplication of a "SIX cluster"
(Kawakami et al., 2000; Seo et al., 1999). All family members are marked by the presence of
two conserved domains, the SIX domain, which mediates protein-protein interactions, and a
HOMEOBOX DNA binding domain (Figure 1; Pignoni et al., 1997). sine oculis (so), the
founding member of this family, is crucial for proper proliferation and patterning during eye
development (Pignoni et al., 1997), and also plays roles in brain (Daniel et al., 1999) and gonad
development (Fabrizio et al., 2003). Strikingly, SO is the only RD gene network member that
cannot induce ectopic eyes when expressed alone, although it can synergize with EYA to
increase the frequency of ectopic eyes (Pignoni et al., 1997).
so falls into a SIX family subgroup with vertebrate SIXI and SIX2. SIX1 mutant mice
display defects in ear, kidney, thymus, skeletal muscle and nose (Ozaki et al., 2004; Xu et al.,
2003; Zheng et al., 2003). Recently SIXI was shown to be upregulated in a mouse model of
metastatic skeletal muscle cancer (Yu et al., 2004), and increased levels of SIX1 were associated
with greater ability to form metastases (Yu et al., 2004), perhaps by overcoming mitotic
checkpoints in G2 (Ford et al., 1998).
Another subgroup of the SIX family contains Drosophila d-SIX4, which plays an
important role in muscle and gonad formation (Kirby et al., 2001), and vertebrate homologs Six4
and Six5. Six4 mutant mice have no apparent defects (Ozaki et al., 2001), despite its strong
expression throughout the nervous system and in many sensory organs, and Six5 knockout mice
appear normal except for a higher incidence of cataracts (Klesert et al., 2000; Sarkar et al.,
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2000). The effect of simultaneous knockout of these closely related genes with overlapping
expression patterns remains to be examined.
In humans, the Six5 locus is associated with myotonic dystrophy (DM 1), and patients
with that disease show lower levels of Six5 expression (Wansink and Wieringa, 2003). Although
the loss of Six5 in mice does not mimic the entire phenotype of patients with DM1, it is thought
that loss of Six5 may contribute to the cataracts observed in these patients (Wansink and
Wieringa, 2003), while downregulation of the associated gene DM protein kinase (DMPK) is
responsible for the myopathy phenotype (Sarkar et al., 2000).
As described earlier, the members of the SIX subfamilies SIX1/2 and SIX4/5 are thought
to generally function in a complex with EYA proteins as bipartite transcription factors. The SIX
Domain interacts with the EYA domain, forming a transcription factor with the SIX
HOMEOBOX as the DNA binding domain and the N-terminus of EYA as the transactivation
domain that together direct transcription of target genes (Kawakami et al., 2000; Silver et al.,
2003). This also brings the phosphatase activity of EYA to the promoter region, where it may
play a role in regulation of itself or other factors. In another example of independent functions of
members of the RD gene network, vertebrate SIX1/2 and SIX4/5 genes have some activation
ability independent of EYA (Kawakami et al., 2000).
The most divergent branch of the SIX family includes Drosophila optix and the
vertebrate genes Six3 and Six6 (Kawakami et al., 2000). All members of this subfamily show
strong expression in the developing eye (Kawakami et al., 1996c; Seimiya and Gehring, 2000),
and are necessary for proper eye formation (Carl et al., 2002; Li et al., 2002; Seimiya and
G(ehring, 2000). Similar to its vertebrate counterparts, which when overexpressed induce
enlarged forebrains (Kobayashi et al., 1998), overexpression of optix leads to ectopic eyes
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(Seimiya and Gehring, 2000). OPTIX, like EYG, does not require EY for the induction of
ectopic eyes, and may act in a parallel pathway to direct eye formation (Figure 2; Seimiya and
Gehring, 2000). However the lack of mutants that affect optix makes it difficult to place this
protein more definitively within the RD gene network hierarchy.
Mutations in the human Six3 gene are associated with holoprosencephaly (Pasquier et al.,
2000; Wallis et al., 1999), stemming from defects in neural plate formation. Loss of the other
human member of that subfamily, Six6, is associated with bilateral anophthalmia, a condition
where babies are born with no eyes, as well as pituitary defects (Gallardo et al., 1999). Similar
to the human phenotype, mice homozygous for knockout of Six6 survive but have retinal and
pituitary hypoplasia (Li et al., 2002). Overexpression of SIX3/6 causes overproliferation, and
mutations in these genes cause phenotypes associated with proliferation defects, suggesting that
they may play a direct role in cell cycle regulation. Recent work suggests that the SIX3/6
subfamily performs this role through transcriptional regulation and protein-protein interactions.
Unlike the other SIX family members, which are largely thought to coordinate
transcriptional activation through interactions with EYA, the SIX3/6 subfamily do not interact
with EYA family members (Kawakami et al., 2000). Instead, they are proposed to act as
transcriptional repressors, one mechanism for which may be their interactions with the
GROUCHO (GRO) family of corepressors, called GRG in vertebrates, through an engrailed
homology 1 (ehl) motif in the SIX domain (Kobayashi et al., 2001; Lopez-Rios et al., 2003; Zhu
et al., 2002).
The interaction between SIX3/6 and GRG family members has been demonstrated to be
crucial for proper eye and brain formation in zebrafish and medaka (Kobayashi et al., 2001;
Lopez-Rios et al., 2003) as well as mice (Zhu et al., 2002). In overexpression studies, the GRG
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homolog TLE can act synergistically with SIX3 and SIX6 to expand the eye field, while a
dominant negative form has the opposite effect (Lopez-Rios et al., 2003).
At least one direct target of SIX6 mediated repression is the cyclin-dependent kinase
inhibitor p27Kip l, which must be repressed to allow early proliferation of the presumptive eye
(Li et al., 2002), providing a direct link between SIX and cell cycle regulation. In this way, SIX
family members may serve to coordinate growth with other targets important for appropriate
differentiation of the organ.
A transcription independent role of SIX3 in control of cell proliferation has recently been
identified in vertebrate eye development. SIX3 and SIX6 were shown to interact with the DNA
replication inhibitor GEMININ (Del Bene et al., 2004). GEMININ inhibits cell proliferation
through sequestration of CDTI, an important component of the replication machinery, such that
SIX3 can compete with CDTI for GEMININ, thus releasing CDT1 and with it cell cycle
inhibition (Del Bene et al., 2004). This combined with the more direct transcriptional regulation
of cell cycle components, illustrates how cell proliferation and cellular differentiation may be
knitted together by deployment of common proteins to interact with distinct elements that insure
the appropriate development of a complex organ.
Transcriptional repression may not be limited to the SIX3/6 subfamily, as the GRG
interaction motif is found in all SIX proteins within the SIX domain (Kobayashi et al., 2001),
indicating interactions with this corepressor family may be a common feature of the entire SIX
family. Recently we showed that Drosophila GRO can interact with SO, and can repress SO
mediated transcription of a reporter gene, likely by competing with EYA for SO binding (Silver
et al., 2003). As studies in mice have shown that SIXI can also have transcriptional repressor
function (Li et al., 2003) it is likely that the members of the SIX family may play more elastic
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roles in transcriptional regulation dependent upon their specific cofactor or context. As EYA
and SO expression patterns are not wholly coincident, this dual function may provide a clear
distinction between cells which express genes necessary for differentiation into eye tissue,
expressing EYA and SO, and cells where those genes are actively repressed, expressing only SO.
This model may be better understood once more targets of the SO/SIX family are identified.
Thus far only a handful of direct transcriptional targets have been identified for the SIX
family (Table 3), most of them in mice. The SIX 1I/2 and SIX4/5 subfamilies have the most
similar homeobox domains and are likely to bind the same or similar target sequences
(Kawakami et al., 2000). The promoters of the myogenin and aldolase A genes contain SIX
binding sites known as MEF3 (TCAGGTT), which is necessary for the embryonic expression of
myogenin (Spitz et al., 1998). Another known target from mice is the housekeeping gene
Na+/K+ ATPase alpha I subunit which contains a SIX family target sequence in the enhancer
element AREC3 (core sequence GGNGNCNGGTTGC, includes TCAGGTT in bold;
Kawakami et al., 1996b).
SIX and SIX4 have been shown to activate transcription via binding to the MEF3 site
(Spitz et al., 1998), while SO, SIX2, SIX4 and SIX5 can all bind the AREC3 site and with EYA
activate transcription of a reporter gene (Kawakami et al., 1996c; Silver et al., 2003). More
recently, microarray analysis of mouse cells expressing dominant active or dominant negative
SIX1 suggested c-Myc and Gdnf as direct targets. This result was confirmed by chromatin IP
experiments, which showed SIX and EYA localization to the c-Myc and Gdnfpromoters (Li et
al., 2003). The single target of this family identified thus far in Drosophila is the lozenge gene,
whose expression is activated by SO binding to an imprecise repeat in the lozenge minimal eye
enhancer (LMEE) (Yan et al., 2003).
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Table 3 - SIX family target genes have been identified in vertebrates and Drosophila
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Target gene SIX family DNA binding site Reference
member Ist (# found)
identified to bind
Na+/K+ATPase SIX4 TCAGGTT(1) (Kawakami et al.,
acl subunit 1996a)
pUC119 SO GATAC (Hazbun et al., 1997)
(plasmid)
myogenin SIX1/SIX4 TCAGGTT (1) (Spitz et al., 1998)
aldolase A SIX1/SIX4 TCAGGTT(1) (Spitz et al., 1998)
Pkip27 SIX6 Seq not ID'd (Li et al., 2002)
lozenge SO TGATAT (2) (Yan et al., 2003)
c-myc SIXI ATCCTGA (1) (Li et al., 2003)
Gdnf SIXI ATCCTGA (3) (Li et al., 2003)
DACH: A novel DNA binding protein
Dacschund (dac) in Drosophila, and its vertebrate homologs, Dachl and Dach2, encode a
family of novel nuclear proteins characterized by two conserved domains, the DachBox-N and
the DachBox-C (Figure 1; Davis et al., 2001b; Kozmik et al., 1999). Analysis of the amino acid
sequence of DACH family members revealed some similarity to the ski proto-oncogene
(Hammond et al., 1998). Recent crystallization of the human DachBox-N revealed a striking
structural resemblance to the winged helix/forkhead subgroup of the helix-turn-helix family of
DNA binding proteins (Kim et al., 2002). While no specific DNA binding sites for DACH have
been identified, it has been shown to bind naked DNA (Ikeda et al., 2002). The DachBox-C is
thought to be a protein-protein interaction motif, and has been demonstrated to interact with
EYA family members via the EYA DOMAIN (Chen et al., 1997). Thus DAC with its DNA
binding ability may like SO be a co-factor responsible for bringing the transcriptional activator
and phosphatase activity of EYA to the promoter of target genes.
dac homozygous mutants lack eye tissue, and have striking leg and wing defects; those
that survive to adulthood die within a few days (Mardon et al., 1994). In mice lacking Dachl,
which like Drosophila dac is expressed in the eye and limbs (Kozmik et al., 1999), there are no
gross defects in development but mice die soon after birth (Backman et al., 2003; Davis et al.,
2001 a). As the expression patterns of Dachl and Dach2 overlap greatly during development,
this relatively mild phenotype may be due to partial redundancy of these genes, and/or may
reflect a greater postnatal need for Dach I.
Like other members of the RD gene network, ectopic expression of DAC leads to
induction of EY expression and the formation of ectopic eyes (Chen et al., 1997; Shen and
Mardon, 1997). DAC can synergize with EYA to increase both the size and frequency of ectopic
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eyes when the two are expressed together (Chen et al., 1997), support for the model that these
two proteins act in a complex to direct eye development.
However, there are some discrepancies in the literature regarding the ability of DAC and
EYA to interact directly. For example, Heanue et al. has shown that GST-DACH2 can pull down
radiolabeled EYA2 (Heanue et al., 1999), while Ikeda et al. found no interaction between GST-
DACHI and EYA1, EYA2, or EYA4 in a similar assay. However, Ikeda and colleagues report
that a DACH/EYA complex is formed in the presence of Creb binding protein (CBP) using co-
immunoprecipitation assays and that the DACH/EYA complex can activate transcription of a
synthetic promoter (Ikeda et al., 2002). These results may reflect differences between the
1DACH1 and DACH2, or between cofactors available in different cell types.
Directed yeast-two-hybrid analysis has twice suggested interactions between the
DachBox-C and the EYA domain (Bui et al., 2000; Chen et al., 1997), but genome wide yeast-
two-hybrid did not observe this interaction (Giot et al., 2003). In Drosophila cell culture, we
found that we could not observe interactions between EYA and DAC, nor did DAC affect EYA-
SO mediated transcription of the reporter ARE-luciferase (Silver et al., 2003). However, we do
observe co-activation properties of DAC with the EYA-SO transcription factor in the context of
a more native reporter (Chapter 4). Taken together, these results suggest that interactions
between EYA and DAC are likely to be dynamic, highly context-dependent, and may be
influenced by extrinsic factors that strengthen or stabilize the complex.
The DACH protein is a novel nuclear factor that has the potential to promote
transactivation of targets (Ikeda et al., 2002; Chapter 4) and to repress them (Li et al., 2002).
The DachBoxN from mouse DACH 1I has been shown to interact with co-repressors such as
Histone Deacetylase 3 (HDAC3) and nuclear receptor corepressor (N-CoR), and this repressor
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complex can be recruited to DNA through DACHI interactions with SIX6 (Li et al., 2002). One
target for repression via this complex is the p27Kip 1 promoter, which must be repressed to allow
mitotic cell division (Li et al., 2002). A similar repressor complex between SIX1 and DACH has
been described, and it has recently been suggested that this complex can switch from repressor to
activator through the function of the EYA protein phosphatase (Li et al., 2003). Our work has
shown a role for DAC in co-activation of EYA-SO mediated regulation of the lozenge eye
enhancer independent of EYA phosphatase function (Chapter 4). It is interesting that we do not
observe DAC co-activation in the same cells when using a reporter gene of seven tandem SO
binding sites, ARE-luciferase (Silver et al., 2003). All of the reported experiments which
observe a DAC/DACH dependent effect on transcription use endogenous promoter sequences
ranging in size from 250 bp- 2.2 kb, raising the intriguing possibility that the DachBox-N must
bind directly to the DNA to play its role in co-regulation of target genes.
EYE DEVELOPMENT REQUIRES THE INTEGRATION OF SIGNALING PATHWAYS
WITH RD GENE NETWORK COMPONENTS
The RD gene network is a group of nuclear transcription factors and co-factors that are
required for eye development and can even induce ectopic eyes when overexpressed in the fly.
Study of these genes and proteins has revealed new paradigms for transcriptional regulation and
a valuable model for organ formation. However these nuclear factors do not act alone, but are
employed coordinately by and with components of conserved signaling pathways to achieve the
specificity necessary to result in appropriate developmental cues.
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Specification of Eye and Head primordia in the Embryo
The beautifully ordered Drosophila adult eye is the end result of many coordinated
signals and processes that begin with the specification of the initial eye primordium in the
embryo. The eye primordium is contained within a dorsal region termed the anterior brain/eye
anlage, where it can be identified by early expression of the RD gene network member SO
(Cheyette et al., 1994; Daniel et al., 1999). This single domain expands as the cells divide until
in Stage 11 I when it is split bilaterally and two presumptive eye fields are observed. This split
requires that RD gene network expression is repressed in the dorsomedial cells to insure the
formation of two discrete eyes, and requires high levels of DPP/TGF[3 signaling (Chang et al.,
2001).
DPP is a secreted molecule that is thought to act in a gradient, with the highest levels of
protein close to where it is expressed and lower levels as the signal travels across cells. Though
high levels of DPP signaling specify non-eye, medium levels of DPP signal are required for eye
formation and induce expression of EYA and SO (Chang et al., 2001). In strong or null dpp
alleles, the head and eye are not formed, while in weak alleles, only the most dorsal structures,
including the head cuticle, are affected, resulting in a cyclopic phenotype (Chang et al., 2001).
Thus two discrete levels of DPP signaling are required for appropriate eye and head formation,
similar to the high and low levels of DPP signaling required in the wing (Lecuit and Cohen,
1998). Through this graded interpretation of the DPP signal, cells can determine their precise
physical location and develop into the appropriate structure, a system that will be redeployed
later in eye development.
Early eye formation also requires signal through the HEDGEHOG (HH) pathway, as hh
is found in a transverse stripe along the posterior of the eye field, and is necessary for expression
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of the RD gene network member ey, but not eya or so (Chang et al., 2001; Suzuki and Saigo,
2000). Consequently, loss of HH signaling is associated with small head structures and absence
of visual structures (Chang et al., 2001; Suzuki and Saigo, 2000), and conversely, ectopic HH
induces cyclopia (Chang et al., 2001). Thus, independent activation of both DPP and HH
signaling must occur together to achieve appropriate expression of multiple RD gene network
members to ensure formation of the eye; EYA and SO induction by DPP, and EY induction by
HH.
Differentiation of the EYE-ANTENNAL disc
After embryogenesis, Drosophila melanogaster embryos hatch into a larval stage, which
is broken up into three instars and lasts approximately six days, after which the larva forms a
pupal case and undergoes metamorphosis before eclosing as an adult fly. During the larval
stages, tissues that will give rise to the adult grow and differentiate in epidermal sacs known as
imaginal discs. One of these discs is derived from the eye anlage described above and is known
as the eye-antennal disc.
Little is known about the steps taken by the eye-antennal discs between embryogenesis
and second instar larval stage beyond cell proliferation. However during the third instar larval
stage, the larval eye-antennal disc begins its final differentiation program. Proper formation of
the adult eye requires a delicate balance of signaling and communication in order to ensure
appropriate size, shape, and place.
One of the earliest decisions to be made in the eye-antennal disc is the separation of this
single epithelium into two discrete primordia; the eye region that will give rise to the eye and the
ocelli, and the antennal region, which gives rise to the antenna and the palpus. Additionally,
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both eye and antennal primordia contribute to formation of specific regions of head cuticle.
Initially, eyeless is expressed throughout the eye-antennal disc; as cell fates are restricted, these
primordia are associated with specific expression of EY in the eye and the marker CUT in the
antenna (Kenyon et al., 2003).
One proposed mechanism for this restriction is a balance of antagonism between EGFR
and NOTCH signaling, where EGFR induces antennal fate by repression of ey, and NOTCH
induces eye fate by repression of the antennal gene dll and activation of ey (Kumar and Moses,
2001). However these studies were performed using eye specific overexpression of dominant
active or negative regulators of the NOTCH and EGFR pathways. Dependence on
overexpression analysis to determine epistatic relationships can be misleading, as high levels of
protein may behave differently than endogenous levels, and appropriate timing may be crucial
for endogenous function.
More recent work using clonal analysis of mutant tissue, as well as temperature sensitive
mutations, reveals that NOTCH is not required for expression of RD gene network members; in
NOTCH mutant tissue ey, eya, and dac expression are unchanged, and the antennal marker dl is
not ectopically expressed (Kenyon et al., 2003). Thus loss of NOTCH signaling does not result
in a fate change from eye to antennal primordia, and it remains to be understood how these
primordia truly are restricted. It remains unclear whether EGFR actually plays a homeotic role
in antennal specification, however it is certain that in both the eye and antennal primordia EGFR
signaling is crucial for cell survival and differentiation, as described below.
Although NOTCH signaling is not required to specify eye fate, it is linked to the
maintenance of that fate. If NOTCH signaling is blocked through expression of dominant
negative ligands, eye tissue is specified and can express EYA normally (Kenyon et al., 2003).
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However this fate is not maintained and EYA expression is soon lost. Tissue without NOTCH
signaling displays clear defects in cell proliferation, leading Kenyon et al. to investigate whether
the loss of EYA expression might be a secondary defect. They found that EYA expression is
tied to cell proliferation, as it can be restored independently of NOTCH signaling via an increase
in cell division (Kenyon et al., 2003). At this stage, a link between EYA expression to cell
proliferation may be a mechanism for checks and balances system between cell number and cell
differentiation.
Thus NOTCH signal is required for maintenance of eye fate through control of
proliferation, and one means by which it signals to the cell proliferation machinery may be
activation of the PAX6-like protein EYG. Evidence for the relationship between NOTCH and
EYG comes from genetic interactions between eyg and members of the NOTCH signaling
pathwayfng, Dl, and NOTCH itself, which suggest a role for eyg as a positive transducer of
NOTCH signaling in the eye (Dominguez et al., 2004). In support of this model, eyg expression
is induced in regions with high levels of NOTCH signaling, and absent in cells that cannot
transduce the NOTCH signal (Dominguez et al., 2004). As discussed earlier, high levels of EYG
can induce cell proliferation (Dominguez et al., 2004), and though it is still unclear exactly how
EYG performs this function, it is likely to act through transcriptional activation or repression of
key cell-cycle regulators.
DPP and HH regulate morphogenetic furrow progression
The eye develops in a wave of differentiation that moves from posterior to anterior and
can be visualized by progression of the morphogenetic furrow. For a review of the
differentiation events following furrow progression see Voas and Rebay, 2004. Our focus will
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be on the establishment and regulation of the furrow itself, which is formed initially at the most
posterior part of the eye disc, and requires the expression of dpp and hh (Figure 3; Curtiss and
Mlodzik, 2000).
It has been suggested that DPP and HH signaling act somewhat redundantly to initiate
and drive morphogenetic furrow progression, as cells that cannot signal through either pathway
never differentiate into photoreceptors, while cells defective for only one signal have defects
which are less penetrant (Curtiss and Mlodzik, 2000). DPP and HH are both secreted factors,
and thus their signal is thought to be received by cells outside the boundaries of their expression
pattern in addition to the cells indicated in Figures 3 and 4, and DPP signaling in particular is
important for establishment of the preproneural region (PPN; Bessa et al., 2002). One
mechanism for both DPP and HH effects on eye specification is through their regulation of RD
gene expression.
dpp transheterozygotes lose expression of RD gene network members eya, so, and dac in
the eye disc (Chen et al., 1999b), although they do not affect eyeless expression (Kenyon et al.,
2003), suggesting that DPP acts downstream of or in parallel to EY to activate expression of RD
genes. More detailed work using somatic clonal analysis revealed that DPP signaling is required
for EYA, SO, and DAC expression only prior to morphogenetic furrow initiation (Curtiss and
Mlodzik, 2000), and that once they are turned on by DPP in the furrow, their expression can be
maintained independently of DPP signaling. The expression patterns of the RD gene network
members in the eye disc is not wholly coincident (Figure 4), suggesting that even those which
can physically interact also play independent roles. EY is expressed in tissue prior to the furrow
(Figure 4D; Bessa et al., 2002)), and EYA is expressed just anterior to the morphogenetic
furrow and in all eye tissue posterior to the furrow (Figure 4A,D), while DAC is expressed in a
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wide stripe centered on the morphogenetic furrow (Figure 4C,D). SO is expressed in all cells in
the eye disc (Figure 4B,D), while another SIX family member, OPTIX, is only expressed in
undifferentiated tissue anterior to the furrow (Figure 4D; Seimiya and Gehring, 2000).
HH signaling plays a key role in formation of the Drosophila eye, and high levels of HH
are expressed just posterior to the DPP signal in the morphogenetic furrow (Figure 4), and are
required for proper furrow progression (Pappu et al., 2003), which occurs through mutual
activation of HH and DPP. Unlike in the embryo, in the eye disc HH is crucial for EYA
expression (Pappu et al., 2003), through what seems to be a permissive mechanism. HH
signaling inside the cell is effected by changes in the transcription factor CUBITUS
INTERRUPTUS (CI); in the absence of signal, CI is cleaved to a shorter repressor form (CIr),
which enters the nucleus and downregulates target genes, while in the presence of signal,
phosphorylation of Cl is blocked, preventing cleavage thus allowing it to remain an activator and
direct transcription of target genes (Chen et al., 1999a). HH's role in regulation of EYA
expression is through elimination of a block to transcription, rather than activation; removal of
CIr is sufficient to promote EYA expression, while CIact is not necessary for eye formation
(Pappu et al., 2003).
The eye field undergoes a wave of differentiation directed by the expression of DPP and
HH at the morphogenetic furrow, which together activate or allow transcription of the second tier
of the RD gene network, EYA, SO, and DAC. These three genes are coincident only at, and just
adjacent to, the morphogenetic furrow (Figure 4), where they and the DPP signal come together
to direct terminal differentiation in the eye. The discrete domains of the eye disc which express
each complement of RD gene network members (Figure 4) undergo quite different
developmental processes; where SO and OPTIX overlap, cells have yet to differentiate, while
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Figure 3: Morphogenetic furrow progression is driven by DPP and HH signals
The eye disc undergoes waves of differentiation as the morphogenetic furrow, driven by
cooperative action of the HH and DPP signaling pathways, moves from the posterior to the anterior
of the eye disc. The most posterior cells have differentiated into the photoreceptor cells, while
anterior cells still proliferate. WG expression in the dorsal and ventral most anterior regions of the
disc prevents eye tissue formation in that region leading to head cuticle formation.
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Figure 4: RD gene network members are expressed in overlapping and distinct domains
in the eye disc
EYA is expressed just before the furrow in the preproneural (PPN) region and in all
differentiated cells after the morphogenetic furrow (MF; A), while SO is expressed in all cells
anterior to the furrow and differentiated cells posterior to the furrow (B). DAC is expressed
in a broad stripe encompassing the furrow and cells on each side (C). The expression pattern
of RD gene network members is depicted schematically in (D), where the eye disc is broken
up into six regions based on the level of differentiation. Lowercase indicates RNA
expression, while uppercase indicates protein localization. EYG is not depicted on this
schematic as it is expressed in a stripe along the Dorsal/Ventral boundary.
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where EY, SO, EYA, and DAC overlap, the neural fate of photoreceptors begins to be specified,
along with other accessory cells. Finally just EYA and SO remain expressed in the differentiated
cells, perhaps playing a role in their survival or function. Further studies of EYA, SO, and DAC,
alone and in combination, should reveal their targets both independently and as a group, yielding
insight as to how this precise program of eye development is orchestrated.
EGFR signaling: Cell survival and differentiation
The EGFR/RAS/MAPK pathway is an important growth and differentiation cue, which
also plays a key role in control of cell survival (Bergmann et al., 2002). In the Drosophila eye,
EGFR signaling is required at a low level in all cells to prevent apoptosis (Bergmann et al.,
2002), but is also used selectively in the process of cellular differentiation. EGFR is required for
morphogenetic furrow initiation but not its propagation (Kumar and Moses, 2001), and is used
reiteratively to specify the fate of every eye cell in waves of differentiation following the
recruitment of the first photoreceptor, R8 (Voas and Rebay, 2004).
Signaling through EGFR leads to activation of the small GTPase RAS, which then
activates the MAPK cascade, which regulates downstream transcription factors and thus effects
transcriptional change in response to receptor activation (Freeman, 1998). The EGFR pathway
provides one of the few direct links between a signaling pathway and regulation of the RD gene
network, where at least some part of the mechanism linking EGFR signaling and the network is
understood. The first hint that EGFR signaling might directly affect RD gene function was the
isolation of mutant alleles of eya in a screen for modifiers of the phenotype produced by eye
specific expression of an activated negative regulator of EGFR signaling, yan"'ct (Rebay et al.,
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2000). Isolation of eya alleles as dominant enhancers of yan "ct suggested a role for EYA in
positive transduction of the EGFR signal.
Further analysis of the interactions of EYA with components of the EGFR signaling
pathway revealed that activation of RAS signaling leads to activation of EYA, through
phosphorylation of EYA by MAPK (Hsiao et al., 2001). More recent work demonstrates that
one effect of MAPK phosphorylation of EYA is to increase the activation potential of the EYA-
SO transcription factor (Silver et al., 2003). This demonstrates a role for EGFR signaling in
modulation of the EYA-SO transcription factor, and may represent a way for EYA to overcome
repression of a target gene or simply to express it to higher levels. The role of MAPK in
regulation of EYA phosphatase activity is not known, and it will be important to ascertain
whether EGFR signaling also affects this function.
Another RD gene member genetically implicated in EGFR pathway function is dac,
which was initially isolated in a screen for dominant modifiers of the dominant active EGFR
allele Ellipse (Elp) (Mardon et al., 1994). While the mechanistic link between DAC and EGFR
signaling remains unclear, mutations in dac suppress the Elp phenotype (Mardon et al., 1994),
suggesting that DAC plays a positive role in transduction of the EGFR signal in the eye. As
DAC is expressed just around the morphogenetic furrow (Figure 4C), perhaps it may function
during EGFR mediated photoreceptor recruitment near the furrow.
In addition to genetic data linking RD gene network members to EGFR signaling,
molecular data has provided clues that link PAX6 family members to this pathway. Early studies
of vertebrate PAX6 indicated that it is phosphorylated on Serine residues (Carriere et al., 1993),
consistent with MAPK phosphorylation. More detailed studies of zebrafish PAX6 reveal a
conserved MAPK phosphorylation site, Serine 413 (Ser413), which is phosphorylated in vitro by
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MAPK family members Extracellular-signal Regulated Kinase (ERK) and p38 and in vivo upon
stimulation of ERK or p38 (Mikkola et al., 1999). Ser4 13 lies within the transactivation domain
of PAX6, and similar to EYA, may be a mechanism to modulate activation levels of PAX6
targets, as mutations mimicking phosphorylation display greater transactivation potential
(Mikkola et al., 1999).
Another RD gene network member regulated via phosphorylation is the so homolog SIXI
(Ford et al., 2000). In this case phosphorylation is tied directly to the cell cycle, as Casein
Kinase II (CKII) phosphorylates SIX1 at the G2/M transition, thereby inhibiting SIX1 DNA
binding ability (Ford et al., 2000). It is worth noting that the SIXi phosphoprotein is less active
than non-phosphorylated SIX1, the opposite effect observed upon phosphorylation of EYA or
PAX6.
It is possible that a complex interplay of cues from both the cell cycle and extracellular
signaling pathways are coordinated through the regulation of distinct members of the RD gene
network, which then, like EYA and SO, interact physically to allow a coordinated response to
both signals. It remains to be determined whether SO is regulated similarly to SIX1, but it is
clearly expressed in cells undergoing coordinated mitosis (Bessa et al., 2002), and is a
phosphoprotein (E. Davies, personal communication). Another interesting aspect is the
interaction observed in the C.elegans interactome between EYA and the regulatory subunit of
CKII, CKII3 (Li et al., 2004), which suggests that EYA might be involved in regulation of SO
phosphorylation. The mechanism by which CKII proteins are regulated is not well understood,
but they are known to be phosphorylated at both serine and tyrosine residues (Litchfield, 2003),
raising the intriguing idea that CKII or CKII3 might serve as a substrate for EYA phosphatase
activity.
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Antagonistic signals determine EYE versus CUTICLE
Opposing signals in the eye primordia distinguish tissue destined to become eye from that
which will become head cuticle. These signals come through the DPP/TGF[ and WINGLESS
(WG) signaling pathways. High levels of DPP at the most posterior of the eye disc repress the
WG signal and allow the formation of the morphogenetic furrow, while WG expression is
highest at the most dorsal and ventral boundaries of the disc (Figure 3), where it inhibits eye
formation (Hazelett et al., 1998). The RD gene network members play important roles in the
specification and maintenance of these expression patterns.
The eye-antennal discs give rise to most of the adult head, including the eye and antenna
as well as head cuticle. The distinction between cells that will go on to form head cuticle versus
those that will contribute to the retina depends upon WG signaling (Royet and Finkelstein,
1997). The WG signaling pathway is active at the most dorsal and ventral parts of the disc,
which will give rise to nonneural head tissue (Figure 3). In the absence of WG signaling, ectopic
morphogenetic furrows form, indicating that WG is necessary to restrict dpp and hh expression
to the most posterior region of the eye disc (Royet and Finkelstein, 1997). In addition, ectopic
expression of RD genes EYA and DAC is observed in the absence of WG signal (Baonza and
Freeman, 2002), indicating that WG signaling represses RD gene expression. It is difficult to
distinguish from this data whether loss of WG signal directly derepresses EYA and DAC, or if
this effect is secondary to the ectopic activity of DPP and HH. However, analysis of
overexpression of WG suggests that it may play a more direct role in RD gene regulation.
Ectopic WG signaling in the eye field leads to inappropriate cell proliferation and lack of
differentiation of eye tissue, resulting in the formation of ectopic head cuticle (Baonza and
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Freeman, 2002; Royet and Finkelstein, 1997) as well as leg or antenna-like structure (Baonza
and Freeman, 2002), indicating the loss of eye fate specification. Although eye formation is
prevented by ectopic WG signaling, the expression of EYELESS is unchanged (Baonza and
Freeman, 2002), suggesting that this block occurs either at the level of EY protein function, or
through downstream components necessary for eye formation.
Consistent with either of these mechanisms, the expression of EYA, SO, and DAC are
downregulated upon ectopic WG pathway activation (Baonza and Freeman, 2002).
Downregulation of DAC is likely to be a key step in formation of head cuticle, as in DAC mutant
tissue, head cuticle can be formed rather than eye (Mardon et al., 1994). Arguing against
repression of DPP signaling as an indirect mechanism for WG downregulation of RD genes,
epistasis analysis shows that WG mediated repression cannot be overcome by activation of
I)Pl/'TGF3 signaling (Hazelett et al., 1998).
However, blocks in transcription of RD gene network members are not solely responsible
for WG mediated repression of eye formation, as ectopic expression of EYA, which induces SO
and DAC, cannot rescue this phenotype (Baonza and Freeman, 2002). Thus in tissue with high
levels of WG signal, EYA, SO, and DAC are not sufficient to direct eye formation. This
suggests that WG signaling may have posttranslational effects on RD gene network function, or
may affect unknown factors that act in parallel to the RD gene network.
The opposing roles of DPP and WG signaling in eye development are redeployed in other
tissues during ectopic eye induction. DPP appears to play a permissive role in ectopic eye
induction; overexpression of RD gene network members promotes eye specification only in
regions where DPP signaling is present (Chen et al., 1999b). Moreover, WG signaling can
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restrict ectopic eye induction, limiting the potential of EY to induce eye tissue in the wing disc
(Halder et al., 1998).
Eye and head development must be regulated spatially to determine the primordia of
these structures, but also must be regulated temporally to allow for the appropriate order of cell
differentiation. Initial differentiation of eye tissue is initiated by DPP signaling, but then EGFR
signaling is required for photoreceptor recruitment. As discussed above, epistasis analysis shows
that WG mediated repression occurs downstream of DPP (Hazelett et al., 1998), but it has also
been placed upstream of EGFR, as it can be suppressed by activation of the EGFR/RAS pathway
(Hazelett et al., 1998). Therefore one effect of WG signaling may be to block EGFR activation,
which as discussed above, may also result in lower posttranslational activity of RD gene network
members, particularly EYA, DAC, and EY.
WG repression of RD gene network components explains their absence in WG
expression domains, but does not explain how WG expression is itself limited to the most lateral
regions of the eye disc. One potential mechanism for this limit is through EYG control of wg
expression (Hazelett et al., 1998; Jang et al., 2003), as WG expression is upregulated in eyg
mutants and downregulated upon EYG overexpression. Support for this model comes from
epistasis analyses where defects in eyg mutant eye discs can be suppressed by inactivation of the
WG pathway (Hazelett et al., 1998). Thus EYG activates growth, and represses WG, creating a
doubly permissive environment for RD gene expression and function. One way to test whether
EYG limits WG mediated repression of eye formation is by using ectopic eye formation assays.
Analysis of where ectopic eyes are formed after coexpression of EYG with EYA might reveal a
combinatorial code that can direct eye formation contexts where EYA alone is not sufficient.
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This antagonistic relationship between RD gene network members and WG signaling
may be conserved in vertebrates. Evidence from studies of SIX3 in the brain show that loss of
SIX3 is associated with posteriorization of the brain, and further analysis suggests that the role of
SIX3 in anterior-posterior specification of the brain is to repress WNT expression (Lagutin et al.,
2003). It remains to be explored whether OPTIX behaves in a similar manner in Drosophila, or
whether PAX6(5A) plays a role in WNT repression in vertebrates.
The RD gene network members are expressed in dynamic temporal and spatial patterns in
the eye, where they are likely to interact with each other and with other co-factors to regulate
transcription of appropriate target genes. Although the RD genes are required for eye
development, and misexpression outside of the normal eye field can induce ectopic eye
specification, overexpression in the eye itself results in small eyes (Curtiss and Mlodzik, 2000;
Hsiao et al., 2001), which may be due to apoptosis (S.J.S. and I.R., unpublished observation).
Thus inappropriate expression can have deleterious effects on the same organ that requires these
proteins at endogenous activity levels. Endogenous control of RD genes is maintained through
interactions with balanced signal networks at the level of both transcriptional and post-
translational regulation, elaborate regulatory networks which are just beginning to be understood
and will require much future work to reveal the full complement of regulation.
The RD gene network is deployed in the development of multiple organs
While the RD gene network has been best characterized for its role in eye development,
insight into its regulation and function has been gained from study of other organs and
appendages. In particular, study of RD gene network function in other organs illustrates the
context specificity inherent in the interactions between extracellular signaling pathways and the
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RD gene network. There are four major organ systems where this has been well studied; in
vertebrates, the RD gene network plays important roles in muscle development (Heanue et al.,
1999), and some members were independently identified in that context (Kawakami et al., 2000).
In Drosophila, DAC plays key roles in formation of the proximodistal axis of the leg (Mardon et
al., 1994), while multiple members of the network, including EYA, SO, and DAC play critical
and context specific roles in gonad development (Bai and Montell, 2002; Bonini et al., 1998;
Fabrizio et al., 2003; Keisman and Baker, 2001).
RD genes can direct muscle specification
In early muscle development, the expression of PAX3, a protein related to PAX6 but not
orthologous to EY, overlaps with that of DACH2, a DAC homolog, and their expression is
mutually regulated through positive feedback loops (Heanue et al., 1999) similar to those
observed between EY and DAC during Drosophila eye development (Shen and Mardon, 1997).
Slightly later during development, other RD gene network members EYA2 and SIX1 are
expressed, so that all four components have overlapping expression in the dorsal somite prior to
differentiation of skeletal muscle (Heanue et al., 1999).
Strikingly, when these genes are misexpressed in combination in cell culture, EYA2 and
SIXI, as well as EYA2 and DACH2, can synergize to direct the expression of muscle markers
indicative of myogenic differentiation, including PAX3 (Heanue et al., 1999). This is similar to
the synergism observed between EYA and SO, and EYA and DAC in ectopic eye induction upon
overexpression in Drosophila, and indicates that the interactions between these proteins may
play conserved roles in the development of multiple organ types in addition to the eye.
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DAC is negatively regulated by EGFR signaling in the leg
DAC earned its gene name for the severe leg defects observed in homozygotes, giving
them "dachshund" like proportions of large body and small legs (Mardon et al., 1994). As might
be expected given this phenotype, DAC expression must be carefully regulated in the larval leg
disc, which will give rise to the adult leg, to allow proper leg development. DAC expression is
activated in the leg disc in response to the combined signals of DPP and WG at distinct spatially
graded levels of both signals (Lecuit and Cohen, 1997).
DAC is necessary for the formation of proximal structures in the leg, while a gradient of
EGFR signaling is required for and can induce the formation of the most distal structures, the
tarsus and claw (Campbell, 2002). Analysis of temperature sensitive alleles of EGFR in addition
to clonal analysis, reveals cell autonomous repression of DAC by this signaling pathway, where
loss of EGFR results in ectopic DAC expression (Campbell, 2002). The relationships between
DAC and these signaling pathways in the leg are distinct from the relationships observed in the
eye, where DPP and EGFR both act positively and WG negatively regulates DAC expression
(Figure 5). In contrast, in the leg DAC is regulated positively by DPP and WG and negatively by
EGFR (Figure 5). It is not clear mechanistically how these signals are interpreted in a context
specific manner, but context represents an important aspect of RD gene network regulation that
requires more intense study. Another example of these context specific interactions between
D)AC and WG signaling is observed in the gonad.
Sex-specific regulation of RD gene network members
Many patterning genes are expressed in homologous patterns in both male and female
genital discs, including the morphogens DPP and WG. In both males and females, wg
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expression is found in a stripe along the anterior posterior border, and is flanked by broad stripes
of dpp expression (Keisman and Baker, 2001). Other genes, including RD member dac
(Keisman and Baker, 2001) are expressed in a sex-specific manner.
In males, DAC expression is seen overlapping the dpp stripes, while in females DAC
expression is observed overlapping the central wg expression domain (Keisman and Baker,
2001). DAC function is important for the proper development of both male and female genitalia,
as males lacking DAC have reduced claspers and females lacking DAC have defects in duct
formation (Keisman and Baker, 2001).
WG is required to activate DAC expression in the leg (Lecuit and Cohen, 1997), and
similarly, is required to activate DAC in the female genital discs (Figure 5; Keisman and Baker,
2001). Strikingly, the opposite effect is observed in male genital discs, where WG appears to
restrict DAC expression (Keisman and Baker, 2001), similar to WG repression of DAC in the
eye (Figure 5). The converse is observed for DPP signaling, which activates DAC expression in
male genital discs, but represses expression in female genital discs (Keisman and Baker, 2001),
while in the eye and leg DPP plays only a positive role in DAC regulation (Figure 5).
This sex-specific regulation of DAC is likely mediated by components of the sex-
determination pathway doublesex and transformer (Keisman and Baker, 2001). However it
remains unclear just how the sex of this tissue determines DAC responsiveness to WG and DPP
signaling, and it is intriguing to ask whether the specificity observed in sex determined
expression uses a similar mechanism to determine appropriate DAC response as does the eye and
leg. This provides an example of the importance of context, which is observed again and again
to be crucial for the function of RD gene network members, and is outlined in Figure 5.
54
In the eye:
bPP
HH
EGFR
NOTCH
WG
In the
DPP
WG
EGFR
In the
DPP
WG
In the
DPP
WG
-- EYA, SO,
- EYA
DAC
EYA, DAC
+ EYG
EA, SO, AC
leg:
-.
1
DAC
DAC
DAC
female gonad:
-I DAC
' AC
male gonad:
t DAC
I bAC
In the somadic gonadal precursors (SGPs):
DPP -- P. EYA
WG ' EYA
In the ovarian follicle cells:
HH I EYANOTCH I EYA
Figure 5: The relationship between signaling pathways and the RD gene network is
highly context dependent. Positive interactions shown in green, negative in red.

EYA is a crucial determinant for somatic gonadal precursor cells
EYA also plays a role in both female and male fertility; hypomorphic alleles that survive
to adulthood are sterile in addition to defects such as small eyes (Boyle et al., 1997; Fabrizio et
al., 2003). EYA is expressed in the somatic gonadal precursor (SGP) cells, cells that associate
with the germ cells and insure proper incorporation of the germ cells into the gonad (Boyle et al.,
1997). In eya mutants, the SGP cells develop but do not maintain their fate and thus do not
coalesce around the germ cells (Boyle et al., 1997). EYA may work downstream of the WG
signaling pathway, which is also required for SGP formation, as ectopic activation of WG
signaling leads to ectopic EYA and the recruitment of extra SGPs (Boyle et al., 1997). Here,
WG plays a positive role in EYA regulation, while in the eye WG and EYA are antagonists.
In contrast, DPP and EYA retain their positive relationship from the eye. DPP signaling
is crucial for EYA expression and the formation of SGPs through the activation of a secondary
regulator, in this case tinman (Boyle et al., 1997). Thus context once again determines the
direction of interaction between signaling pathways and the RD gene network, where here WG
and DPP together activate EYA in contrast with their opposing functions in the eye (Figure 5).
EYA plays a SO independent role in oogenesis
In addition to patterning roles early in gonad formation, EYA function is required during
oogenesis, in the somatic tissue crucial for proper germ cell development and function. There
are three types of somatic follicle cells that surround the oocyte during oogenesis; polar cells,
stalk cells, and main body epithelial cells. Polar cells are found at the anterior of the egg
chamber, and recruit border cells to surround them and facilitate movement through the nurse
cells to the anterior of the oocyte, where they develop into the micropyle, the organ that allows
57
sperm to enter the oocyte. In ovaries mutant for EYA, extra polar cells are observed, a
phenotype similar to that observed upon ectopic activation of the HH signaling pathway (Bai and
Montell, 2002). Conversely ectopic expression of EYA prevents specification of polar cells (Bai
and Montell, 2002).
These results suggest an antagonistic link between HH and EYA, which is supported by
loss of EYA in follicle cells upon HH pathway activation (Bai and Montell, 2002). As discussed
above, the HH signal is transduced by the full length form of CI, Clact, which in the absence of
signaling is processed to a shorter repressor form, CIR. In EYA mutant cells, higher levels of
CIact are present (Bai and Montell, 2002), suggesting a mutually repressive relationship between
HH signaling and EYA in the differentiation of ovarian follicle cells.
Another signaling pathway associated with the proper formation of polar cells is the
NOTCH pathway, which like HH is required for polar cell formation. Ectopic NOTCH signaling
can induce the formation of ectopic polar cells in a non-cell autonomous manner which includes
downregulation of EYA expression (Bai and Montell, 2002), although the mechanisms behind
NOTCH and HH mediated repression of EYA remain to be determined. Both NOTCH and HH
here function antagonistically to EYA, unlike their positive or at least permissive effects on EYA
in the eye (Figure 5), suggesting that there is some key tissue specific difference which changes
the way these signals interact with the RD gene network.
Oogenesis also provides an example of independent roles for EYA and SO. SO is not
expressed in polar cells, where EYA seems to act alone. Instead, SO plays a role in development
of a different type of follicle cell, the stalk cell, and is required for the specification of that cell
type without help from EYA (Bai and Montell, 2002).
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In contrast, spermocyte development may require the EYA-SO complex, as they are both
required in the somatic cyst cells for proper spermocyte development, and genetic interactions
between the two are observed in this tissue (Fabrizio et al., 2003). This suggests that in
spermatogenesis, the EYA-SO complex may act to direct transcription of target genes, while in
the oocytes EYA may complex with different DNA binding proteins or may only function as a
protein phosphatase. SO may interact with other co-activators in the stalk cells, or may play its
role there through transcriptional repression. It will be interesting to determine how the
transcriptional targets of the EYA-SO complex might be different in these distinct contexts.
Concluding Remarks
The RD gene network provides a sensitive model for signal integration whose study may
give insight into the broader questions of signal specificity in different developmental contexts.
Formation of organs requires coordination of cell division and cell differentiation to insure
appropriate size and organization. Signal integration between the RD gene networks and
signaling pathways provides a mechanism to link differentiation and cell division such that
differentiation does not occur before appropriate cell division takes place. Moreover the
signaling back and forth between the RD gene network and signaling pathways provides a model
for study of context specificity in activity and regulation, where identification of co-factors and
targets may elucidate the mechanisms for this specificity.
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Abstract
The Retinal Determination (RD) gene network encodes a group of transcription factors and
cofactors necessary for eye development. Transcriptional and post-translational regulation of RD
family members is achieved through interactions within the network and with extracellular
signaling pathways, including Epidermal Growth Factor Receptor/RAS/MAPK, Transforming
Growth Factor-f/DPP, Wingless, Hedgehog, and Notch. Here we present the results of structure-
function analyses that reveal novel aspects of Eyes absent (EYA) function and regulation. We
find that the conserved C-terminal EYA domain negatively regulates EYA transactivation
potential, and that GROUCHO-SINE OCULIS (SO) interactions provide another mechanism for
negative regulation of EYA-SO target genes. We have mapped the transactivation potential of
EYA to an internal P/S/T-rich region that includes the EYA domain 2 (ED2) and two MAPK
phosphorylation consensus sites, and demonstrate that activation of the RAS/MAPK pathway
potentiates transcriptional output of EYA and the EYA-SO complex in certain contexts.
Drosophila S2 cell two-hybrid assays were used to describe a novel homotypic interaction that is
mediated by EYA's N-terminus. Our data suggest that EYA requires homo- and hetero-typic
interactions and RAS/MAPK signaling responsiveness to ensure context appropriate RD gene
network activity.
78
Introduction
Proper development of an organism requires a formidable amount of cell-cell
communication, wherein successful information transfer is effected by signaling cascades that
ultimately alter the gene expression profile of a cell. Additionally, cells must integrate signals
firom multiple pathways to coordinate morphogenesis and differentiation in a spatially and
temporally appropriate manner. Examples of this combinatorial control paradigm have been
elucidated using the Drosophila eye as a model system, and have demonstrated that unique
combinations of general and tissue-specific transcription factors are required to specify and
maintain distinct cell fates (Flores et al., 2000; Halfon et al., 2000; Xu et al., 2000).
Components of the retinal determination (RD) gene network, which includes twin-of-
eyeless (toy), eyeless (ey), eyes absent (eya), sine oculis (so), and dachshund (dac), are essential
for eye fate specification in metazoans. The RD gene network collectively encodes a cohort of
nuclear transcription factors and/or cofactors whose expression is regulated by a conserved
hierarchy of transcriptional regulation, such that TOY activates ey expression, EY induces so and
e)a, and EYA turns on dac (Chen et al., 1997). In addition to assuming pivotal roles during
visual system development, the RD genes function in a variety of other contexts, including
gonadogenesis (Bai and Montell, 2002), myogenesis (Heanue et al., 1999), limb formation
(Galindo et al., 2002; Xu et al., 1997a), neurogenesis (Li et al., 2002), and the cell cycle (Kurusu
et al., 2000). Consequently, null mutations are lethal and exhibit complex phenotypes that are
reflective of the pleiotropic roles assumed by RD network proteins during development (Bonini
et al., 1998; Cheyette et al., 1994; Kronhamn et al., 2002; Mardon et al., 1994). Additionally, the
expression patterns of the RD genes are not wholly coincident (Bessa et al., 2002), suggesting
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that reiterative deployment of the entire RD network module is not obligatory for the function of
specific RD network proteins.
Much analysis of RD gene function and regulation has focused on the visual system,
particularly in Drosophila, where gene activity can be manipulated without compromising
viability or fertility of the animal. RD genes are best known for the "eyeless" phenotype
associated with eye-specific hypomorphic mutations, and for the ability to induce formation of
ectopic eye tissue upon overexpression (Bonini et al., 1997; Chen et al., 1997; Czerny et al.,
1999; Halder et al., 1998; Pignoni et al., 1997; Shen and Mardon, 1997). Use of these two assays
has revealed a complex system of positive feedback loops superimposed on the defined linear
hierarchy of transcriptional regulation, which most likely amplifies and stabilizes expression of
the RD gene products.
eya is the founding member of a novel gene family characterized by a highly conserved
C-terminal motif that contains both SO (31) and DAC (9) binding sites, termed the EYA domain
(ED; a.a. 486-760; Figure IA). Vertebrate homologs, such as murine EYA1-4, are strikingly
similar in their EYA Domain, yet their N-termini, with the exception of a small tyrosine rich
region, the EYA Domain 2 (ED2; Figure 1A), are largely divergent (Xu et al., 1997b;
Zimmerman et al., 1997). so, and vertebrate Six family genes, encode nuclear proteins with a
homeobox type DNA binding domain and the conserved SIX domain (Kawakami et al., 2000).
The latter is an important mediator of EYA-SO interactions (Pignoni et al., 1997). DAC, a novel
nuclear protein, and its vertebrate DACH counterparts, contain two regions of high homology,
the DACH-box-N and the DACH-box-C (Mardon et al., 1994). Like SO, DAC has been shown
to physically interact with the EYA Domain, via the DACH-box-C (Heanue et al., 1999).
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Analysis of loss-of-function eya mutants in Drosophila and in human patients suffering
from Branchio-oto-renal (BOR) syndrome underscores the importance of EYA-SO and/or EYA-
DAC interactions in vivo. BOR syndrome, a disease characterized by craniofacial, ear, and
kidney defects, arises from mutations in the human Eyal gene (Abdelhak et al., 1997; Bui et al.,
2000). In Drosophila, point mutations in the conserved EYA domain (ED) appear to cause loss-
of-function phenotypes by impairing EYA's ability to interact with SO and DAC (Bui et al.,
2000). Similarly, a recent study has shown that human BOR alleles that map to the EYA domain
also have impaired interactions with SIX and DACH family members, emphasizing the
evolutionarily conserved importance of interactions between these three RD family members in
vivo (Ozaki et al., 2002).
The combined physical interaction, colocalization, and genetic data have led to a model
whereby EYA and SO together constitute a functional transcription factor, with EYA providing
the activation domain and SO contributing the DNA binding moiety. Consistent with this, in
mammalian cell culture, SIX2, SIX4 and SIX5 are able to synergize with EYA to drive
expression from a reporter construct (Ohto et al., 1999). The functional consequences of EYA-
DAC interactions remain less well understood. Although initial characterization of Drosophila
&da and its vertebrate counterparts, Dachl and Dach2, failed to identify a DNA binding domain,
it has been postulated that the DACH-box-N may encode a novel DNA binding motif similar to
the winged helix/forkhead subgroup (Kim et al., 2002). Thus, like SO, DAC may play a role in
recruiting EYA to the promoters of target genes (Ikeda et al., 2002).
In addition to the complex interactions observed within the RD gene network, numerous
signaling pathways, including Epidermal Growth Factor Receptor (EGFR)/RAS/MAPK (Hsiao
et al., 2001), Transforming Growth Factor-P (TGFO)/Dpp (Chen et al., 1999; Pignoni and
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Zipursky, 1997), Wingless (Baonza and Freeman, 2002), Hedgehog (Curtiss and Mlodzik, 2000),
and Notch (Bai and Montell, 2002; Kumar and Moses, 2001) have been shown to interact
genetically with members of the RD network. However, with the exception of the EGFR
pathway (Hsiao et al., 2001), little is known about how extracellular signaling pathways regulate
RD gene expression and/or activity.
In order to better understand RD gene network regulation, we have performed an
extensive structure-function analysis of the EYA protein. Using a series of Drosophila S2 cell
based transcriptional activation assays, we have defined a P/S/T rich region of EYA,
encompassing both the MAPK phosphorylation consensus sites and the tyrosine-rich ED2, that is
necessary for EYA transactivation potential in cell culture and for ectopic eye induction ability in
vivo. We demonstrate that RAS/MAPK signaling can positively regulate EYA transactivation,
and that GROUCHO is a potent repressor of EYA-SO mediated transcription through its
interactions with SO. Finally we show that EYA is able to self-associate, adding yet another
layer of functional complexity to the elaborate hierarchy of interactions that exists among the RD
gene products.
Materials and Methods
Construction of Transactivation Assay expression plasmids
pUAST-luciferase was constructed by amplifying the luciferase cDNA from pGL31uc (Promega)
with primers LUCI, 5'-TTGGAATTCCAACATGGAAGACGCCAAAAAC-3,' and LUC2: 5'
TTGGGTACCTTACACGGCGATCTTTCCGC-3', digesting with EcoRI and KpnI, and
inserting into the EcoRI/Kpnl sites of pUAST. All eya constructs were made using the eyal
cDNA. pRmHa3-Gal4DBD-eyawt, S-A, and S-D/E full length fusion constructs have a similar
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design. The MAPK consensus sequence is defined as P-X-S/T-P, and Drosophila eya contains
two adjacent phosphorylation sites at amino acids S402 and S407. The construct referred to as
pRmHa3Gal4DBD-eyaS-A contains two S-A point mutations in place of the phosphoacceptor
residues, and conversely the pRmHa3-Gal4DBD-eyaS-D/E construct contains S-D and S-E point
mutations at these sites. A three-piece ligation was performed to insert a 660 bp, N-terminal eya
PCR amplified fragment and a 1.6 kb, C-terminal eya restriction fragment containing either
wildtype or mutated MAPK sites into pRmHa3-Gal4DBD, cut with KpnI and Sall. The N-
terminal PCR product was generated using primers EYAI, 5'-tgggtaccttgtataatgtgccgtgctatc-3,'
and EYA2, 5'-cgaagagttgaccgccactg-3,' and was digested with KpnI and BamHl. BamHI-Sall
restriction fragments from pRmHa3-eya, pRmHa3-eyaS-A, and pRmHa3-eyaD/E (these
constructs described previously in (Hsiao et al., 2001)) were then combined with the digested eya
PCR product in a ligation with pRmHa3-Gal4DBD, cut with Kpnl and Sall.
Similarly, three truncated pRmHa3-Gal4DBD-eya constructs that lack the conserved EYA
domain (amino acids 486-760) were made containing each of the MAPK site variants described
above. Primers EYA1 and EYA3, 5'-TTGGTCGACTTACACACTGCTGCCTCCGCTC -3,'
were used to amplify a 1.3 kB product from a pRmHa3-eya, pRmHa3-eyasA, or pRmHa3-eyaD/E
template. PCR products were digested with KpnI and SalIl, and ligated into the pRmHa3-
Gal4DBD vector. A construct encoding the first 353 amino acids of EYA, including the N-
terminal portion of the P/S/T-rich region, was also generated. This construct, pRmHa3-
Gal4DBD-eya 1-353, was generated using primers EYAl and EYA1545A, 5'-TTGGTCGACG
TAGTTGGCCGGACTGTA-3'. The 920 bp PCR product and pRmHa3-Gal4DBD were digested
with Kpnl and SalI, and ligated directionally. An internal deletion construct that lacks the entire
P/S/T-rich region, pRmHa3-Gal4DBD-eya A223-438, was made by inserting an annealed,
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double-stranded linker with 5' BamHl and 3' KpnI sticky ends into pRmHa3-myc-eya, cut with
the aforementioned enzymes. Primers EYAD , 5'-GATCCATTTTGTACGGTACC-3,' and
EYAD2, 5'-CGTACAAAATG-3,' were annealed and used in the directional ligation described
above to generate pRmHa3-myc-eya A223-438. pRmHa3-Gal4DBD-eya A223-438 resulted from
a two piece ligation between pRmHa3-Gal4DBD-eya, cut with BamHI and SalI, and a
complementary restriction fragment from pRmHa3-myc-eya A223-438. A construct encoding a
truncated EYA in which the ED2 domain (amino acids 318-353) is also deleted, pRmHa3-
Gal4DBD-eya AED2 AED, was made using the Stratagene Quikchange site-directed mutagenesis
protocol. Primers dEya 1351/1455 (S), 5'-
CAGCTGTACAGCAGTCCGTCACCGTATGCGGTCAGC3,' and dEyal351/1455(A), 5'-
GCTGACCGCATACG GTGACGGACTGCTGTACAGCTG-3,' were used to generate pBSSK-
eya AED2. A 600 bp BamHI-SacII eya AED2 fragment was then shuttled into the truncated
pRmHa3-Gal4DBD-eya construct in a directional ligation. pRmHa3-Gal4DBD-eya 318-436 was
made using primers KpnI-EYA D2 (S), 5'-TTGGGTACCTACGCCGGCTACAACAACTTC-3,'
and EYA3 to amplify a 350 bp product. The PCR product and pRmHa3-Gal4DBD were digested
with KpnI and Sall, and used in two-piece ligations.
Development of S2 Cell 2-Hybrid (S2-2H) Assay
A vector containing the DNA binding domain of yeast Gal4 (a.a. 1-147), pRMHa3-Gal4DBD,
was constructed as follows. Gal4DBD was amplified from pCasperUbGal4 using primers 5'-
TGGAATTCCAACATGAAGCTACTGTCTTCTATCG-3' and 5'-
TGGGTACCCGATACAGTCAACTGTCTTTG-3', which contain 5' and 3' EcoRI and KpnI
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sites, respectively. The digested PCR product was ligated into pRmHa3, a pUC9-derived vector
containing a metallothionein responsive promoter upstream of the Multiple Cloning Site (MCS).
pRmHa3-Gal4AD was made by amplification of the Gal4 activation domain (a.a. 768-874) from
pCasperUbGal4 via PCR with primers Gal4AD S2302 5'-
TGGAATTCCAACATGGCCAATTTTAATCAAAGTG-3' and Gal4AD A2673 5'-
TTGGTACCGTATCTTCATCATCGAATAGA-3', cut with EcoRI and Kpnl, and inserted into
pRmHa3. To ensure nuclear expression of these constructs, an NLS was added using these two
oligos, Gal4AD NLS S-50 5'-
TGTGACCCCCCCCAAGAAGAAGCGCAAGGTGGAGGACGATGGTAC-3' and Gal4 AD
NLS A-54 5'-CATCGTCCTCCACCTTGCGCTTCTTCTTGGGGGGGGTCACAGTAC-3'.
Oligos were annealed and then ligated into the Kpnl site of the pRmHa3-Gal4AD to make
pRMHa3-Gal4AD-NLS, which we refer to as pRMHa3-Gal4AD. pRmHa3-Gal4AD-eya resulted
from a three-piece ligation using Kpnl-BamHl eya and BamHI-Sall eya restriction fragments,
and pRmHa3-Gal4AD cut with KpnI and SalI. Primers SoS4 5'-
TTGGTACCTTACAGCATCCCGCCACAG-3' and So1234 5'-
TTG(GTCGACTCATAAGTGCTGGTACTC-3' were used to amplify full length so cDNA from
pBSSK so (gift of G. Mardon), with unique 5' KpnI and 3'SalI cut sites. The digested PCR
product was inserted into pRmHa3-Gal4DBD in a directional, two piece ligation to make
pRmHa3-Gal4DBD-so. To make pRmHa3-Gal4AD-so, so was cut out of pRmHa3-GaI4DBD-so
with Kpnl and SalIl inserted into pRmHa3-GaI4AD cut with the same enzymes. To make dac
constructs, DacS622 5'-TTGGTACCGATTCTGTGACAAGTGAAC-3' and DacA1370 5 '-AAG
1TGCTTCAGGAAGAGCTCG-3' primers were used to amplify the 5' region of dac from
pBSSK-dac (gift of G. Mardon), adding a 5'Kpnl site. The PCR product was cut with Kpn I and
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Stu I, which is found internally in the amplified dac fragment. A three-piece ligation was
performed using Kpnl/StuI 5 'dac and a Stul/Sall restriction of fragment from pBSSK-dac, into
the KpnI/SalI sites in pRmHa3-Gal4DBD. For the AD construct, full length dac was cut out of
pRmHa3-Gal4DBD-dac with Kpnl and SalIl and ligated into those sites in pRmHa3-Gal4AD to
create pRmHa3-Gal4AD-dac. For pRmHa3-Gal4DBD-eya AD2, the N-terminal eya AD2
construct described above was shuttled into full length pRmHa3-Gal4DBD-eya using BamHI
and Sacll. For pRmHa3-GaI4DBD-eya domain, the eya domain was PCR amplified using
primers EYADS 5'-TTGGGTACCGAACGGGTGTTCGTCTGG-3'
and EYA DA 5'-TTGGGATCCTCATAAGAAGCCCATGTC-3', which contain KpnI and
BamHI sites used to clone into the pRmHa3-Gal4DBD vector.
Construction of Transcription Assay expression plasmids
To construct ARE-luciferase, luciferase cDNA was isolated as an XhoI/Xbal fragment (-1.6Kb)
from Promega's pGL3-Luciferase, and inserted into XhoI/XbaI sites of pBluescript-SK+. To add
the hsp70 TATA box, oligos EBS link 1 5'-CCATATGATCTGCAGAGGGTATATAATGC-3'
and EBS link 2 5'-TCGAGCATTATATACCCTCTGCAGATCATATGGGTAC-3' were
annealed and inserted into the Kpnl/XholI sites of pBSSK-luciferase. KpnI and XhoI sites were
retained and Ndel and Pstl sites and a TATA box were inserted. ARE-luciferase was made by
multimerizing the AREC3 (SIX4) binding site, as defined in (Kawakami et al., 1996) using
oligos ARES 5'-TCGAGGGTGTCAGGTTGCG-3' and AREA 5'-
TCGACGCAACCTGACACCC-3'. Oligos were annealed and ligated, then cut with Xhol and
SalI A resultant 7mer was cloned into the MCS of pBSSK, and then shuttled into pBSSK-TA TA-
luciferase. To make pRmHa3-flag-eya, full length eyal cDNA was PCR amplified using primers
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EYAI 5397 5'-TTGTATAATGTGCCGTCGTATC-3' and EYA STOP 5'-
TT'TCATAAGAAGCCCATGTCGAGG-3' and then digested with SmaI which cuts the eya
cDNA internally. The 0.7 kb blunt/SmaI fragment was inserted into Smal cut pBSSK + Flag
vector (gift from R. Fehon) to produce an in-frame fusion of the FLAG epitope with the 2nd
amino acid of EYA. A three piece ligation was done to join the 5' end offlag-eya, obtained as a
Sacl/SmaI fragment from pBSSK-flag-eya, with the 3' end of eya, (obtained from pRMHa3-eya)
as a SmaI/SalIl fragment. These were inserted into SacI/SalI cut pRMHa3. Similarly, pBSSK-
mnyc-eya was generated by PCR amplification using primers EYAI and EYA STOP, and blunt
ligated into the StuI site of pBSSKmyc. A three piece ligation between the EcoRI/BamHI
fragment from pBSSK-myc-eya, and BamHi and SalI from pRmHa3-eya, into the EcoRI and
Sall sites of pRMHa3, resulted in pRMHa3-myc-eya. In order to construct pRMHa3-dac, first a
Clal fragment was cut out of pBSSK-dac (gift from G. Mardon) and cloned into pBSSK to
remove most of the large 5'UTR (Cla-dac). A 3' fragment was cloned into pBSSK using BamHI
and HindIllI sites (HI/HIII-dac). A full length construct was made by four piece ligation with
EcoRI-Stul from Cla-dac plus Stul-BamHI fragment from pBSSK-dac plus BamHI-XhoI
fragment from HI/HIII-dac into the EcoRI/XhoI sites of pUAST. The entire full length dac
cDNA including approximately 45 bp of the 5'UTR and 245 bp of the 3'UTR was then excised
with EcoRI and XhoI and ligated into the EcoRI/Sall sites of pRMHa3. pRMHa3-myc-so was
generated by PCR amplification of full length so cDNA using primers So S805 5'-
TTACAGCATCCCGCCACAGAT-3' and So A2268 5'-AACTAGAATCATAAGTGCTGG-3',
and blunt end ligated into the Stul site of pBSSK-myc, resulting in an in-frame fusion of the
MYC epitope to the 2 nd amino acid of SO. This was moved into pUAST using EcoRI and Xbal .
To move the full length tagged so into pRMHa3, myc-so was cut out of pUAST-myc-so with
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XbaI, blunted with Klenow, then digested with EcoRI and subcloned into EcoRI-Smal sites of
pRMHa3. A full-length groucho expression construct, pMT-GROUCHO, was generated by PCR
amplifying the N-terminus of Groucho, using the groucho cDNA clone LD33829 as template
and primers Groucho-start 5'-ATGAATTCAACAACATGTATCCCTCACCGG-3' and
Groucho-A879 5'-TGTGCGATACTTCTCACGATCGG-3', digesting with EcoRI and XbaI, and
ligating with an XbaI/XhoI fragment from LD33829 into EcoRI/SalI cut pRMHa-3.
All regions generated by PCR were verified by sequencing, and all constructs were tested for
expression and localization in S2 cells by immunohistochemistry. Further subcloning details
available upon request.
Co-immunoprecipitation and Western Blots
Transfected cells were harvested, then lysed by rocking at 40 C for 20 minutes in 1 ml of lysis
buffer (100 mM NaCI; 50 mM Tris, pH7.5; 2 mM EDTA; 2 mM EGTA; 1% NP-40 + one
Complete, Mini protease inhibitor cocktail tablet(Roche)/10 ml). Clarified lysates were subjected
to immunoprecipitation with anti-flag conjugated agarose beads (Sigma) for 1.5. hours at 4°C.
Beads were washed 3X with lysis buffer. The immunoprecipitates were boiled in 40 gl of 2x
SDS buffer, and western blotting was carried out as previously described (O'Neill et al., 1994)
(mouse oc-myc (1:300), mouse ot-GRO (1:50), Rb (o-flag (1:5000).
For western blots to analyze protein levels, half of the transfected cells were lysed as described
below for [3-galactosidase assays, and the other half were pelleted, vortexed briefly, and
resuspended in 40ul 2X SDS buffer. Transfection efficiency was measured by gal assays and
appropriate amounts of crude lysate were run on the gel. Efficiency was confirmed by western
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blotting for 3gal (Rb anti-f3gal, 1:20,000). Protein levels were examined with GP u-EYA
(1:10000), mouse c-myc (1:300), and Rb cx-flag (1:5000).
Generation of Transgenic Lines
pRmHa3-flag-eya and pRmHa3-myc-eya AD2 were cut with Smal and Sall, and a directional
ligation was performed to create pRmHa3-flag-eya AD2. Likewise, a SmaI/Sall double digest
was performed on pRmHa3-myc-eya A223-438 to generate pRmHa3-flag-eya 223-438.
EcoR.I/Sall double digests were used to excise theflag-eya,flag-eya-eya AD2, and flag-eya A223-
438 cDNAs from the pRmHa3 vector for insertion into pUAST, cut with EcoRI and Xhol.
pUAST-flag-eya, pUAST-flag-eya AD2, and pUAST-flag-eya A223-438 were subsequently used
to generate transgenic lines as previously described (Rebay et al., 1993).
S2 Cell Transactivation and Transcription Assays
Drosophila S2 cells were transiently transfected using calcium phosphate as described
previously (Pascal and Tjian, 1991). 2.5 ug of each construct indicated was transfected for 6
hours along with 2.5ug ofpUAST-luciferase or lOug of ARE-luciferase as the reporter gene, and
i ug pActin 5.1-V5His-lacZ (Invitrogen) to normalize for transfection efficiency. Cells were
allowed to recover for 17 hours, whereupon expression was induced by addition of 0.1 M CuS0 4.
After 24 hours, cells were harvested by spinning at 1000 rpm for 1 minute and lysed by rocking
at 4°C for 20 minutes in 250 gl of lysis buffer (Tropix/Applied Biosystems). Samples were
subsequently microfuged at 14K for one minute at 40 C, and supernatants transferred to fresh
tubes. Luciferase and 13-galactosidase activities were quantified using a Luciferase Assay Kit
(Tropix/Applied Biosystems) or Galacto-Star Assay kit (Tropix/Applied Biosystems). Assays
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were performed in triplicate on whole cell extracts, according to the manufacturer's instructions
(TROPIX/Applied Biosystems). A minimum of four independent transfections were performed
for each condition. The average luciferase/13-galactosidase signal for Gal4DBD/pUAST-
luciferase or ARE-lhciferase alone was set to I and the experimental averages were normalized
relative to this value. Data were analyzed and graphed using Microsoft Excel. Error bars denote
one standard deviation above and below the mean for each construct. In Figures 3, 5, and 6, SO
is always tagged with the FLAG epitope. In Figure 3, EYA constructs are tagged with the FLAG
epitope, and in Figures 5 and 6, EYA constructs are tagged with the MYC epitope.
Results
Eya functions as a transactivator
To address the question of whether EYA can function as a transcriptional coactivator, we
took advantage of the well-characterized yeast transcription factor Gal4 and its target sequence,
UAS (Fields and Song, 1989), to design an assay for transactivation in Drosophila S2 cells. The
DNA binding domain of Gal4 (Gal4DBD) was fused in frame to the eya coding region
(Gal4DBD-Eya; Figure 1 B) and subcloned into a vector containing a metallothionein promoter,
which allows inducible expression in S2 cells. Gal4DBD-EYA fusion proteins were tested for
their ability to activate expression of a UAS-luciferase reporter gene; co-transfection of a
constitutively expressed, Actin-lacZ plasmid enabled us to normalize activity levels based on
transfection efficiency. Immunohistochemistry with anti-Gal4DBD antibodies confirmed the
expression and nuclear localization of all Gal4DBD-EYA fusion proteins in transfected S2 cells
(data not shown).
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First, we tested the full-length eya coding region fused in-frame to the Ga14DBD (Figure
1B). As shown in Figure 1B, constructs 1 and 2, Gal4DBD-EYA exhibits 3.5-fold greater
activity than the GaI4DBD alone. A series of deletion and truncation constructs were designed to
define a minimal and sufficient domain for this activity. Strikingly, a fusion protein expressing
the N-terminal 485 amino acids of EYA but lacking the conserved EYA Domain, Gal4DBD-
EYA AED, displays an approximate 70-fold increase in transactivation potential relative to the
full length Gal4DBD-EYA construct (Figure IB, constructs 3 versus 2, note scale). The converse
fusion protein expressing only the C-terminal EYA domain, Gal4DBD-EYA Domain (a.a. 486-
'760) does not transactivate (data not shown). This difference is likely not due to changes in
protein stability, as EYA and EYA AED are expressed at similar levels (Figure 1C). The
discrepancy in activity levels of the full length versus GaI4DBD-EYA AED chimeras suggests
that the EYA Domain may function as an autoregulatory inhibitor in this context.
A Proline, Serine, Threonine rich region is critical for Eya transactivation
EYA AED was dissected further to determine the regions critical for transactivation.
EYA AED contains the conserved EYA Domain 2 (ED2, a.a. 318-353), a tyrosine-rich region
that has not been functionally characterized (Figure 1A). ED2 lies within a larger Proline/
Serine/Threonine (P/S/T)-rich region (a.a. 223-438) that includes two consensus MAPK
phosphorylation sites previously shown to be important for EYA regulation in vivo (Hsiao et al.,
2001).
We found that Gal4DBD-EYA 2-353, an N-terminal construct that contains the ED2 but
truncates the P/S/T-rich region, exhibits very low transactivation activity, suggesting a critical
requirement for this latter domain (Figure 1 B, construct 4). Consistent with these results, the
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fusion protein that contains the last two-thirds of the P/S/T rich region, Gal4DBD-EYA 318-436,
exhibits a 22-fold increase in transactivation potential relative to the Gal4DBD alone control
(Figure B, construct 5 versus 1). Therefore the P/S/T-rich region of EYA is critical but not
entirely sufficient for transcriptional co-activation, and upstream regions of the protein (a.a. 2-
223) are required to achieve maximal transactivation levels.
Interestingly, deletion of the conserved ED2 (Gal4-DBD-EYA AED2, AED; a.a. 2-317;
353-485; Figure lB, construct 6) results in a 6 fold reduction in transactivation potential relative
to that of EYA AED (Figure I B, construct 3) yet shows a 41-fold increase relative to the
Ga14DBD control (Figure B, construct 1). Although the ED2 is not essential for EYA
transactivation per se, our results suggest that it is needed to achieve maximal levels, and
ascribes a function to this previously uncharacterized domain.
Although the full-length EYA is a weaker transactivator in this assay than any of the
"active" deletion constructs that lack the C-terminal EYA domain, we wanted to determine
whether the P/S/T-rich region is necessary for the trans-activation potential of full-length EYA.
To address this question, the entire P/S/T rich region, including ED2, was deleted to generate
Gal4DBD-EYA A223-438. We found that this internal deletion abrogates transcriptional
activation in full length Eya (Figure 1 B, construct 7 versus 3). The identical result, namely a
complete lack of transactivation, was obtained when the C-terminal EYA Domain is also deleted
from construct 7 (data not shown).
RAS/MAPK signaling increases EYA transactivation potential
As the P/S/T region important for EYA transactivation potential also contains the MAPK
phosphorylation sites (Ser402 and Ser407) shown to affect EYA activity in vivo, we asked
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Figure 1: The N-terminus of Eya is a potent transactivator
(A) Drosophila EYA contains two conserved regions, the EYA Domain 2 (ED2), and the EYA
domain (ED). The P/S/T rich region includes both the ED2 and the two MAPK phosphoacceptor
sites.
(B) Gal4DBD-Eya fusions were used to assay the ability of Eya to activate transcription from a
UAS-luciferase reporter gene. Transactivation potentials were calculated by taking the ratio of
luciferase/13-gal activity for each construct, and were plotted relative to the activity of the
Gal4DBD vector alone. As shown in B, construct 2, full length EYA can activate transcription
:3.5 fold above Gal4DBD alone. The N-terminus of EYA (construct 3), a construct that lacks the
EYA domain, is a potent transactivator, activating transcription over 250 fold (note scale change
on axis). Gal4DBD-EYA 1-353 (construct 4), a truncation that contains the ED2 but removes
part of the P/S/T rich region, reduces transactivation potential to only 5 fold. The ED2 plus part
of the P/S/T rich region is able to activate transcription at low levels (construct 5), indicating that
the entire N-terminus is necessary for full transactivation potential. Deletion of the conserved
ED2 within the N-terminus of EYA (construct 6) sharply reduces transactivation to 41 fold
above background, 1/5 the activity of the intact N-terminus. Strikingly, deletion of the entire
P/S/T rich region (construct 7) results in complete loss of transactivation potential.
(C) Deletion of the EYA domain does not affect protein expression levels.
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Figure 1: The N-terminus of Eya is a potent transactivator
(A) Drosophila EYA contains two conserved regions, the EYA Domain 2 (ED2), and the
EYA domain (ED). The P/S/T rich region includes both the ED2 and the two MAPK
phosphoacceptor sites.
(B) Gal4DBD-Eya fusions were used to assay the ability of Eya to activate transcription
from a UAS-luciferase reporter gene. Transactivation potentials were calculated by taking
the ratio of luciferase/-gal activity for each construct, and were plotted relative to the
activity of the Gal4DBD vector alone. As shown in B, construct 2, full length EYA can
activate transcription 3.5 fold above Gal4DBD alone. The N-terminus of EYA (construct 3),
a construct that lacks the EYA domain, is a potent transactivator, activating transcription
over 250 fold (note scale change on axis). Gal4DBD-EYA 1-353 (construct 4), a truncation
that contains the ED2 but removes part of the P/S/T rich region, reduces transactivation
potential to only 5 fold. The ED2 plus part of the P/S/T rich region is able to activate
transcription at low levels (construct 5), indicating that the entire N-terminus is necessary
for full transactivation potential. Deletion of the conserved ED2 within the N-terminus of
EYA (construct 6) sharply reduces transactivation to 41 fold above background, 1/5 the
activity of the intact N-terminus. Strikingly, deletion of the entire P/S/T rich region
(construct 7) results in complete loss of transactivation potential.
(C) Deletion of the EYA domain does not affect protein expression levels.
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whether RAS signaling modulates EYA's transactivation potential. To examine this possibility,
we cotransfected activated ras (rasvJ2) with the Gal4DBD-EYA fusion constructs. We did not
observe an increase in the transactivation potential of Gal4DBD-EYA (data not shown), but
observed a variable but significant increase in Gal4DBD-EYA AED transactivation potential in
the presence of RASV12 (Figure 2). In repeated trials, this increase in transactivation ranged from
1 0%/ to 66%, the latter of which is depicted in Figure 2.
As we had previously shown that site-specific mutations in the MAPK consensus
phosphoacceptor residues affect EYA function in vivo (Hsiao et al., 2001), we wanted to test
whether these mutations might also influence transactivation in the Gal4DBD assay system.
Mutation of the two MAPK consensus sites S402 and S407 to alanine (EYAS-A) significantly
reduces EYA activity in ectopic eye induction assays. Conversely, mutation of the
phosphoacceptor residues to aspartic or glutamic acid (EYAS-D/E) produces a hyperactive protein,
presumably by mimicking its phosphorylated state (Hsiao et al., 2001). Surprisingly, we found
that both EYAS-A and EYAS -D/E point mutations increased transactivation activity of Gal4DBD-
EYA AED to slightly higher levels than were seen upon addition of RASV2 (Figure 2).
As EYA transactivation potential is increased upon cotransfection of rasV12 or mutation
of the MAPK phosphoacceptor residues, it seems likely that these residues are important for
proper regulation of EYA transactivation. Our finding that in this system both EYAS-A and
EYAs -D mutations result in increased transactivation relative to wildtype Eya may reflect the
complexity of the consequences of RAS/MAPK signaling. However, it is important to note that
the chimeric Gal4DBD-EYA fusion proteins and/or the truncations we engineered may have an
altered conformation relative to native EYA, such that MAPK phosphorylation events have
different consequences in this context.
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Figure 2: RAS/MAPK Signaling activates Eya transactivation
Transactivation via Gal4DBD-EYA AED is increased significantly but variably upon
the addition of RASVI2. Mutations of the MAPK phosphoacceptors to alanine (EYAS-
A) to prevent phosphorylation, or to aspartic or glutamic acid (EYAS-D) to mimic
phosphorylation, both increase Gal4DBD-EYA AED transactivation activity,
suggesting that these sites are important for regulation of EYA transactivation
potential. Taken with the increase seen upon addition of RASV2 , we conclude that
RAS signaling can increase EYA transactivation potential.
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ARE-luciferase is responsive to the EYA-SO transcription factor
The synthetic assay system described above enabled us to map the regions crucial for
EYA transactivation activity to the ED2 and the surrounding P/S/T rich region. RAS/MAPK-
dependent effects on EYA transactivation levels indicate that RAS signaling can activate EYA
transactivation but that such effects may not afford themselves to straightforward interpretation.
In order to examine this question in a more native system, we designed a transcription assay
system to measure the transactivation potential of EYA-SO complexes.
Currently, the genomic DNA target sequences bound by Drosophila SO are not known,
but several studies in mammalian cells and tissues have identified SIX family response elements.
In particular, the Na, K-A TPase al subunit gene (ATPlal) Regulatory Element (ARE) has been
shown to respond to SIX family members SIX2, SIX4 and SIX5 in vivo and in vitro (Kawakami
et al., 1996). As SO and SIX2 belong to the same SIX family subgroup (SIX1/2) (Kawakami et
al., 2000), and their homeodomains are 93% identical (Seo et al., 1999), we reasoned that they
are likely to bind similar sequences. We therefore multimerized the core ARE binding site (see
Materials and Methods) and placed this enhancer in front of a minimal promoter followed by
luciferase cDNA, which we will refer to as ARE-luciferase.
We found that ARE-luciferase is responsive to co-transfection of eya and so, and together
they activate ARE-luciferase 27-fold over the reporter alone (Figure 3A). ARE-luciferase is not
appreciably activated alone, nor upon transfection of eya or so individually (Figure 3A).
Therefore ARE-luciferase activation provides a measure of EYA's efficacy as a transcriptional
co-activator when bound to SO. We also asked whether the addition of DAC affects ARE-
luciferase transcription and found that DAC did not affect transactivation potential of the EYA-
SO transcription factor (data not shown).
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The P/S/T rich region of Eya is necessary for transactivation but not for EYA-SO
interactions
We used the ARE-luciferase reporter and full length EYA and SO to ask whether the ED2
and the P/S/T rich region determined to be critical in the synthetic Gal4DBD assay system are
essential in a more physiologically relevant context. In this assay, we used otherwise full length
EYA constructs that lack either the ED2 or the entire P/S/T rich region, EYA AED2 and EYA
A223-438. As shown in Figure 3A, deletion of the ED2 reduces transactivation to only 14-fold
relative to controls, while deletion of the entire P/S/T-rich region, EYA A223-438, virtually
eliminates transcriptional co-activation.
One possible explanation for this lack of activity might be a decrease in protein
expression levels in the EYA deletion constructs. In order to test this, we performed quantitative
Westerns blots to assay tagged EYA protein levels. Transient transfections were normalized for
effieciency using Bgal assays and appropriate amounts of lysate were loaded. We found that
while the AED2 deletion did not alter protein expression levels (Figure 3B, lane 2), EYA A223-
438 was less abundantly expressed than full length EYA (Figure 3B, lane 3). In order to correct
for this difference, we transfected sufficient EYA A223-438 plasmid to produce protein levels
above that of EYA full length (Figure 3B, lanes 4 and 5). Using these higher amounts of EYA
A223-438 plasmid we still observe only low levels of transactivation (Figure 3A), indicating that
deletion of this region of EYA compromises activity.
To confirm that the loss of transactivation potential seen in these deletions was not due to
a loss of EYA-SO binding, we developed a system to test for direct protein-protein interactions
in S2 cells, which we term S2 cell two-hybrid (S2-2H) assays (refer to Methods for details). Use
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of Drosophila cultured cells, rather than the more common yeast or mammalian cell based
systems (14,15), allows interactions between Drosophila proteins to be assayed in a more
physiologically native environment, thereby increasing the probability that necessary cofactors
and/or protein modifications are present.
Using our S2-2H assay, Gal4DBD-EYA, EYA AED2, and EYA A223-438 fusions were
each tested for interaction with a Gal4AD-SO fusion protein. As shown in Figure 3C, Gal4AD-
SO is able to interact with all three Eya proteins, and demonstrates even stronger interactions
with Gal4DBD-Eya A223-438. This, combined with our western analysis, indicates that the
reduced transactivation observed upon deletion of the ED2 and the P/S/T-rich region (Figure 3A)
reflects a change in activity levels of the EYA-SO transcription factor, rather than simply the loss
of EYA protein or loss of the ability to form an EYA-SO complex.
We confirmed that the P/S/T rich region and ED2 are necessary for EYA activity in vivo
by assaying the ability of these deletions to induce ectopic eyes when overexpressed using the
UAS/Gal4 system (Brand and Perrimon, 1993). We found that when driven by the 57Aldpp-
Gal4 driver, EYA AED2 and EYA A223-438 exhibited drastically reduced activity relative to
wildtype EYA (Figure 3D), though all constructs were expressed at comparable levels as assayed
by western blots of Ub-Gal4 driven expression of UAS-EYA constructs in embryos (data not
shown). Thus ED2 and the P/S/T rich region are critical for EYA function in vivo.
I)AC does not interact with EYA or SO in S2-2H assays
As DAC did not affect EYA-SO mediated transcription of ARE-luciferase, we asked
whether DAC was able to interact with EYA or SO using our S2-2H system. Gal4DBD and
GaI4AD fusions were made with full length EYA and DAC and tests were performed in both
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Figure 3: ARE-luciferase is responsive to the EYA-SO transcription factor
(A) EYA and SO alone do not affect transcription of the ARE-luciferase reporter gene, but
together can activate transcription 27 fold. Full length EYAAED2 is unable to fully activate
transcription of this gene, and neither is a construct missing the entire P/S/T rich region,
EYA 223438 . This construct was not expressed at the same level as wildtype EYA, so we
transfected two (indicated by ++) and three times (indicated by +++) the amount of plasmid to
raise protein levels to and above the levels of EYA. These levels still do not activate ARE-
luciferase.
(B) Quantitative Western blotting shows that EYA (lane 1) and EYA ED2 (lane 2) are expressed
at similar levels, while the same amount of EYAA22 3 -4 3 plasmid (lane 3) is not. However,
transfection of two and three times more EYAA22 3 4 3 8 plasmid results in robust expression as
shown in lanes 4 and 5.
(C) EYA and SO show a strong interaction in an S2-2H assay. The deletions in EYA do not
affect interactions with SO, and in fact EYAA22 3-438 appears to have a stronger interaction with
SO. DAC does not interact with EYA in S2-2H assays.
(D) Overexpression of EYA using the 57A1dpp-Gal4 driver causes ectopic eye induction in over
98% of animals (n=413). Overexpression of EYAAED2 results in ectopic eyes in only 35% of
animals (n=506). Deletion of the entire P/S/T rich region, EYAA223 438, results in a protein that
can only rarely induce ectopic eyes, seen in only 1.5% of animals examined (n=204).
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directions. Surprisingly, no interaction was observed in either direction (data shown in one
direction, Figure 3C). We also asked whether SO might be required to nucleate an EYA-DAC
complex, but did not observe an interaction (data not shown). To determine whether
RAS/'MAPK signaling might be required for formation of an EYA-DAC complex we
cotransfected Ras V l2 or used the Eyas 'A and Eyas -D constructs described above, but still did not
observe an EYA-DAC interaction (data not shown). SO and DAC also fail to interact in the S2-
2H assay (data not shown).
EYA-EYA interactions are mediated via the N-terminus
As the RD gene network is known to function in reiterative feedback loops, we wondered
if EYA might interact with itself to potentiate or restrict function. Using our S2-2H assay, we
find that full length EYA shows a significant interaction with itself (using Gal4DBD-EYA and
Gal4AD-EYA; Figure 4), at 7 fold above background. We then used our series of deletion and
truncation constructs fused to the GaI4DBD domain coexpressed with the Gal4AD-EYA fusion
to ask which domain mediates this EYA-EYA interaction. In order to distinguish between the
activity of the fusion alone and the S2-2H interaction, we transfected each alone and with AD-
EYA (Figure 4).
As shown in Figure 4, EYA 2-317 (construct 3) shows slightly greater interaction with
AD-EYA than full length EYA, while a construct including the ED2, EYA 2-353 (construct 4)
shows a striking increase in interaction relative to full length EYA. EYA 223-353 (construct 5)
shows interaction levels comparable to full length EYA, however, deletion of the ED2 in the
context of full length EYA also results in a striking increase in EYA-EYA interaction (Figure 4,
construct 6). The EYA domain, which mediates EYA-SO interactions, does not interact above
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background with full length EYA (Figure 4, construct 7). This result, coupled with the striking
increase observed between EYA 2-353 and EYA, leads us to conclude that EYA-EYA
interactions are likely mediated by amino acids in the N-terminus, and that the ED2 (a.a. 318-
353, Figure 1A), and the regions immediately following it, including the MAPK phosphorylation
sites, while not necessary for this interaction, may strongly potentiate it. We could not test other
N-terminal EYA constructs in this assay, such as EYA AED and EYA AED2AED, as expressed
alone they strongly activate the reporter (Figure 1 B). As this interaction maps to regions we
describe above as crucial for full EYA transactivation potential (Figure B) and for EYA
function in vivo (Figure 3D), it seems likely that the EYA-EYA interaction is functionally
significant and could contribute to regulated transcriptional activity.
Phosphorylation increases EYA transactivation potential in the context of the EYA-SO
transcription factor
Having established an assay in which full-length EYA acts as a transcriptional co-
activator when complexed to SO, we returned to the question of whether EYA activity is
regulated by RAS/MAPK signaling. Although activated RAS did not affect EYA-SO mediated
transcriptional regulation, nor did mutation of the EYA phosphoacceptor sites to Alanine,
(Figure 5A), we found that the EYAS-D;E-SO complex consistently exhibited a 50% increase in
transactivation levels relative to the EYA-SO complex (Figure 5A). This result is consistent with
previously reported transgenic analyses, wherein overexpression of EYAS -D/E led to stronger and
more penetrant phenotypes than did EYA (Hsiao et al., 2001). Analysis of protein levels in flies
expressing EYAS-A or EYAS-D/E transgenes indicated no differences in protein stability (Hsiao et
al., 2001), and we repeated these results in cell culture with quantitative westerns as shown in
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Figure 4: EYA-EYA interactions are mediated by the EYA N-terminus
Using the S2-2H system, Gal4DBD-EYA fusions shown on the left were co-expressed with
(+) and without (-) full length Gal4AD-EYA. Full length EYA interacts with itself 7 fold
above background. This interaction is mediated by amino acids 223-317, as all constructs that
contain this minimal region can interact with Gal4AD-EYA. Strikingly, the Gal4DBD-EYA
2-353 and Gal4DBD-EYA AED2 (constructs 4 and 6) show more than three fold stronger
interaction than that of full length EYA. The Gal4DBD-EYA domain fusion (construct 7)
does not interact with Gal4AD-EYA, consistent with our finding that the EYA N-terminus
mediates this interaction.
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Figure 5: The EYA-SO transcription factor is regulated by phosphorylation
(A) As shown in Figure 3, the EYA-SO transcription factor can activate expression of
ARE-luciferase. This expression is not affected by addition of RASVl2 nor upon
mutation of the MAPK phosphoacceptor sites to alanine (EYAS-A). A striking increase
in activation is seen when the EYAS-D phosphomimetic mutant is used, showing that
phosphorylation acts to increase EYA transactivation potential. That RAS V2 itself does
not produce the same increase on wildtype EYA in this assay suggests that RAS
signaling may have multiple effects on the RD gene network, and in particular may
negatively regulate SO.
(B) EYA phosphoacceptor mutations do not affect protein expression levels.

Figure 5B, where wildtype and mutant EYA are expressed at the same levels. The S2-2H system
was used to rule out the possibility that the transactivation increase seen with the EYAS-'E-SO
complex results from an increase in EYA-SO interactions (data not shown). Therefore the
increase in transactivation exhibited by the EYAS-D'E-SO complex suggests that phosphorylation
directly increases EYA's transactivation potential.
As we see this result only upon mutation of the phosphoacceptor site, but not in response
to RAS/MAPK activation, it remains possible that a different signaling pathway mediates this
phosphorylation event. However, previously reported genetic and biochemical evidence (Hsiao
et al., 2001) indicates that RAS/MAPK signaling is responsible for phosphorylation of this site in
vivo. Thus we favor the interpretation that EYA transactivation is potentiated by MAPK
phosphorylation, as evidenced by the increased activity of the EYAS-D/E-SO complex, and that
the lack of response to RAS stimulation likely reflects a more complex role for RAS within the
RD gene network.
GROUCHO is a repressor of the EYA-SO transcription factor
Recent studies in zebrafish (Kobayashi et al., 2001), mice (Zhu et al., 2002) and medaka
(Lopez-Rios et al., 2003) have revealed a functional role for SIX3 interactions with GROUCHO
(GRO), a transcriptional co-repressor. One of these studies also demonstrates weak interactions
between SO and a murine Groucho homolog, GRG5 (Zhu et al., 2002). As SO belongs to a
different class of SIX homologs, and SIX3/SIX6 are distinct from other families in that they do
not interact with EYA or EYA homologs, we wanted to ask if this SO-GRG5 interaction
indicated a functional role for GRO in regulation of the EYA-SO transcription factor. We found
that co-expression of GRO strongly reduces but does not eliminate activation via the EYA-SO
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transcription factor. As shown in Figure 6A, EYA-SO activates transcription more than 33-fold,
while co-expression of GRO abrogates activation to only 20-fold.
This co-repressor function of GRO may be mediated by interactions with SO through the
previously characterized engrailed homology 1 (ehl) domains within the SIX domain
(Kobayashi et al., 2001), or may be mediated through an ehl domain found within the EYA
domain (Ze'ev Paroush, personal communication). In order to address this question, we
performed co-immunoprecipitation (CO-IP) to look at direct interactions between GRO and
EYA or SO. Strikingly, we found that GRO can CO-IP with SO alone, but not in the presence of
EYA (Figure 6B, lanes 5 and 4). This is not due to competition with EYA for GRO binding, as
IP of EYA cannot CO-IP GRO (Figure 6B, lane 6). We therefore propose an additional negative
regulatory mechanism for EYA-SO targets, whereby in the absence of high levels of EYA, GRO
interactions with SO leads to repression and downregulation of target genes. Thus SO may
function both as a transcriptional activator and repressor dependant upon the context specific
expression levels of particular co-factors.
Discussion
The RD gene network encodes proteins that operate in multiple contexts to effect
differentiation of various cell types. Inputs from extracellular signaling pathways, such as the
RAS/MAPK cascade, may provide instructive, context-dependent cues that regulate the
expression and/or activity of RD gene family members. We have shown that Drosophila EYA is
a potent transactivator, either on a heterologous promoter or in conjunction with SO, and that
that this activity maps to an internal P/S/T-rich region encompassing the ED2 and MAPK
consensus sites. This activity is negatively regulated by the EYA domain, and positively
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Figure 6: The EYA-SO transcription factor is negatively regulated by interactions with
GROUCHO
(A) When co-expressed with EYA and SO, GRO is a repressor of the EYA-SO transcription
factor.
(B) Lanes 1 and 2 show that myc-EYA and GRO are not pulled down by anti-Flag beads. In
lane 3, IP of SO can co-IP EYA. Lane 4 shows that IP of SO can co-IP EYA but not GRO,
however in lane 5 we see that without EYA, GRO can associate with SO. Thus co-
immunoprecipitation of GRO with SO is disrupted by cotransfection of EYA. This result
does not seem to be due to direct competition between EYA and SO for GRO, as IP of EYA
cannot co-IP GRO. All proteins were expressed at similar levels in crude cell lysates (data
not shown).

modulated by phosphorylation, likely through RAS/MAPK signaling. We also provide evidence
for direct EYA-EYA interactions, and demonstrate that the ED2 may be critical in this context.
Together our results suggest a complex cooperation and interplay among the distinct structural
motifs of EYA that reflects the importance of proper regulation of the RD gene network.
Our transcription assay results correlate well with those obtained in mammalian cell
culture studies of murine EYA homologs, mEYA1-4, which showed that their N-termini can
function as transactivators on a heterologous promoter (Xu et al., 1997a). Our functional
dissection of Drosophila EYA enables us to propose a role for a second, and previously
uncharacterized, conserved domain in EYA, the EYA Domain 2 (ED2), in mediating EYA
transactivation potential. The P/S/T rich region surrounding the ED2, which includes two MAPK
phosphorylation consensus sites, is absolutely necessary for EYA transactivation, and both the
ED2 and the P/S/T rich region are essential for EYA function in vivo.
Ectopic expression of EYA is associated with a wide range of deleterious phenotypes
(Hsiao et al., 2001), suggesting that EYA activity must be precisely regulated to ensure
appropriate growth and development. Our observation that the conserved EYA Domain functions
as an autoregulatory inhibitor of EYA transactivation potential suggests that regulation of and by
this domain is critical for proper EYA function. Relief of this inhibition in vivo may require co-
factor binding or protein modification. Alternatively, the inhibition mediated by the EYA domain
might be dependent on interactions with an unidentified negative regulator of EYA. In this
context, it would be interesting to ask whether any of the BOR alleles that map to the Eya
Domain (Ozaki et al., 2002) affect the transactivation potential of human EYA1.
Another negative regulatory component of the EYA-SO transcription factor arises from
our finding that striking repression is achieved in the presence of GROUCHO. Furthermore, we
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provide evidence that SO-GRO interactions are disrupted by EYA, providing an intriguing
model for SO target gene regulation. As EYA and SO are not entirely co-expressed and GRO is
widely expressed (Knust et al., 1987), a SO-GRO complex may provide tight regulation of EYA-
SO targets, functioning as an OFF switch in the absence of EYA. This may explain the lack of
ectopic eye induction seen upon overexpression of SO alone (Pignoni et al., 1997) compared to
EYA alone (Bonini et al., 1997), and a mechanism for the cooperativitity observed when EYA
and SO are coexpressed (Pignoni et al., 1997), as EYA is necessary to overcome SO-GRO
mediated repression.
Our finding that DAC does not interact with EYA or SO in S2-2H assays is surprising but
does not preclude their interaction in vivo. It is possible that the EYA-DAC interaction requires
cofactors or modifications not made in Drosophila S2 cell culture, or that some factor present in
S2 cells inhibits the interaction. As well, the use of Gal4DBD and Gal4AD fusions may in some
way disrupt an EYA-DAC interaction. It will be interesting to ask whether cotransfection of one
known mammalian cofactor, CREB binding protein (Ikeda et al., 2002), can nucleate an EYA-
DAC interaction in S2 cells. Alternatively, EYA may indirectly associate with DAC in the
context of an as yet uncharacterized macromolecular complex that may vary according to the
particular transcriptional target being regulated.
The observation that EYA interacts with itself reveals yet another potential mechanism
for complex and reiterative interactions within the RD gene network. This interaction appears to
be mediated by the N-terminal half of EYA, a region that we have found necessary for full
transactivation potential. Furthermore, we find that the ED2 potentiates EYA-EYA interactions.
As the EYA-EYA interaction maps to regions of EYA necessary for transactivation, we propose
that homotypic interactions may contribute to EYA function as a transcription factor in vivo.
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Determination of cell fate is dependent on both the presence of a particular complement
of transcription factors and the appropriate activation state of these factors. Here we provide
evidence that while RAS/MAPK activation is not necessary for Eya transactivation potential, it
can potentiate EYA mediated transactivation. This leads to an intriguing mechanism for
modulation of the EYA-SO transcription factor, whereby in the absence of RAS/MAPK
signaling, it is competent to activate some transcription, but in the presence of signal, this
function is potentiated such that target genes may be activated to higher levels. An alternative but
not mutually exclusive role for RAS/MAPK activation of EYA may be to allow the higher
activation potential of EYA to overcome negative regulation of specific target genes.
Activation of EYA by RAS/MAPK signaling provides a direct point of crosstalk between
a signal transduction module and the RD gene network. Our results suggest that RAS/MAPK
signaling may regulate multiple aspects of RD network function. In the context of Gal4DBD-Eya
fusions acting on UAS-luciferase, RAS signaling clearly increases transactivation activity.
Surprisingly, we found that mutation of the MAPK phosphoacceptor sites in this fusion protein
to either Alanine, to prevent phosphorylation, or a negatively charged residue, to mimic
phosphorylation, result in higher transactivation levels. We believe that these results may be due
the nature of this assay, which uses chimeric and truncated Gal4DBD-EYA AED fusions, as we
do not observe the same effect in the context of full length EYA working with SO to promote
transcription. Rather, in the context of an EYA-SO complex acting on ARE-luciferase, RAS V 12
does not affect transcription yet there is a consistently strong increase in activation when the
phosphomimetic EYAS-D is used. One possible explanation for the lack of RAS responsiveness is
that RAS signaling could simultaneously upregulate EYA but downregulate SO. This would
provide a mechanism for fine-tuned transcriptional regulation, whereby RAS signaling can
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activate the EYA-SO transcription factor through phosphorylation of EYA but negatively
regulates SO to prevent sustained high levels of activation. Such dual and conflicting inputs by
the RAS/MAPK pathway are consistent with previous genetic observations. Specifically, our
previous work has demonstrated a positive role for the pathway with respect to RD network
function using EYA as a point of cross-talk, whereas work by others has implicated the RAS
pathway as antagonizing RD gene function, although in this case the molecular mechanisms
underlying the inhibitory regulation is unknown (Kumar and Moses, 2001). Thus it remains to be
seen how RAS/MAPK signaling regulates SO or other members of the RD gene network, or if
this direct interaction is unique to EYA.
In addition to RAS/MAPK signaling, Notch, Hedgehog, Wingless, and TGF3/DPP
signaling all play important roles in eye development (Treisman and Heberlein, 1998). The
integration of multiple signaling pathway inputs with our existing knowledge of RD gene
network transcriptional regulatory loops suggests a mechanism for unique specification of
multiple cell fates in the eye. Our work provides evidence that EYA is a crucial modulator of its
own activity, through autoinhibition and homo-typic interactions. We also show evidence that
the RAS/MAPK pathway directly enhances the transactivation potential of EYA, and that the co-
repressor GROUCHO inhibits EYA-SO mediated transcription. It will be important to discover
whether other signaling pathways interact directly with RD gene network proteins, and how such
inputs effect the expression of distinct cadres of target genes, thereby establishing and/or
reinforcing unique cell fates.
120
Acknowledgements
We thank S. Artavanis-Tsakonas for GRO monoclonal antibody, Z. Paroush for gro cDNA, G.
Mardon for so and dac plasmids and R. Fehon and T. Orr-Weaver for helpful comments on the
manuscript. We thank all Rebay Lab members for their valuable advice on this project and
manuscript. S.J.S. is a Howard Hughes Medical Institute Predoctoral Fellow. I.R. is a recipient
of a Burroughs Wellcome Fund Career Award in the Biomedical Sciences and is a Rita Allen
Foundation Scholar. This work was supported in part by National Institutes of Health Grant RO 1
EY-1 2549.
121
References
Abdelhak, S., Kalatzis, V., Heilig, R., Compain, S., Samson, D., Vincent, C., Weil, D., Cruaud,
C., Sahly, I., Leibovici, M., et al. (1997). A human homologue of the Drosophila eyes
absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene
family. Nat Genet 15, 157-164.
Bai, J., and Montell, D. (2002). Eyes Absent, a key repressor of polar cell fate during Drosophila
oogenesis. Development 129, 5377-5388.
Baonza, A., and Freeman, M. (2002). Control of Drosophila eye specification by Wingless
signalling. Development 129, 5313-5322.
Bessa, J., Gebelein, B., Pichaud, F., Casares, F., and Mann, R. S. (2002). Combinatorial control
of Drosophila eye development by Eyeless, Homothorax, and Teashirt. Genes Dev 16,
2415-2427.
Bonini, N. M., Bui, Q. T., Gray-Board, G. L., and Warrick, J. M. (1997). The Drosophila eyes
absent gene directs ectopic eye formation in a pathway conserved between flies and
vertebrates. Development 124, 4819-4826.
Bonini, N. M., Leiserson, W. M., and Benzer, S. (1998). Multiple roles of the eyes absent gene in
Drosophila. Dev Biol 196, 42-57.
Brand, A., and Perrimon, N. (1993). Targeted gene expression as a means of altering cell fates
and generating dominant phenotypes. Development 118, 401-415.
Bui, Q. T., Zimmerman, J. E., Liu, H., and Bonini, N. M. (2000). Molecular analysis of
Drosophila eyes absent mutants reveals features of the conserved Eya domain. Genetics
155, 709-720.
122
Chen, R., Amoui, M., Zhang, Z., and Mardon, G. (1997). Dachshund and eyes absent proteins
form a complex and function synergistically to induce ectopic eye development in
Drosophila. Cell 91, 893-903.
Chen, R., Halder, G., Zhang, Z., and Mardon, G. (1999). Signaling by the TGF-beta homolog
decapentaplegic functions reiteratively within the network of genes controlling retinal
cell fate determination in Drosophila. Development 126, 935-943.
Cheyette, B. N., Green, P. J., Martin, K., Garren, H., Hartenstein, V., and Zipursky, S. L. (1994).
The Drosophila sine oculis locus encodes a homeodomain-containing protein required for
the development of the entire visual system. Neuron 12, 977-996.
Curtiss, J., and Mlodzik, M. (2000). Morphogenetic furrow initiation and progression during eye
development in Drosophila: the roles of decapentaplegic, hedgehog and eyes absent.
Development 127, 1325-1336.
Czerny, T., Halder, G., Kloter, U., Souabni, A., Gehring, W. J., and Busslinger, M. (1999). twin
of eyeless, a second Pax-6 gene of Drosophila, acts upstream of eyeless in the control of
eye development. Mol Cell 3, 297-307.
Fields, S., and Song, 0. (1989). A novel genetic system to detect protein-protein interactions.
Nature 340, 245-246.
Flores, G. V., Duan, H., Yan, H., Nagaraj, R., Fu, W., Zou, Y., Noll, M., and Banerjee, U.
(2000). Combinatorial signaling in the specification of unique cell fates. Cell 103, 75-85.
Galindo, M. I., Bishop, S. A., Greig, S., and Couso, J. P. (2002). Leg patterning driven by
proximal-distal interactions and EGFR signaling. Science 297, 256-259.
123
Halder, G., Callaerts, P., Flister, S., Walldorf, U., Kloter, U., and Gehring, W. J. (1998). Eyeless
initiates the expression of both sine oculis and eyes absent during Drosophila compound
eye development. Development 125, 2181-2191.
Halfon, M. S., Carmena, A., Gisselbrecht, S., Sackerson, C. M., Jimenez, F., Baylies, M. K., and
Michelson, A. M. (2000). Ras pathway specificity is determined by the integration of
multiple signal-activated and tissue-restricted transcription factors [In Process Citation].
Cell 103, 63-74.
Heanue, T. A., Reshef, R., Davis, R. J., Mardon, G., Oliver, G., Tomarev, S., Lassar, A. B., and
Tabin, C. J. (1999). Synergistic regulation of vertebrate muscle development by Dach2,
Eya2, and Sixl, homologs of genes required for Drosophila eye formation. Genes Dev
13, 3231-3243.
Hsiao, F. C., Williams, A., Davies, E. L., and Rebay, I. (2001). Eyes absent mediates cross-talk
between retinal determination genes and the receptor tyrosine kinase signaling pathway.
Dev Cell 1, 51-61.
Ikeda, K., Watanabe, Y., Ohto, H., and Kawakami, K. (2002). Molecular interaction and
synergistic activation of a promoter by Six, Eya, and Dach proteins mediated through
CREB binding protein. Mol Cell Biol 22, 6759-6766.
Kawakami, K., Ohto, H., Ikeda, K., and Roeder, R. G. (1996). Structure, function and expression
of a murine homeobox protein AREC3, a homologue of Drosophila sine oculis gene
product, and implication in development. Nucleic Acids Res 24, 303-310.
Kawakami, K., Sato, S., Ozaki, H., and Ikeda, K. (2000). Six family genes--structure and
function as transcription factors and their roles in development. Bioessays 22, 616-626.
124
Kimn, S. S., Zhang, R., Braunstein, S. E., Joachimiak, A., Cvekl, A., and Hegde, R. S. (2002).
Structure of the retinal determination protein dachshund reveals a DNA binding motif.
Structure (Camb) 10, 787-795.
Knust, E., Bremer, K. A., Vassin, H., Ziemer, A., Tepass, U., and Campos-Ortega, J. A. (1987).
The enhancer of split locus and neurogenesis in Drosophila melanogaster. Dev Biol 122,
262-273.
Kobayashi, M., Nishikawa, K., Suzuki, T., and Yamamoto, M. (2001). The homeobox protein
Six3 interacts with the Groucho corepressor and acts as a transcriptional repressor in eye
and forebrain formation. Dev Biol 232, 315-326.
Kronhamn, J., Frei, E., Daube, M., Jiao, R., Shi, Y., Noll, M., and Rasmuson-Lestander, A.
(2002). Headless flies produced by mutations in the paralogous Pax6 genes eyeless and
twin of eyeless. Development 129, 1015-1026.
Kumar, P., and Moses, K. (2001). EGF Receptor and Notch Signaling Act Upstream of
Eyeless/Pax6 to Control Eye Specification. Cell 104, 687-697.
Kurusu, M., Nagao, T., Walldorf, U., Flister, S., Gehring, W. J., and Furukubo-Tokunaga, K.
(2000). Genetic control of development of the mushroom bodies, the associative learning
centers in the Drosophila brain, by the eyeless, twin of eyeless, and Dachshund genes.
Proc Natl Acad Sci U S A 97, 2140-2144.
Li, X., Perissi, V., Liu, F., Rose, D. W., and Rosenfeld, M. G. (2002). Tissue-Specific Regulation
of Retinal and Pituitary Precursor Cell Proliferation. Science 297, 1180-1183.
Lopez-Rios, J., Tessmar, K., Loosli, F., Wittbrodt, J., and Bovolenta, P. (2003). Six3 and Six6
activity is modulated by members of the groucho family. Development 130, 185-195.
125
Mardon, G., Solomon, N. M., and Rubin, G. M. (1994). dachshund encodes a nuclear protein
required for normal eye and leg development in Drosophila. Development 120, 3473-
3486.
Ohto, H., Kamada, S., Tago, K., Tominaga, S.-I., Ozaki, H., Sato, S., and Kawakami, K. (1999).
Cooperation of Six and Eya in Activation of Their Target Genes through Nuclear
Translocation of Eya. Mol Cell Biol 19, 6815-6824.
O'Neill, E. M., Rebay, I., Tjian, R., and Rubin, G. M. (1994). The activities of two Ets-related
transcription factors required for Drosophila eye development are modulated by the
Ras/MAPK pathway. Cell 78, 137-147.
Ozaki, H., Watanabe, Y., Ikeda, K., and Kawakami, K. (2002). Impaired interactions between
mouse Eyal harboring mutations found in patients with branchio-oto-renal syndrome and
Six, Dach, and G proteins. J Hum Genet 47, 107-116.
Pascal, E., and Tjian, R. (1991). Different activation domains of Sp govern formation of
multimers and mediate transcriptional synergism. Genes Dev 5, 1646-1656.
Pignoni, F., Hu, B., Zavitz, K. H., Xiao, J., Garrity, P. A., and Zipursky, S. L. (1997). The eye-
specification proteins So and Eya form a complex and regulate multiple steps in
Drosophila eye development. Cell 91, 881-891.
Pignoni, F., and Zipursky, S. L. (1997). Induction of Drosophila eye development by
decapentaplegic. Development 124, 271-278.
Rebay, I., Fehon, R. G., and Artavanis-Tsakonas, S. (1993). Specific truncations of Drosophila
Notch define dominant activated and dominant negative forms of the receptor. Cell 74,
319-329.
126
Seo, H. C., Curtiss, J., Mlodzik, M., and Fjose, A. (1999). Six class homeobox genes in
drosophila belong to three distinct families and are involved in head development. Mech
Dev 83, 127-139.
Shen, W., and Mardon, G. (1997). Ectopic eye development in Drosophila induced by directed
dachshund expression. Development 124, 45-52.
Treisman, J. E., and Heberlein, U. (1998). Eye development in Drosophila: formation of the eye
field and control of differentiation. Curr Top Dev Biol 39, 119-158.
Xu, C., Kauffmann, R. C., Zhang, J., Kladny, S., and Carthew, R. W. (2000). Overlapping
activators and repressors delimit transcriptional response to receptor tyrosine kinase
signals in the Drosophila eye. Cell 103, 87-97.
Xu, P. X., Cheng, J., Epstein, J. A., and Maas, R. L. (1997a). Mouse Eya genes are expressed
during limb tendon development and encode a transcriptional activation function. Proc
Natl Acad Sci U S A 94, 11974-11979.
Xu, P. X., Woo, I., Her, H., Beier, D. R., and Maas, R. L. (1997b). Mouse Eya homologues of
the Drosophila eyes absent gene require Pax6 for expression in lens and nasal placode.
Development 124, 219-231.
Zhu, C. C., Dyer, M. A., Uchikawa, M., Kondoh, H., Lagutin, O. V., and Oliver, G. (2002).
Six3-mediated auto repression and eye development requires its interaction with
members of the Groucho-related family of co-repressors. Development 129, 2835-2849.
Zimmerman, J. E., Bui, Q. T., Steingrimsson, E., Nagle, D. L., Fu, W., Genin, A., Spinner, N. B.,
Copeland, N. G., Jenkins, N. A., Bucan, M., and Bonini, N. M. (1997). Cloning and
characterization of two vertebrate homologs of the Drosophila eyes absent gene. Genome
Res 7, 128-141.
127
128
Chapter 3
Novel function for the transcription factor Eyes absent
as a protein tyrosine phosphatase
Tina L. Tootlel ' 2*, Serena J. Silver ' 2*, Erin L. Davies ' 3 *, Victoria Newman l, Robert R. Latek',
Ishara A. Mills '12, Jeremy D. Selengut4, Beth E. W. Parlikar"'2 and Ilaria Rebay '2
'Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA
2Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
02142, USA
3Current address, Department of Developmental Biology, Stanford University School of
Medicine, Stanford, California 94305, USA
4 TIGR, Rockville, Maryland 20850, USA
:*These authors contributed equally to the work
S.J.S. performed analysis of HAD family members, performed
developed and performed kinetic phosphatase assays with T.T.
transcription assays, and
This Chapter was previously published as a Letter to Nature:
Tootle, T. L., Silver, S. J., Davies, E. L., Newman, V., Latek, R. R., Mills, I. A., Selengut, J.
D., Parlikar, B. E., and Rebay, I. (2003). The transcription factor Eyes absent is a protein
tyrosine phosphatase. Nature 426, 299-302.
129
Abstract
Post-translational modifications provide sensitive and flexible mechanisms to dynamically
modulate protein function in response to specific signaling inputs(Hunter, 2000). In the case of
transcription factors, changes in phosphorylation state can influence protein stability,
conformation, subcellular localization, interactions with cofactors, transactivation potential and
transcriptional output (Hunter, 2000). Here we show that the evolutionarily conserved
transcription factor Eyes absent (Treisman, 1999; Wawersik and Maas, 2000) belongs to the
phosphatase subgroup of the haloacid dehalogenase superfamily (Collet et al., 1998; Thaller et
al., 1998) and propose a novel function for it as a non-thiol based protein tyrosine phosphatase.
In vitro assays demonstrate that Eyes absent has intrinsic phosphatase activity that is blocked by
mutations altering the active site. Experiments performed in Drosophila cultured cells and in
vitro indicate that Eyes absent has protein tyrosine phosphatase capability and may act
autocatalytically to dephosphorylate itself. Confirming the biological significance of this
function, mutations that disrupt the phosphatase active site severely compromise Eyes absent's
ability to promote eye specification and development in Drosophila. Given the functional
importance of phosphorylation-dependent modulation of transcription factor activity, our
evidence of a nuclear transcriptional coactivator with intrinsic phosphatase activity suggests
exciting new mechanisms for fine-tuning transcriptional regulation.
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Introduction
The transcriptional coactivator Eyes absent (EYA) is a member of an evolutionarily
conserved set of nuclear transcription factors and cofactors collectively termed the retinal
determination (RD) gene network (Bonini et al., 1997; Treisman, 1999; Wawersik and Maas,
2000). While RD network members are perhaps best known for their roles in eye specification,
redeployment of these genes, either individually or as a network, contributes to a diverse array of
essential developmental processes in all metazoans (Treisman, 1999; Wawersik and Maas,
2000). EYA family members are defined by a conserved -275 amino acid motif, referred to as
the EYA domain (ED), that has been shown to bind two other RD members, Sine oculis (SO)
and Dachshund (DAC) (Bonini et al., 1997; Chen et al., 1997; Pignoni et al., 1997). Together,
EYA and SO form a potent transcriptional activator (Silver et al., 2003), while the mechanistic
implications of EYA-DAC interactions are less clear (Ikeda et al., 2002; Kim et al., 2002).
Emphasizing the functional conservation among EYA homologs, mammalian EYA transgenes
can rescue the "eyeless" phenotype of Drosophila eya mutations (Bonini et al., 1997; Bui et al.,
2000).
Results and Discussion
We have explored a new function for EYA's C-terminal ED that is suggested by protein
motif searches and structural modeling studies. These investigations place EYA within the
phosphatase subgroup of the Haloacid dehalogenase (HAD) superfamily (Fig. 1 a and
Supplementary Fig. S la). HAD family members constitute a diverse collection of enzymes found
in all organisms ranging from bacteria and archaea to humans, that includes dehalogenases,
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ATPases, phosphonatases, phosphomutases, epoxy hydrolases and a growing number of
magnesium-dependent phosphatases (Collet et al., 1999; Collet et al., 1998; Thaller et al., 1998).
Understanding of the in vivo function of HAD family phosphatases remains extremely limited,
particularly in eukaryotic systems.
X-ray crystallography combined with mutagenesis studies of several HAD family
proteins has revealed a conserved ocl/-hydrolase fold that unites three non-contiguous sequence
motifs to form the catalytic core of the enzyme (Aravind et al., 1998; Collet et al., 1999;
Selengut, 2001). Structural modeling studies predict that the ED will form a HAD ol3-
hydrolase-like fold (Fig. b). Five conserved residues brought together by this tripartite
configuration surround the active site and are essential for catalysis (Aravind et al., 1998; Collet
et al., 1999; Selengut, 2001). These residues are strikingly conserved in the ED of all EYA
proteins (Fig. la and Supplementary Fig. Slb). In Motif 1 (DXDX(T/V)) the invariant first
aspartic acid serves as the nucleophile in all HAD family proteins and likely forms a phospho-
aspartate intermediate (Cho et al., 2001; Ridder and Dijkstra, 1999). The second aspartic acid
distinguishes the phosphatase/phosphohydrolase subgroup from other branches of the HAD
superfamily (Collet et al., 1998; Selengut, 2001; Thaller et al., 1998) and is strictly conserved in
all EYA homologs. Motif 2 contains an essential Serine/Threonine at the end of the 3-strand and
Motif 3 contributes at least three required residues, a lysine and two aspartic acids, the second of
which has undergone a conservative substitution to glutamic acid in EYA proteins. Requirement
for the two acidic residues within Motif 3 appears strictest within the phosphatase/
phosphohydrolase branch of the HAD superfamily (Thaller et al., 1998). The high degree of
conservation of this catalytic quintet (D, S/T, K, D, E) in invertebrate, vertebrate and plant EYA
homologs suggests that EYA belongs to the phosphatase subgroup of the HAD superfamily.
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Figure 1: EYA is a member of the phosphatase subgroup of the HAD superfamily.
a, The non-contiguous sequences comprising the HAD Motifs 1, 2, and 3. Pink residues
define the HAD motif, with those mutated in this study marked with a "*". Blue residues
are most strongly conserved among the phosphatase subgroup of the HAD superfamily.
Green residues are highly conserved in both ATPases and phosphatases (Aravind and
Koonin, 1998; Collet et al., 1999).
b, Structural modeling studies predict a similar active site configuration for Drosophila
EYA and other HAD proteins. The HAD template backbone is identified with a white
ribbon and the EYA model backbone is rendered with a cyan ribbon. Key active site
residues are highlighted as sticks, either white for the HAD or yellow for EYA.
c, Superimposition of mutant DmEYAHAD residues on the DmEYA model. Alignment
of the substitutions (in magenta) and their wild type counterparts (in yellow) is shown.

To investigate whether EYA has intrinsic phosphatase activity, we tested the ability of
recombinant GST-tagged ED fusions to dephosphorylate the synthetic substrate para-nitrophenyl
phosphate (pNPP). Using a murine homolog, we demonstrate that EYA can function as a
phosphatase (Fig. 2). Mutations altering the presumptive HAD active site residues severely
compromise activity (Fig. 2a; see Supplementary Information for details). Sensitivity to the
tyrosine phosphatase inhibitor vanadate, but not to inhibitors of serine/threonine phosphatases
(Fig. 2a and b), and a requirement for Mg++ are consistent with EYA being a HAD family
phosphatase (Selengut and Levine, 2000). We also tested recombinant Drosophila EYA in these
assays, and although its activity is significantly lower, it remains Mg++-dependent and vanadate
sensitive (Fig. 2c). While the most likely explanation for the weak in vitro activity of the fly ED
is that we have not identified appropriate conditions for purifying properly folded and active
protein, we cannot rule out the possibility that Drosophila EYA, although it retains all the
conserved residues comprising the HAD motif (Fig. 1), may have only limited ability to function
as a phosphatase. However, the fact that the mouse EYA isoform used in our in vitro assays is
able to substitute for Drosophila EYA in vivo (Bui et al., 2000), when considered together with
the results of the in vivo experiments described below, leads us to propose that EYA proteins
possess a conserved phosphatase function.
To investigate whether EYA might have protein phosphatase capability, something that
has not been definitively demonstrated for any other HAD family protein (Selengut, 2001),
several phosphotyrosine or phosphothreonine containing synthetic peptides were tested as
substrates. We find that EYA exhibits robust activity toward one of the tyrosyl phosphorylated
peptides, with a Km significantly lower than that measured using pNPP as a substrate (Fig. 2d).
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Figure 2: EYA exhibits phosphatase activity in vitro.
a, Kinetics for mouse EYA3 GST-ED fusion proteins (GST-MmEYA). D246N, T420A, K449Q,
D474N and E478Q are mutations analogous to the D493N, S670A, K699Q, D724N and E728Q
described for Drosophila EYA. For those mutant enzymes whose activity was too low to be
measured, >>> indicates a Km significantly higher and an efficiency (kcat/Km) significantly
lower than that measured for D246N.b, Like the HAD family phosphatase MDP1 (Selengut and
Levine, 2000), phosphatase activity of MmEYA is blocked by tyrosine phosphatase inhibitors
(Inhibitor II and Na3VO4) but not serine/threonine phosphatase inhibitors (Inhibitor I).c,
Phosphatase activity of Drosophila EYA (DmEYA), although significantly weaker than that
obtained with MmEYA, is also blocked by addition of the tyrosine phosphatase inhibitor
Na3VO4.d, Kinetics for mouse EYA3 GST-ED fusion proteins (GST-MmEYA) with respect to
the tyrosyl phosphorylated peptide substrate l(pY)GEF.
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No measurable activity was detected with the phosphothreonine or other phosphotyrosine
containing peptides (data not shown; see Methods for details). These results demonstrate that
EYA has protein tyrosine phosphatase (PTP) capability, although they do not rule the possibility
that EYA could dephosphorylate other substrates as well. The fact that not all tyrosyl
phosphorylated peptides were hydrolyzed suggests EYA has specific sequence preferences with
respect to its putative protein substrates. Because HAD family phosphatases employ a catalytic
aspartate (Cho et al., 2001; Ridder and Dijkstra, 1999) as the nucleophile rather than the cysteine
residue used by standard PTPs (Andersen et al., 2001), these results suggest EYA is the founding
member of a new class of non-thiol-based PTPs.
We have used the genetically tractable Drosophila system to investigate the physiological
relevance of EYA's putative PTP activity. For these experiments, site-directed mutagenesis was
used to target the five HAD active site residues in Drosophila EYA (Fig. c). Five single and
four double mutant combinations were generated and will be referred to collectively as the
EYAHA D mutants. These EYAHAD mutants were first tested in transfected Drosophila S2 cultured
cells where immunostaining and western blotting analyses revealed no apparent changes in
subcellular localization (data not shown) or expression levels (Supplementary Fig. S2a) relative
to EYAWT
EYA, like most other RD genes, induces formation of eye tissue outside the normal eye
field when ectopically expressed (Bonini et al., 1997; Hsiao et al., 2001; Treisman, 1999;
Wawersik and Maas, 2000). Scoring the percentage of flies exhibiting ectopic eye formation
provides a sensitive measurement of EYA activity (Hsiao et al., 2001). To determine whether the
HAD active site mutants compromise EYA's ectopic eye induction potential, we generated
transgenic lines carrying full-length EYAHAD mutant expression constructs. All EYAHA D mutants
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exhibit strikingly reduced ectopic eye induction relative to EYAWT (Fig. 3a). Protein expression
levels from the EYAHAD transgenes were comparable to those from EYAWT lines (Supplementary
Fig. S2b), indicating that the reduction in ectopic eye inducing potential reflects a change in
protein activity rather than reduced expression. Comparable reductions in EYA activity were
also observed with EYAHAD transgenes in which two of the five HAD active site residues were
mutated simultaneously (data not shown).
Because the HAD motif active site mutants compromise EYA's ability to induce ectopic
eye formation, we asked whether an intact HAD motif is required for normal EYA function
during eye development. We compared the ability of EYAWT versus EYAHAD transgenes to
complement the eye-specific loss-of-function eya2 allele. eya2 homozygous mutant flies exhibit a
completely penetrant "eyeless" phenotype, in which the entire eye is missing (Fig. 3c, d). For
these experiments we define "rescue" as the ability of a given transgene to produce recognizable
eye tissue within the normal eye field of an adult fly. We also estimate the size of the rescued eye
tissue relative to that of a wild type eye in order to compare the extent of rescue.
Expression of EYAWT transgenes rescues the eya2 "eyeless" phenotype with complete
penetrance (Fig. 3b, e) in both eyes of each individual fly (data not shown). In striking contrast,
all EYAHA D mutant transgenes exhibit a significantly reduced frequency and extent of rescue,
with rescue usually occurring in only one of the two eye fields of an individual (Fig. 3b, f). For
all EYAHAD transgenes tested, even in cases where rescue efficiency is only two to three fold
lower than that of EYAWT, the size of the rescued eye tissue is always significantly (5-10 fold)
reduced relative to that obtained with EYAWT lines (Fig. 3b, e, f). Western blot analyses of eye
imaginal discs again ruled out the possibility that reduced protein expression might be
responsible for this result (Supplementary Fig. S2c). In combination with the ectopic eye
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Figure 3: EYAHAD mutants exhibit severely reduced activity relative to EYAWT in ectopic
eye induction and genetic rescue assays.
a, The frequency of ectopic eye induction associated with expression of EYA transgenes was
calculated from multiple independent transgenic lines: EYAW T, 2465 flies from 8 lines (Hsiao
et al., 2001); EYAD4 93N, 1502 flies from 5 lines; EYAS67 0A, 955 flies from 3 lines; EYAK699Q,
953 flies from 3 lines; EYAD724N, 265 flies from a single line; EYAE72 8Q - 1239 flies from 4
lines.
b, The percentage of eyes from flies of the genotype eya2;UAS-EYA/dpp-GAL4 exhibiting
rescue of the eya2 "eyeless" phenotype (black bars) and average size of the rescued tissue
relative to a wild type eye (grey bars) is plotted. Data derives from the following lines:
EYAWT, 155 flies from two independent lines; EYAD493N, 124 flies from a single line;
EYAS6 70A, 281 flies from a single line; EYAK699Q, 176 flies from a single line; EYAD493N+S670 A,
209 flies from two independent lines; EYAD493N+D724N, 151 flies from two independent lines.
c-f, Scanning electron micrographs of adult eyes. c, w1118. d, eya2. e, eya2;UAS-EYAWT/dpp-
GAL4. f, eya2; UAS-EYAHAD/dpp-GAL4, arrow points to a small patch of rescued eye tissue.
-
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induction assay data, the results of these rescue experiments argue strongly that EYA's activity
as a putative HAD family phosphatase is required to promote normal eye development in
Drosophila.
Because the region of the ED that binds to the RD gene network protein SO (Bui et al.,
2000; Pignoni et al., 1997) partially overlaps with Motif I of the HAD domain (Supplementary
Fig. Slb), we checked whether the EYAHAD missense mutations compromise EYA's ability to
interact productively with SO. EYA and SO interact to form a potent transcriptional activator
required for eye specification, in which SO contributes the DNA binding domain and EYA
provides the transactivation potential (Ikeda et al., 2002; Pignoni et al., 1997; Silver et al., 2003).
Using a transcription assay in Drosophila S2 cultured cells (Silver et al., 2003), we find that the
ability of EYA"AD mutant proteins to synergize with SO to activate transcription of a reporter
gene is comparable to that of EYAWT (Fig. 4 and Supplementary Fig. S3). Although we cannot
rule out the formal possibility that in vivo the EYAHAD mutations disrupt interactions with other
proteins rather than blocking phosphatase activity, the finding that mutational disruption of the
HAD motif active site does not abrogate EYA's ability to function as a transcriptional coactivator
in conjunction with SO leads us to propose that EYA proteins have two essential functions: a
previously described role as a transcription factor and a novel role as a protein tyrosine
phosphatase.
To investigate further EYA's intrinsic PTP capability with respect to physiologically
relevant substrate candidates, we exploited our finding that EYA can be tyrosine phosphorylated
in Drosophila S2 cells (Fig. 5a; see Supplementary Information for discussion) by affinity
purifying full-length EYA from these cells and using it as a protein substrate in an in vitro
phosphatase reaction. Because the phosphotyrosine signal associated with the EYAHA D mutant
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proteins was consistently elevated relative to EYAWT (Fig. 5a; see Supplementary Information
for discussion), the EYAHAD protein was used as the substrate. We find that incubation of
EYA"AD protein with recombinant murine GST-ED fusion protein strongly reduces the
phosphotyrosine signal (Fig. 5b). HAD active site mutants that exhibit impaired activity both in
vitro and in vivo (Figs. 2 and 3) also have severely reduced activity in this assay (Fig. 5b). These
results demonstrate that EYA has PTP capability with respect to a full-length endogenous protein
substrate and that such activity depends on an intact HAD motif. Although we do not yet
understand the physiological relevance of tyrosine phosphorylation and dephosphorylation of
EYA, the results of these experiments (Fig. 5), together with our previous demonstration that
EYA is able to self-associate (Silver et al., 2003), suggest that EYA may act autocatalytically to
dephosphorylate itself.
In conclusion, we propose that EYA is both the founding member of a novel class of non-
thiol based PTPs and to our knowledge, the first example of a transcription factor with intrinsic
phosphatase activity. Further work will be required to understand how tyrosine phosphorylation
and dephosphorylation regulates EYA function in vivo, and what substrates, potentially
including EYA itself, may be regulated by its PTP activity. Elucidation of the biochemical
regulatory mechanisms that coordinate EYA's dual functions as transactivator and phosphatase
during eye specification will provide new insights into the function of the RD gene network, and
more generally a new paradigm for transcriptional regulatory strategies. Although preliminary
analyses have not identified other HAD-motif containing proteins that are annotated as
transcriptional regulators (R. R. L. and I. R., unpublished observation), it seems likely that dual
function mechanisms analogous to that we propose for EYA may prove to be a general strategy
for fine-tuning transcriptional output, particularly in highly regulated developmental systems.
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Figure 4: EYAHAD mutations do not disrupt EYA's role as a transcriptional
coactivator in conjunction with Sine oculis.
The Drosophila cell culture based transcription assays were performed as recently
described (Silver et al., 2003). Lanes: 1, Are-Luciferase; 2, WT; 3, D493N; 3, S670A; 4,
K699Q; 5, D724N; 5, E728Q; 6, D493N + S670A; 7, D493N + K699Q; D493N + D724N;
D493N + E728Q. See Supplementary Figure S3 for further details.
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Figure 5: EYA has protein tyrosine phosphatase capability.
Top panels show immunoblots probed with anti-phosphotyrosine (anti-P-Y); bottom
panels show immunoblots of the same samples probed with anti-Flag to detect EYA
(anti-EYA).
a, Lanes: 1-2, independent transfections of EYAWT; 3, EYAD4 93N + S670A;
4,EyAD 4 93 N + K699Q; 5, EyAD4 93N + D724N; 6, EyAD4 93N + E728Q. Fold increase in P-Y
levels for the EYAHAD mutants relative to an average of the P-Y signal in the two
EYAW T lanes, and corrected relative to the strength of the anti-EYA signal, is
indicated underneath the anti-P-Y blot.
b, Dephosphorylation of Drosophila EYA by recombinant GST-ED. Full length
tyrosine phosphorylated Drosophila EYAD4 93N + D724N (all lanes) was
immunoprecipitated and incubated with recombinant mouse GST-ED, either wild type
(WT) or HAD mutant variants (Lanes: 1-2, control; 3-4, WT; 5, D246N, 6, T420A; 7,
K449Q; 8, D474N; 9, E478Q). The percentage of anti-P-Y signal on EYAD493N + D724N
relative to controls and corrected for relative protein levels is indicated. Numbers
shown are an average from two independent experiments for each GST-ED tested;
results from only one of the two experiments are shown for the GST-ED HAD
mutants. Samples were run on the same gel to allow quantitative comparisons.
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Methods
Bioinformatics
The phylogenetic tree of a number of different hydrolase family members (PFAM 00702.6) was
generated by the neighbor-joining method using ClustalX(Thompson et al., 1997). EYA protein
sequences from Drosophila (Dm, gi:17737399), mouse (Mm, gi:6753794), human (Hs,
gi:3183005), zebrafish (Dr, gi:18858653), arabidopsis (At, gi:21593200) and nematode (Ce,
gi:3875091) were aligned with the Bacillus cereus phosphonoacetaldehyde hydrolase (Bc,
gi:10835405) HAD protein using ClustalX (Thompson et al., 1997). For the structural modeling
analyses, Prospect Pro (Xu and Xu, 2000) was used to thread the Drosophila EYA ED sequence
(DmEYA) against structures in the protein data bank. From these comparisons,
Phosphonoacetaldehyde hydrolase (PDB: FEZ) was selected as a suitable modeling template.
DmEYA and the template initially were aligned according to threading results and then modified
by anchoring several phosphonatase active site residues to their synonymous positions within
DmEYA. The structural model of DmEYA was created with Modeler (Sali and Blundell, 1993)
employing the alignment and using the coordinates of the Phosphonoacetaldehyde hydrolase
structure. The original template, FEZ, and the DmEYA model were aligned using CCP4
(Otwinowski, 1993). Key active site positions within the DmEYA model were replaced with the
variants described in this study using the Builder module within InsightIl (Accelrys TM, 2001).
Phosphatase assays
Phosphatase assays were performed using GST-ED fusion proteins (purification protocol
described in Supplementary Information). For enzyme kinetics with the synthetic substrate p-
Nitrophenyl Phosphate (pNPP, Sigma), assays were done in triplicatewith six substrate
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concentrations over six timepoints. 80ul reactions performed in microfuge tubes at 30°C in
200mM PIPES pH 7.0, 5mM EDTA and 0mM MgC12 were quenched by addition of 40ul of
10M NaOH. PNP anion was detected at 405 nm (extinction coefficient eM= 1.78 x 104 /cm M)
using a Tecan GENios plate reader. Reactions were normalized to buffer alone controls and the
results analyzed by Lineweaver-Burk plot using Microsoft Excel. Synthetic peptide substrates
tested were: I(pY)GEF and TSTGPE(pY)EPGENL (Calbiochem); END(pY)INASL,
DADE(pY)LIPQQG and RRA(pT)VA (Promega). 50ul reactions were performed at 250 C in
200mM HEPES pH7.0, 10 OmM MgC12, 5mM EDTA and quenched with 50g1 of Molybdate Dye
Solution (Promega). Malachite Green/Ammonium Molybdate-phosphate complex was detected
at 595 nm and converted to moles of free phosphate using a phosphate standard curve. Assays
with I(pY)GEF were carried out for five substrate concentrations over five timepoints and the
results were analyzed as described for pNPP.
Phosphatase Inhibitor Cocktail Sets I and Set II (Calbiochem) were used at 1:50 in pNPP
phosphatase assays. Sodium Orthovanadate was used at 4mM final concentration in pNPP
phosphatase assays.
Amino terminally flag epitope tagged EYA constructs were subcloned into the copper inducible
metallothionein promoter vector. 5 gig of DNA for each construct was transfected into S2 cells as
previously described(Tootle et al., 2003). Following published protocols(Cohen et al., 1997;
Huyer et al., 1997; Imbert et al., 1994; Ruff et al., 1997; Scanga et al., 2000), cells were treated
with 100MM NaVO 3, 200tM H202 for 15 minutes prior to lysis in 100mM NaCI, 50mM Tris, pH
7.5, 2mM EDTA, 2mM EGTA, 1% NP-40, lmM Na3VO4, and one mini-complete protease
inhibitor tablet (Roche) per 10 ml. All subsequent solutions include lmM Na3VO4. Clarified
lysates were incubated with 251tl of anti-flag M2 agarose affinity gel (Sigma) for 1.5 hours at
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4°C. Beads were washed twice in lysis buffer and twice in 10mM Tris, pH 7.5, 150mM NaCl,
resuspended in 30gl of 2x SDS sample buffer, boiled and 10 gl were loaded per lane. Westerns
were performed as previously described(O'Neill et al., 1994) except that blocking and antibody
incubations were performed in 1% Casein According to Hammarsten (EM Science). Antibodies:
guinea pig anti-Eya 1:16,000, rabbit anti-phosphotyrosine 1:400 (.21 mg/ml, Upstate); HRP-
conjugated goat anti-guinea pig and anti-rabbit 1:5000 (Jackson ImmunoResearch).
Determination of fold increase in phospho-tyrosine signal relative to EYA protein amounts was
performed using NIH Image software; samples analyzed in this way were always run together on
the same gel.
To obtain sufficient tyrosine phosphorylated Drosophila EYA to use as a substrate in the in vitro
phosphatase assay, a stable cell line expressing flag-tagged EyaD 4 9 3N + D724N was generated. 500l
of cells were immunoprecipitated for each reaction as described above, except the lmM Na3VO 4
was omitted from the wash buffer. The washed immunoprecipitates were incubated in
phosphatase assay reaction buffer (as described above but without pNPP), either with GST
agarose or with 100g GST-ED proteins for 1 hour at 300C, processed for western blotting and
analyzed as described above.
Molecular Biology and Genetics
Site-directed mutagenesis, subcloning, generation of transgenics, crosses, ectopic eye scoring,
calculation of % ectopic eye induction and scanning electron microscopy were performed as
previously described (Hsiao et al., 2001; Tootle et al., 2003). Fly crosses were at 25C with the
exception of the genetic rescue assays which were performed at 200 C.
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The cell culture based transcription assays were performed as recently described (Silver et al.,
2003). For western blot analyses of protein expression levels, equivalent samples of either S2
cells, embryos or dissected eye-imaginal discs were lysed in SDS-sample buffer, separated by
SDS-PAGE and immunoblotted with GP anti-EYA antiserum diluted 1:10,000.
Protein Purification
GST-MmEYA3 ED (aa 237-510 of mouse EYA3) or GST-DmEYA ED (aa 438-760 of
Drosophila EYA) fusion proteins were purified from BL21 E. coli cells grown to an OD600 of 1.0
and then induced with IPTG for 2.5 hours at 18°C. Cells were harvested by centrifugation,
resuspended in 50mM Tris buffer pH 8.0, 1 mM EDTA and 100mM NaCl plus protease inhibitor
cocktail (1 tablet per 50 mls, Roche) and lysed by three passes through a French Press at 1000
psi. Clarified lysates were rocked overnight at 40 C with glutathione-agarose beads. Beads were
washed five times with 50mM HEPES, 300mM NaC1, and left in a final 1:1 slurry. Protein
concentrations were estimated by Coomassie Blue staining of an SDS-PAGE gel run with a
dilution series of GST-ED and a BSA standard curve. Depending on the protein concentration,
appropriate amounts of beads were diluted for the phosphatase assays. To determine Km and
enzyme efficiency, GST-ED was eluted by rocking for 20 minutes at 4°C with 300mM reduced
glutathione in 50mM Tris pH 7.0, 150mM NaCI. For peptide assays, I 0mM reduced glutathione
was used in the elutions. Protein concentrations were determined by Bradford Assay.
Phosphatase Inhibitor Cocktail Ingredients
Inhibitor Cocktail Set I (Calbiochem) contains p-Bromotetramisole (inhibits alkaline
phosphatase), Oxalate 2.5mM, Cantharidin 500uM (inhibits serine/threonine protein
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phosphatase), Microcystin LR 500nM (inhibits serine/threonine protein phosphatase). Inhibitor
Cocktail Set II (Calbiochem) contains 200mM Imidazole (inhibits alkaline phosphatase), 100mM
Sodium Fluoride (inhibits acid phosphatase), 115 mM Sodium Molybdate (inhibits acid
phosphatase), 100mM Sodium Orthovanadate (inhibits protein tyrosine phosphatase and
alkaline phosphatase), and 400mM Sodium Tartrate Dihydrate (inhibits acid phosphatase).
154
Supplementary Information
Discussion
We have found that EYA is a novel protein tyrosine phosphatase member of the HAD
superfamily. Specific point mutations shown previously to compromise the HAD active site in
other superfamily members severely reduce EYA's phosphatase activity. The in vitro assays, one
using pNPP or a tyrosyl phosphorylated peptide as artificial substrates (Fig. 2) and the other
using tyrosine phosphorylated Drosophila EYA protein as a physiologically relevant substrate
(Fig. 5), and the in vivo assays, ectopic eye induction and genetic rescue (Fig. 3), consistently
reveal this trend. However there are subtle activity differences between the various mutants
tested, as well as slight variations between the same mutants tested in different assays.
The most notable example results from our analyses of the D493N mutant (D246N in
murine EYA3). This mutation alters the aspartic acid residue that serves as nucleophile and
forms a phospho-aspartate intermediate in the reaction(Cho et al., 2001; Ridder and Dijkstra,
1999). Given its critical role in catalysis, the prediction is that a mutation in this residue should
severely compromise activity. In fact, in all the in vitro assays (Fig. 2 and Fig. 5b) and in the
ectopic eye induction assays (Fig. 3a), the activity of D246N is greatly compromised. However
in the genetic rescue experiment, although activity is significantly reduced relative to EYAWT,
the residual activity is greater than that measured for any of the other HAD mutants (Fig. 3b).
While the reason for this is unclear, it presumably reflects the complexity of assaying function in
the context of normal eye development, where both functions of EYA as a phosphatase and as a
transcriptional cofactor are required. Elucidation of the mechanisms whereby EYA's dual
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functions as transcriptional coactivator and phosphatase are coordinated will be required to fully
understand such subtle distinctions in activity between the different HAD active site mutants in
vivo and how these correlate with their relative activities in vitro.
A second example is the D724N mutant (D474N in murine EYA3), which unlike all the
other mutants tested and consistent with its previously characterized role in Mg ++ binding rather
than substrate binding(Cho et al., 2001), does not increase the Km measured in the pNPP assay
(Fig. 2). Activity in both the PTP and ectopic eye induction assays is comparable, although
perhaps slightly elevated, to that measured for the other HAD active site mutants. In general,
interpreting modest differences in activities between different mutants in the various assays must
be performed with caution because we do not yet understand the biochemical mechanisms that
coordinate and regulate EYA's dual functions as transcription factor and phosphatase.
The Drosophila EYAHAD protein used in the PTP assay (Fig. 5b) was purified from a
stably transfected S2 cell line that had been artificially stimulated with pervanadate. Confirming
that EYA is tyrosine phosphorylated in the absence of pervanadate, we find that EYAHA D is
tyrosine phosphorylated in unstimulated cells, although the signal is reduced relative to that
observed in stimulated cells (Fig. S4a). We have been unable to immunoprecipitate sufficient
EYAW T protein from transient transfections to detect a signal in the absence of pervanadate and
efforts to generate a stable cell line have not yet been successful(Clark et al., 2002). Therefore, to
facilitate detection of PTP activity in our assay (Fig. 5b), we elected to purify EYAHA D protein
from pervanadate stimulated cells in order to increase the pool of tyrosine phosphorylated
protein substrate.
The most likely explanation as to why we require the use of pervanadate to detect
tyrosine phosphorylation of EYA in transiently transfected cells (Fig. 5a) is that EYA has
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autocatalytic activity and actively dephosphorylates itself. Drosophila S2 cells express
significant levels of endogenous wild-type EYA. We have recently shown that EYA has the
ability to self-associate(Silver et al., 2003), leading us to postulate that endogenous EYA may
associate with the transfected EYA and dephosphorylate it. Addition of pervanadate presumably
greatly impairs, but does not totally knock out phosphatase activity resulting in a weak but
detectable signal for EYAWT (Fig. 5a, Lanes I and 2). This interpretation is consistent with our
finding that addition of vanadate in the pNPP assay doubles the apparent Km, but does not
completely inactivate the enzyme (Fig. 2a). EYAHAD mutants exhibit increased phosphotyrosine
signal in this assay (Fig. 5a), likely reflecting their reduced activity as a phosphatase (Fig. 2). In
the case of the stable cell lines expressing the catalytically inactive EYAHAD mutants, in the
absence of pervanadate, the endogenous EYA is sufficiently active to dephosphorylate a
significant portion, but not all, of the overexpressed EYAHAD mutant protein (Fig. S4a).
However, because these experiments were carried out in Drosophila cells rather than in vitro, it
is possible that rather than reflecting impairment of intrinsic PTP activity in the EYAHAD
mutants, the increased phosphotyrosine signal resulted from a second coprecipitating PTP that
interacts more strongly with EYAWT than with EYAHAD, or from the EYAHAD proteins serving as
better substrates for the relevant tyrosine kinase. Arguing against this interpretation, we find that
incubation with recombinant EYAWT fusion protein, but not EYAHAD fusion protein, strongly
reduces the phosphotyrosine signal associated with Drosophila EYAH A D (Fig. 5b). This suggests
that EYA may serve as its own substrate, likely acting in trans to dephosphorylate itself. Based
on our genetic analyses indicating that EYA's phosphatase activity is required for eye
specification and development (Fig. 3), we propose that EYA may autoactivate by
dephosphorylating itself on specific tyrosine residues.
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Figure SI: EYA is a member of the phosphatase subgroup of the HAD superfamily.
a, A HAD superfamily phylogenetic tree suggests EYA proteins are related to protein
phosphatases. Branches are labeled with the two letter species abbreviation and common protein
name. The EYA branch is highlighted in red.b, Multiple Sequence Alignment reveals that the
conserved EYA domain shares similarity with the HAD hydrolase domain, particularly in those
regions implicated in forming the active site (PFAM 00702.6). Residues comprising Motifs 1-3
of the HAD domain are boxed. Labeled arrows designate the positions of variant residues used in
this study or identified in Drosophila and human EYA mutations. Site-directed mutations
generated in this study are shown in red. Additional variants associated with specific Drosophila
eya alleles (Bui et al., 2000) or derived from human patients suffering from the EYA1-specific
branchio-oto-renal syndrome (Azuma et al., 2000) are shown in black, with the human mutations
prefaced with the letter "h". While none of these variants overlap with the five residues focused
on in this study, one, the Drosophila G723E mutation, affects a conserved glycine residue in
Motif 3 of the HAD domain. The putative SINE OCULIS binding site (Bui et al., 2000; Pignoni
et al., 1997) is denoted with a solid black line.
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Figure S2: HAD active site mutations do not result in appreciable changes in protein
levels relative to wild type EYA.
a, Western blot of transfected S2 cells showing comparable expression of EYAHAD mutants
relative to EYAW T . Equivalent samples from pools of stably transfected S2 cell lines
expressing EYAW T and four different EYAHAD mutants. Lanes 1-5: EYAWT; EYAD493N + S670A;
EyAD 4 93N + K699Q; EYAD 4 93N + D724N; EYAD49 3 N + E728Q
b, Western blots of equivalent samples of embryos in which the EYA transgenes have been
expressed using a ubiquitin-GALA driver line reveal comparable expression levels in
EYAHAD lines relative to EYAWT. Each lane represents an independent transgenic line.
Lanes: 1-4, EYAWT; 5-9, EYAD4 9 3N; 10-13, EYA S670A; 14-17, EYAK69 9 Q; 18, EYAD 72 4N; 19-
22, EYAE72 8Q; 23-24, EYAD49 3 N + D724N
c, Western blots of equivalent samples of eye imaginal discs in which the EYA transgenes
have been expressed using a dpp-GAL4 driver line reveal comparable expression levels in
EYAHAD lines relative to EYAWT. Each lane represents an independent transgenic line used
in the rescue assay. EYA sometimes runs as a doublet (for example, lanes 1 and 2 and lanes
16-20 of panel 3c). Lanes: 1, EYAWT; 2, EYAD493N; 3, EYAS6 7OA; 4, EYAK6 9 9Q; 5&6,
EYAD 4 93N + S670A; 7, EYAD4 93N + D724N
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Figure S3: EYAHAD mutations do not disrupt EYA's role as a transcriptional
coactivator in conjunction with SO.
EYAWT versus EYAHAD activity was tested at three different concentrations of EYA
DNA (1.25 ug, 2.5 ug and 5 ug) to confirm the linearity of response. A mutation
(A223-438; last sample in graph) that deletes the transactivation domain of EYA, but
can still bind SO (Silver et al., 2003), demonstrates that it is possible to block activity
in this assay system. The reporter baseline level in the absence of EYA and SO is
shown (ARE-luciferase; first sample in graph).
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Figure S4: Using tyrosine phosphorylated
vitro phosphatase reaction.
EYAHAD as a substrate in an in
a, Tyrosine phosphorylation of EYAHAD in the absence of pervanadate is reduced
relative to levels achieved in the presence of pervanadate. Quantitation was not
performed because the exposure time necessary to obtain a sufficiently strong signal
in the (-) pervanadate lane placed the signal in the (+) pervanadate range outside of
the linear range of detection. b, A titration curve of amounts of GST-ED necessary
to achieve maximal activity in the PTP assay was performed. Duplicate experiments
are shown. Lanes: 1-2, lug, set at 100%; 3-4, 5ug; 5,6, 10ug; 7,8, 50ug.
EYAD493N+D724N was used as the substrate as in Figure 4b.

References
Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., Olsen, O. H.,
Jansen, P. G., Andersen, H. S., Tonks, N. K., and Moller, N. P. (2001). Structural and
evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol
21, 7117-7136.
Aravind, L., Galperin, M. Y., and Koonin, E. V. (1998). The catalytic domain of the P-type
ATPase has the haloacid dehalogenase fold. Trends Biochem Sci 23, 127-129.
Aravind, L.,'and Koonin, E. V. (1998). The HD domain defines a new superfamily of metal-
dependent phosphohydrolases. Trends Biochem Sci 23, 469-472.
Azuma, N., Hirakiyama, A., Inoue, T., Asaka, A., and Yamada, M. (2000). Mutations of a
human homologue of the Drosophila eyes absent gene (EYA 1) detected in patients with
congenital cataracts and ocular anterior segment anomalies. Hum Mol Genet 9, 363-366.
Bonini, N. M., Bui, Q. T., Gray-Board, G. L., and Warrick, J. M. (1997). The Drosophila eyes
absent gene directs ectopic eye formation in a pathway conserved between flies and
vertebrates. Development 124, 4819-4826.
I3ui, Q. T., Zimmerman, J. E., Liu, H., and Bonini, N. M. (2000). Molecular analysis of
Drosophila eyes absent mutants reveals features of the conserved Eya domain. Genetics
155, 709-720.
Chen, R., Amoui, M., Zhang, Z., and Mardon, G. (1997). Dachshund and eyes absent proteins
form a complex and function synergistically to induce ectopic eye development in
Drosophila. Cell 91, 893-903.
Cho, H., Wang, W., Kim, R., Yokota, H., Damo, S., Kim, S.-H., Wemmer, D., Kustu, S., and
Yan, D. (2001). Beryllium Fluoride acts as a phoshpate analog in proteins phosphorylated
167
on aspartate:Structure of a Beryllium Fluoride complex with phosphoserine phosphatase.
PNAS 98, 8525-8530.
Clark, S. W., Fee, B. E., and Cleveland, J. L. (2002). Misexpression of the eyes absent family
triggers the apoptotic program. J Biol Chem 277, 3560-3567.
Cohen, J., Altaratz, H., Zick, Y., Klingmuller, U., and Neumann, D. (1997). Phosphorylation of
erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition
of tyrosine phosphatases. Biochem J 327 (Pt 2), 391-397.
Collet, J. F., Stroobant, V., and Van Schaftingen, E. (1999). Mechanistic studies of
phosphoserine phosphatase, an enzyme related to P-type ATPases. J Biol Chem 274,
33985-33990.
Collet, J. F., van Schaftingen, E., and Stroobant, V. (1998). A new family of phosphotransferases
related to P-type ATPases. Trends Biochem Sci 23, 284.
Hsiao, F. C., Williams, A., Davies, E. L., and Rebay, I. (2001). Eyes absent mediates cross-talk
between retinal determination genes and the receptor tyrosine kinase signaling pathway.
Dev Cell 1, 51-61.
Hunter, T. (2000). Signaling--2000 and beyond. Cell 100, 113-127.
Huyer, G., Liu, S., Kelly, J., Moffat, J., Payette, P., Kennedy, B., Tsaprailis, G., Gresser, M. J.,
and Ramachandran, C. (1997). Mechanism of inhibition of protein-tyrosine phosphatases
by vanadate and pervanadate. J Biol Chem 272, 843-851.
Ikeda, K., Watanabe, Y., Ohto, H., and Kawakami, K. (2002). Molecular Interaction and
Synergistic Activation of a Promoter by Six, Eya, and
Dach Proteins Mediated through CREB Binding Protein. Molecular and Cellular Biology 22,
6759-6766.
168
Imbert, V., Peyron, J. F., Farahi Far, D., Mari, B., Auberger, P., and Rossi, B. (1994). Induction
of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of
protein tyrosine phosphatases. Biochem J 297 (Pt 1), 163-173.
Kim, S. S., Zhang, R., Braunstein, S. E., Joachimiak, A., Cvekl, A., and Hegde, R. S. (2002).
Structure of the retinal determination protein dachshund reveals a DNA binding motif.
Structure (Camb) 10, 787-795.
O'Neill, E. M., Rebay, I., Tjian, R., and Rubin, G. M. (1994). The activities of two Ets-related
transcription factors required for Drosophila eye development are modulated by the
Ras/MAPK pathway. Cell 78, 137-147.
Otwinowski, Z. (1993). Oscillation data reduction program. In Proceedings of the CCP4 Study
Weekend: Data Collection and Processing. SERC Daresbury Laboratory N. I. L. Sawyer,
and S. Bailey, ed., pp. 56-62.
Pignoni, F., Hu, B., Zavitz, K. H., Xiao, J., Garrity, P. A., and Zipursky, S. L. (1997). The eye-
specification proteins So and Eya form a complex and regulate multiple steps in
Drosophila eye development. Cell 91, 881-891.
Ridder, I., and Dijkstra, B. (1999). Identification of the Mg 2+ -binding site in the P-type
ATPase and phosphatase members of the HAD (haloacid dehalogenase) superfamily by
structural similarity to the response regulator protein CheY. Biochemical Journal 339,
223-226.
Ruff, S. J., Chen, K., and Cohen, S. (1997). Peroxovanadate induces tyrosine phosphorylation of
multiple signaling proteins in mouse liver and kidney. J Biol Chem 272, 1263-1267.
Sali, A., and Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial
restraints. J Mol Biol 234, 779-815.
169
Scanga, S. E., Ruel, L., Binari, R. C., Snow, B., Stambolic, V., Bouchard, D., Peters, M.,
Calvieri, B., Mak, T. W., Woodgett, J. R., and Manoukian, A. S. (2000). The conserved
PI3'K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila.
Oncogene 19, 3971-3977.
Selengut, J. D. (2001). Mdp-l is a new and distinct member of the haloacid dehalogenase family
of aspartate-dependent phosphohydrolases. Biochemistry 40, 12704-12711.
Selengut, J. D., and Levine, R. L. (2000). MDP-1: A novel eukaryotic magnesium-dependent
phosphatase. Biochemistry 39, 8315-8324.
Silver, S. J., Davies, E. L., Doyon, L., and Rebay, I. (2003). A functional dissection of Eyes
absent reveals new modes of regulation within the retinal determination gene network.
Molecular and Cellular Biology 23, 5989-5999.
Thaller, M. C., Schippa, S., and Rossolini, G. M. (1998). Conserved sequence motifs among
bacterial, eukaryotic, and archaeal phosphatases that define a new phosphohydrolase
superfamily. Protein Sci 7, 1647-1652.
Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F., and Higgins, D. G. (1997). The
CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment
aided by quality analysis tools. Nucleic Acids Res 25, 4876-4882.
Tootle, T. L., Lee, P. S., and Rebay, I. (2003). CRM1-mediated nuclear export and regulated
activity of the Receptor Tyrosine Kinase antagonist YAN require specific interactions
with MAE. Development 130, 845-857.
Treisman, J. E. (1999). A conserved blueprint for the eye? Bioessays 21, 843-850.
Wawersik, S., and Maas, R. L. (2000). Vertebrate eye development as modeled in Drosophila.
Hum Mol Genet 9, 917-925.
170
Xu, Y., and Xu, D. (2000). Protein threading using PROSPECT: design and evaluation. Proteins
40, 343-354.
171

Chapter 4
The lozenge minimal eye enhancer can be used to examine
the function of the EYA-SO transcription factor on a native
promoter
Serena J. Silver and Ilaria Rebay
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Introduction
Studies of the EYA-SO transcription factor have been limited by lack of known in vivo
targets in Drosophila. Recent work from Utpal Banerjee's lab has identified the lozenge (lz)
minimal eye enhancer (LMEE) as a regulatory target of SO (Yan et al., 2003). The LMEE is a
250 bp region which requires DNA binding sites for SO and GLASS to recapitulate the eye
specific expression of LZ (Yan et al., 2003; Figure A).
The SO binding site identified in the LMEE, TGATAT, is similar to the site identified in
vitro through SO homeodomain interactions with plasmid DNA, GATAC (Hazbun et al., 1997).
More striking perhaps is the physical arrangement of the two SO binding sites, which are found
in an almost perfect palindrome separated by 8 bp, and are almost two hundred bp downstream
of the GLASS binding sites. This promoter architecture may be crucial to accommodate
cofactors or multiprotein complexes for endogenous gene regulation.
The LMEE therefore provides an exciting new tool for examination of the EYA-SO
transcription factor in a more native setting. By inserting this genomic region upstream of a
luciferase reporter gene, we can ask whether activation of this reporter is modulated by other
signaling networks or mutations in EYA and SO. We can also compare the effects of these
changes on LMEE-luciferase to those we see with ARE-luciferase, a reporter gene with 7 tandem
copies of the mouse SIX binding site AREC3, which we have previously used to study the EYA-
SO transcription factor (Silver et al., 2003).
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Results and Discussion
LMEE-luciferase can be used as readout of EYA-SO activity in S2 cell culture
LMEE-luciferase is activated to low levels when expressed alone in S2 cells, or with
EYA or SO alone, but when co-expressed with both EYA and SO, 11 fold activation is observed
(Figure B). This activation is due to direct binding of SO to the LMEE sequence, as mutation of
the SO binding sites sharply decreases this activity while mutation of the GLASS binding sites
does not (data not shown). Furthermore, activation of LMEE-luciferase requires the
transactivation potential of the PST-rich region of EYA, implicating the EYA-SO complex in
regulation of this native promoter (Figure B).
I)AC is a co-activator of the EYA-SO transcription factor, independent of EYA-mediated
phosphatase activity
We then examined whether the RD gene member DAC might affect regulation of this
promoter, as DAC is thought to physically interact with EYA and has been suggested to act as a
co-repressor or co-activator (Ikeda et al., 2002; Li et al., 2003; Li et al., 2002). DAC appears to
co-activate the LMEE-luciferase reporter gene (Figure 2). This is unlike our observations with
the ,4RE-luciferase reporter gene, where we did not observe any effect upon contransfection of
DAC (Silver et al., 2003).
Recent work from our lab and others identified a new function for EYA as a protein
phosphatase (Li et al., 2003; Rayapureddi et al., 2003; Tootle et al., 2003), which we have shown
to be independent from its role as a transactivator (Tootle et al., 2003). However, it has been
suggested that the phosphatase activity of EYA might act to switch the function of a SIXI -
DACH complex from repression to activation (Li et al., 2003). These experiments showed
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SIX 1 -DACH mediated repression of a heterologous promoter, which could be relieved by
coexpression of wildtype but not phosphatase mutant EYA (Li et al., 2003). As the LMEE-
luciferase provides a new readout of DAC cooperativity with the EYA-SO transcription factor,
we asked if the EYA phosphatase function affects this coactivation. From the model outlined
above, one would predict that EYA phosphatase activity would be required for DAC coactivation
of LMEE-luciferase, or that EYA phosphatase activity might be required for even EYA-SO
activation of LMEE-luciferase.
In order to remove EYA phosphatase activity we used point mutations in each of the five
key residues for HAD family member function, which we have previously shown to be crucial
for EYA phosphatase function in vitro (Tootle et al., 2003). As mentioned above, these point
mutations, singly or doubly, did not affect EYA-SO mediated activation of ARE-luciferase
(Tootle et al., 2003). Upon testing with LMEE-luciferase, we found that some retained full
activity while others were compromised (Figure 3). More strikingly, we found that all could be
activated further by co-expression of DAC (Figure 3), indicating that EYA phosphatase activity
is not required for DAC to function as a co-activator in S2 cells. It remains to be understood
why this result differs from that found in mammalian cell culture, although cell context specific
differences as well as promoter specific attributes are likely to play important roles. It is also
intriguing that addition of DAC can activate even compromised EYA mutants to similar levels as
wildtype (Figure 3), suggesting that high levels of DAC may in some way compensate for these
point mutations.
It is also quite striking that we observe different results using ARE-luciferase and LMEE-
luciferase. As mentioned above, we do not observe any effect of DAC on ARE-luciferase
activation assays (Silver et al., 2003). It is intriguing to ask whether DAC might require contact
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lozenge locus
5'
!-I v l-T
3,
LMEE
5'- ATCCGATCCCCGAAAGGTGGAGCGCACATTCTTGCCACATCCTTGC
ACAATGCACTTCTGGGGCTTCCACATCGTGGCAATCACGATCATCGGA
CGCAGCCTTATCGGATTCCATGGGTATGATGATCGTGATGATGATACCG
ATGGCGATGATGATGGTGATGCCAGTGAAGATGGGACTGGCATCGCCG
TCGGAATATGCGTAAATTGATATCAATAATTGTTATTGATATCAACGCAC
GAGTCGTTCCCCTTTTTTATTTTGTTAATGCCACCTTTT-3'
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Figure 1: The lozenge minimal eye enhancer (LMEE) is a SO target
In A, the LMEE is found in the second intron of the lozenge gene, and contains two
palindromic SO binding sites, shown here in red, within a larger footprint of SO, shown
in bold (adapted from Yan et al.). Upstream GLASS binding site is shown in blue. In B,
transient transfection reporter assays show that LMEE-luciferase can be used in S2 cells
to measure EYA-SO activity, with 1 -fold induction above background when both are
present. This readout is dependent on EYA transactivation ability, as deletion of the PST
rich region of EYA abrogates activation.
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Figure 2: DAC can potentiate EYA-SO mediated transcription
Co-transfection of DAC leads to greater LMEE-luciferase activitation by EYA and SO.
I

with the DNA independently of EYA and SO, which the architecture of the ARE-luciferase
reporter gene with 7 tandem SO binding sites (compared with LMEE-luciferase in Table 1)
might not allow. In contrast, LMEE-luciferase contains only two SO binding sites found as a
palindrome, with over 200 bp of native promoter sequence which might contain DAC binding
sites.
RAS-MAPK signaling activates EYA-SO mediated transcription
Previously we have shown that phosphorylation of EYA, likely by MAPK, can activate
the EYA-SO transcription factor (Silver et al., 2003). In order to ask whether this is also the case
in the context of LMEE-luciferase, we made use of several tools to examine the effects of RAS
activity on EYA; coexpression of activated RAS, RASV 2, and mutation of the phosphoacceptor
serines in EYA to alanine (EYAS - A) to prevent phosphorylation, and to aspartic or glutamic acid
(EYAS -D) to mimic phosphorylation. We found that serine phosphorylation is not required for
EYA-SO activation of LMEE-luciferase, but that activation is increased upon cotransfection of
Ras V 2 or use of the phosphomimetic EYA mutant (Figure 4). We observe a much greater impact
upon using RASV2, which may reflect more complex affects of RAS activation on the RD gene
network as a whole, or even on EYA. It is likely that the two previously identified MAPK
phosphoacceptor sites are not the only input point for RAS activation of the EYA-SO
transcription factor, as activation is also observed when RAS is cotransfected with mutant
EYAS -A or EYAS -D /E (Figure 4).
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TABLE 1: A Comparison of ARE and LMEE luciferase reporter constructs
2 palindromic binding sites
TGATAT
8 bases between binding sites
glass binding sites
Ets binding sites
250 bp total length
Drosophila lozenge
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TT
zc-99
* EYA, SO
* EYA, SO, DAC
bO
Figure 3: EYA phosphatase activity is not required for DAC coactivation
Some of the EYAHAD mutants which are defective for phosphatase function have lower
levels of transcriptional activation (blue). However, all are co-activated by DAC
expression to levels close to that of wildtype EYA (red), suggesting that DAC
expression might overcome the problem caused by these point mutations.
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Figure 4: RAS activates the EYA-SO transcription factor
Mutation of the EYA phosphoacceptor residues to alanine does not affect transactivation, but mutation
of the residues to glutamic or aspartic acid to mimic phosphorylation increases EYA transcription
factor activity. Activated RAS can also stimulate the EYA-SO transcription factor, likely through
additional residues or functions as stimulation can also be seen for the phosphoacceptor mutants.
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Chromatin IP experiments show SO directly binds to the LMEE in vivo
Chromatin immunoprecipitation (ChIP) experiments can be used to ask whether nuclear
factors that activate promoters do so by direct binding to that promoter sequence. The LMEE
might provide an important tool to study RD gene network member association with target DNA.
Our initial focus was to ask whether SO is associated with the LMEE in Drosophila cell culture
using S2 cells, and if we could detect SO association with the LMEE in Drosophila eye discs,
where genetic and molecular evidence suggested it would bind (Yan et al., 2003).
We found that immunoprecipitation of endogenous SO, from eye discs and from S2 cells,
showed association with the LMEE (Figure 5). This suggested that this promoter might be used
to examine association of other RD gene network members, such as EYA and DAC, that are
thought to complex with SO to affect transcription of target genes.
In summary, the LMEE provides a useful new tool for study of the EYA-SO transcription
factor in a more native setting. Already this promoter can be clearly seen to behave differently
from less native constructs such as ARE-luciferase, and cell culture studies of different promoters
in vertebrates, differences which may help us to better understand the regulatory mechanisms
governing the EYA-SO transcription factor in vivo. Through a combination of ChIP experiments
and transcription assays, we may also be able to differentiate between signals and mutations
which affect EYA-SO localization to DNA versus their ability to activate transcription.
187
188
INPUT a-SO IP
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Figure 5: SO is bound to the LMEE in vivo
PCR from wildtype eye discs following ChIP with SO antibody. The LMEE is
4.5x enriched in the SO IP as compared to input using Ac5c as a control (A;
analysis performed using NIH image). Endogenous SO can also associate with
the LMEE in S2 cells, compare LMEE association after SO IP to preimmune
sera IP (B). Numbers on the left indicate basepairs on ladder.

Materials and Methods
LMEE-luciferase subcloning and transcription assays
The 250 bp LMEE was amplified from the LMEE-lacZ plasmid or LMEES°-lacZ or LMEEg l-
lacZ plasmids (gifts from U. Banerjee, described in Yan et al., 2003) by PCR using the Universal
primer and a LMEE A Pstl 5'-CTGCAGCATTAACAAAATAAAAAAGGGG-3'. This PCR
product includes an endogenous KpnI site upstream of the LMEE, and using that site and the
PCR produced PstI site was cloned into the Kpnl/PstI sites upstream of the hsp70 TATA box in
BSSK-TATA-luciferase. Transcription assays were performed in duplicate as previously
described in Silver et al., 2003, using 5ug per assay of the reporter gene and each expression
plasmid (expression plasmids previously described in Silver et al., 2003 and Tootle et al., 2003,
and normalized using lug of Ac-lacZ per assay.
ChromatinlP experiments
For S2 cells: Protocol used as for Kc cells from D. MacAlpine, Bell lab, with the exception that
a Quiagen PCR purification kit was used to purify DNA after immunoprecipitation, and DNA
eluted in 30ul.
For eye discs: Protocol adapted from D. MacAlpine and R. Austin protocols for Kc cells and
egg chambers, respectively.
1. Approximately 70 eye disc pairs, some with brains attached, were dissected and fixed in
2% formaldehyde for 15 minutes, rocking.
2. Add 2.5 M glycine to 125 mM (if you suspend discs in lml S2 cell media to fix, adding
54 ul of 37% formaldehyde, just add 50ul of 2.5M glycine here). Incubate 5 minutes.
KEEP ON ICE.
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3. Was twice with 1 ml cold TBS. (You may be able to freeze at this point but I have not
tried it - you can certainly keep it in the cold room for a bit if you're dissecting more
samples)
4. Add protease inhibitors to hypotonic and ChIP lysis buffers before use.
5. Resuspend pellet in lml hypotonic buffer, and let sit for 20 minutes on ice.
6. Remove all but 1 00ul of hypotonic buffer from the discs. Use a tight dounce to crush the
disc about 30 times. After douncing add another 900 ul of hypotonic buffer, and pellet at
low speed (1000K on table top) for 10 minutes. Wash with 1 ml hypotonic buffer and
pellet again at low speed.
7. Resuspend pellet in 500 ul ChIP lysis buffer - let cells sit for 15-30 minutes on ice.
8. Sonicate three times for about 15 seconds each at power setting 1.5, 100% duty cycle -
make sure the sonicator is at 1.5 or your sample will fly all over the place!!! Keep
samples on ice when not sonicating.
9. Spin at 14K for 10 minutes at 4 degrees and put supernatant in a fresh tube. Freeze at -80
until you have enough samples to do your experiment.
10. Add antibody. SO immunoprecipitation was performed using 2ul of GP anti-SO per
500ul lysate. Controls were performed using the same amount of prelmmune sera from
GP. Rock overnight at 4 degrees.
11. Wash G protein coupled sepharose beads (also called Gamma-bind beads) twice in 1X
PBS. Add a 30ul slurry of 1:1 beads to each sample and incubate at 4 degrees, rocking
for 3 hours.
12. Pellet the beads at 2500K for 1 minute (4 degree centrifuge), remove 200ul for your
INPUT, save. Wash beads 3X five minutes each time in 1X ChIP lysis buffer.
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13. Wash beads once in high salt ChIP lysis buffer - 500mM NaCi for 5 minutes
14. Wash beads with TE for five minutes
15. Resuspend beads in 150ul TE/SDS buffer and incubate at 65 degrees for 10 minutes,
vortexing every couple of minutes. Pellet beads by spinning 14K for 1 minutes, transfer
the supe to a fresh tube as your IP.
16. Add 1 Oul of INPUT to 140ul TE/SDS
17. Seal tubes with parafilm and put at 65 degrees overnight to reverse crosslinks.
18. Use Quiagen PCR purification kit to extract DNA. Elute sample in 30ul elution buffer.
Perform PCR with appropriate primers. Ac5c is a good control reaction; primers are in
the common primer box.
19. Run PCR products on NuSieve 2% gel
PCR protocol:
Step 1: 95 degrees 2 minutes
Step 2: 95 degrees 30 seconds
Step 3: 55 degrees 30 seconds
Step 4: 72 degrees I minute
Step 5: Return to step 2, 29 times
(adjust cycle number depending on DNA yield)
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Buffers for ChIP assays
Add protease inhibitors prior to use!
Hypotonic buffer
20mM K-Hepes pH
5mM KOAc
0.5 mM MgCI2
0.5 mM DTT
7.8 (adjust pH using KOH)
ChIP lysis buffer
50 mM KHepes 7.8
140 mM NaCI
1 mM EGTA
1 mM EDTA
1% Triton-X 100
0.1 % Na-deoxycholate
High Salt ChIP lysis buffer
Same as above but with 500 mM NaCI
TE/SDS
10 mM Tris pH 8
1 mM EDTA
1% SDS
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Chapter 5
Discussion and Future Directions
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Our functional analysis of the Retinal Determination (RD) gene network member EYES
ABSENT (EYA), a novel nuclear factor, identified the regions necessary for EYA's function as
transactivator and pointed to roles of RAS and GROUCHO in regulation of this activity (Silver
et al., 2003). We have also examined a new and essential role for EYA as a protein tyrosine
phosphatase (Tootle et al., 2003). Thus EYA represents the first identified eukaryotic
transcription factor to also possess phosphatase activity, a dual function whose coordination is
not understood. Each of these functions, transcription factor and phosphatase, can be performed
independently, but both are required for EYA in vivo, suggesting that they may work together to
specify eye fate. However, the targets for both of these functions, and thus the molecular steps
by which EYA promotes organ specification, are largely still unknown.
Identification of phosphatase targets of EYA is hampered by the non-conventional
aspartic acid-based catalytic mechanism of HAD family members, which rules out use of the
elegant substrate trapping methodologies employed to identify substrates of phosphatases which
use cysteine-based catalysis. Instead, targets of the EYA phosphatase will have to be identified
through direct testing of candidates or novel proteomic approaches, perhaps including a version
of substrate trapping for this family of enzymes.
However, several techniques can be used to identify transcriptional targets of EYA on the
genomic level, which may allow us to assay directly the importance of EYA phosphatase
function in the context of target gene transcriptional regulation. As EYA is recruited to the DNA
through interactions with the homeodomain containing protein, SINE OCULIS (SO),
identification of SO binding sites in the Drosophila genome should include many EYA-SO
targets. One method for identifying these targets would be to perform chromatin
immunoprecipitation (ChIP) using antibodies raised to SO (described in Appendix B), and
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hybridization of purified DNA to a genomic microarray to look for enriched regions. This type
of analysis might also be possible to perform using commercially available expression arrays, as
the sheared DNA will include genomic regulatory regions and likely enough coding sequence to
hybridize to arrays. Initial attempts to identify targets using a genomic microarray developed by
the Bell lab were unsuccessful (data not shown), but optimization of the protocol including
amplification procedures may prove more fruitful.
Another less direct method for finding targets of EYA is to overexpress EYA in a non-
eye larval tissue, such as the wing or leg disc, and perform microarray analysis of induced genes
compared to the expression profile of wildtype wing or leg discs, similar to the approach taken
by (Michaut et al., 2003). Microarray data from this type of analysis should reveal both direct
and indirect targets of EYA transcriptional regulation. One way to filter the large data set
produced by this method is to employ computational strategies to identify common promoter
elements, which can then be compared to the known SO family binding sites to predict direct
targets.
While identification of many targets may help in understanding the mechanism behind
EYA-SO mediated eye formation, as well as common promoter architecture, such as number of
SO binding sites or motifs recognized by other transcription factors, the recent identification of
lozenge as a SO target (Yan et al., 2003) provides a good starting place for direct analysis of
promoter regulation by RD genes. SO binds to two imperfect palindromes in the lozenge
minimal eye enhancer (LMEE) (Yan et al., 2003), and this region can be used to study the EYA-
SO transcription factor in a native context.
Recently we showed that we can observe SO localization to the LMEE in both
Drosophila eye discs and in S2 cell culture by ChIP experiments (Chapter 4). This provides a
199
tool to ask whether perturbation of signaling pathways or of other members of the RD gene
network affects SO localization to a promoter. For example, SIX1 association with target
promoters is regulated by cell cycle dependent phosphorylation, such that at the G2/M transition
it does not associate with DNA (Ford et al., 2000). SO from synchronized cell culture
populations could be assayed by ChIP to ask whether its DNA association is also regulated by
the cell cycle.
While it is not known if SO is phosphorylated in a cell cycle dependent manner, one
source of SO phosphorylation may be the stress response pathway (I. Mills, personal
communication). This pathway can be activated in S2 cells or dissected eye discs using osmotic
or heat shock, and SO-LMEE interaction levels analyzed to ask whether stress affects the ability
of SO to bind DNA. These experiments may give us insight as to the regulation of SO-DNA
complexes, and by extension, EYA-SO-DNA complexes.
As we observe DAC co-activation of the EYA-SO regulation of LMEE in cell culture
assays, it would be interesting to ask whether DAC associates with this promoter in vivo, by
ChIP directly of DAC using the available monoclonal antibody. This would provide support for
the in vivo relevance of DAC co-activator function, as thus far it has only been localized in vivo
to a promoter in the context of repression (Li et al., 2002). This experiment could also be
performed in eye discs with lower or higher levels of EYA and SO, through use of mutations or
overexpression, to ask if they are required for DAC association with a promoter.
Another important set of experiments would be to examine association of EYA with the
LMEE. Given the observation that point mutations in the EYA DOMAIN reduce EYA
transactivation potential without affecting the EYA-SO interaction (Chapter 4 and data not
shown), it would be interesting to ask if these mutant EYA proteins have altered levels of
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enhancer association. If these proteins associate to similar levels as wildtype EYA, they may
indicate key residues for interaction with or regulation by other factors, while if they display
defects in promoter localization, they may indicate points of regulation for association of the
EYA-SO transcription factor with DNA. One caveat to these experiments is that they must be
done using overexpression of tagged EYA proteins in cell culture or in eye discs to distinguish
wildtype EYA protein from mutant protein, and this overexpression will have to be carefully
titrated to allow for meaningful results.
Another avenue of regulation for the EYA-SO transcription factor comes from
interactions with the co-repressor GROUCHO (GRO). Our work has shown that in cell culture,
RO can compete with EYA for SO binding, leading to lower levels of target gene transcription
(Silver et al., 2003). It remains to be understood how SO-GRO interactions in vivo contribute to
development, and whether DAC plays a role in SO mediated repression.
GRO has been implicated in regulation of and by many signaling pathways, functioning
as an active corepressor through its interactions with DNA binding proteins such as HAIRY,
DORSAL, ENGRAILED, RUNT (for review see Fisher and Caudy, 1998) and more recently
BRINKER (Hasson et al., 2001). Of particular note is the GRO interaction with RUNX family
members (Fisher and Caudy, 1998), of which the SO target gene LOZENGE is a member.
While GRO has not been shown to interact with LZ, it is intriguing to ask whether SO activation
of lz expression may contribute to a positive feedback loop by LZ protein competing GRO away
from SO and therefore allowing greater EYA-SO activation of target genes.
SO is the only member of the RD gene network which does not induce ectopic eyes when
overexpressed, although it can synergize with EYA to induce larger and more frequent eyes
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(Pignoni et al., 1997). One possible explanation for this observation may be the existence of a
SO-GRO complex which prevents eye formation when SO alone is expressed but that is broken
up only by the addition of ectopic EYA, a model which is supported by our co-
immunoprecipitation data (Silver et al., 2003). In addition to the many gro mutant lines
available in the fly community, there is an inducible groRNAi line which effectively knocks
down GRO expression (Nagel et al., 2002), thereby allowing directed removal of the gro gene
product, which is necessary globally for viability. This can be used in conjunction with
transgenes driving SO to assess ectopic eye induction in the absence of GRO. As the ectopic eye
induction system is highly quantitative, we can also ask whether reduction of GRO affects the
frequency of eyes induced by EYA alone and synergistically by EYA and SO.
As discussed in Chapter 1, there are many links between the RD gene network and
control of cell proliferation. One of the best understood aspects of this relationship is
downregulation of SIX1 at the G2/M transition via phosphorylation by Casein Kinase II (Ford et
al., 2000). This phosphorylation event prevents SIX1 binding to target DNA (Ford et al., 2000),
and may represent an important checkpoint control in cell proliferation. Drosophila SO is also a
nuclear phosphoprotein (E. Davies, personal communication), and a clear triplet of SO similar to
that observed for SIX1 is observed on western blots (Appendix B).
Drosophila, with its varied genetic tools, would provide an excellent model system for
analysis of SIX family roles in cell cycle control. If SO both regulates and is regulated by the
cell cycle similarly to SIXI, the triplet observed by western blot should be due to
phosphorylation. Treatment of cell lysates with a strong phosphatase such as lambda or CIP may
result in collapse of the triplet. In addition, analysis of the SO by western in synchronously
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dividing cells may reveal if phosphorylation state is linked to the cell cycle. It is also intriguing
to ask if EYA, which has been proposed by one group to be a dual-specificity phosphatase (Li et
al., 2003), might itself regulate the phosphorylation state of SO.
It is also worth noting that EYA protein runs much larger than its predicted size on a
western blot, indicating that it is likely highly modified posttranslationally. We have previously
observed both serine-threonine (Hsiao et al., 2001) and tyrosine phosphorylation (Tootle et al.,
2003) of EYA, but particularly the sites and consequences of tyrosine phosphorylation are not
well understood. As EYA has been shown to associate with CKIIP3 (Li et al., 2004), the
regulatory subunit of the dual specificity protein phosphatase CKII, perhaps CKII regulates both
EYA and SO, EYA through tyrosine phosphorylation and SO through serine/threonine
phosphorylation.
Another link between the cell cycle and EYA is the finding that EYA expression can be
turned off in the absence of cell proliferation (Kenyon et al., 2003). As there is at least one
putative SO binding site in the EYA eye enhancer (Zimmerman et al., 2000) it is intriguing to
ask if EYA expression might be negatively regulated by SO in the absence of cell division,
providing a feedback loop to prevent differentiation through the RD network without appropriate
proliferation.
The RD gene network is deployed in many different developmental contexts, including
oogenesis, myogenesis, and eye development. Yet our understanding of the mechanisms which
provide context specific clues to ensure appropriate target gene activation still contains many
gaps. Identification of the targets of these proteins during eye development is an important first
step to understanding how signal integration might take place, as the promoters of target genes
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are likely be coregulated by many pathways in addition to the RD gene network. Another
important role is likely played by posttranslational modification, perhaps dictating when EYA
uses its phosphatase function rather than its transcription factor function, or when SO acts as a
transcriptional activator versus a repressor. Better understanding of the modifications of these
proteins and subsequent effects on activity or association with proteins and DNA will provide
details as to context specific control of RD gene network function.
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Appendix A.
Characterization of a new class of Drosophila Son-of-sevenless (Sos) alleles
highlights the complexities of Sos regulation and function in higher
eukaryotes
Serena J. Silvera'b, Fangli Chena'b, Laura Doyona, Andrina Williams Zinka and Ilaria Rebayab
aWhitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA
bDepartment of Biology, Massachusetts Institute of Technology,
Cambridge, Massachusetts 02142, USA
F.C. and A.Z. mapped the EY2-3 alleles to the SOS locus and performed initial characterization
of the Ras V 2 and yanact genetic interactions, and performed sequencing of two alleles. L.D.
helped with eye sections and with sequencing the remainder of SOS alleles.
This manuscript is currently in press at Genesis.
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Abstract
The guanine nucleotide exchange factor (GEF) Son-of-sevenless (Sos) encodes a complex
multidomain protein best known for its role in activating the small GTPase RAS in response to
Receptor Tyrosine Kinase (RTK) stimulation. Much less well understood is SOS' role in
modulating RAC activity via a separate GEF domain, or how its parallel functions in RAS and
RAC mediated signaling events might be integrated in vivo. In the course of a genetic modifier
screen designed to investigate the complexities of RTK/RAS signal transduction, a
complementation group of eleven alleles was isolated and mapped to the Sos locus. Molecular
characterization of these alleles indicates that they specifically affect individual domains of the
protein, including both enzymatic GEF motifs, one specific for RAS and the other for RAC.
While most appear to be hypomorphic mutations, one of these alleles, SosM98, which contains a
single amino acid substitution in the RacGEF motif, functions as a dominant negative in vivo to
downregulate RTK signaling. These alleles provide new tools for future investigations of role of
SOS in modulating both RAS and RAC activation and how these dual roles are coordinated and
coregulated during development.
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Introduction
Receptor Tyrosine Kinase (RTK) signaling provides an important growth and
differentiation cue which is used reiteratively during development to initiate and maintain cell
fates.. In Drosophila, proper regulation of RTK signaling is crucial for many processes including
eye development, wing vein formation, and embryonic cell fate determination (Schweitzer and
Shilo, 1997).
A crucial link between RTK signaling and its downstream effector, the small GTPase
RAS, is the RAS guanine nucleotide exchange factor (RasGEF), Son-of-sevenless (Sos). Upon
RTK activation, tyrosine phosphorylation of the receptor allows recruitment of the adaptor
protein GRB2/DRK, which brings with it SOS (Buday and Downward, 1993). Once localized to
the membrane, the RasGEF activity of SOS facilitates release of guanine nucleotide, allowing
RAS to bind GTP instead of GDP and thus become activated (Boriack-Sjodin et al., 1998; Liu et
al., 1993). Activated RAS then activates RAF, initiating activation of the MAPK cascade (for
review see (Avruch et al., 2001). Once phosphorylated by MAPKK, MAPK translocates into the
nucleus where it phosphorylates many nuclear factors, including the ETS domain transcription
factors pointed (pnt) and yan (O'Neill et al., 1994), which then effect changes in the
transcriptional program of the cell (Gabay et al., 1996). PNT is a transcriptional activator that is
stimulated by phosphorylation, while YAN is a transcriptional repressor that is exported from the
nucleus and thus downregulated upon phosphorylation (O'Neill et al., 1994; Rebay and Rubin,
1995; Tootle et al., 2003).
As outlined above, RTK/RAS-mediated signals cannot be transduced to the nucleus
without activation of RAS by SOS. While RasGEF activity is the best characterized function of
SOS, its complex protein structure, with several distinct catalytic and protein-protein interaction
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domains (Figure 1), suggests additional roles for SOS in the cell. Current knowledge of each
domain, and how it may allow SOS to coordinate RAS activation with other signaling events, is
outlined below.
The N-terminus of SOS has homology to histones and has recently been shown to fold
into a histone-like pseudodimer (Sondermann et al., 2003). As crystals of the SOS N-terminus
form as nonamers, and oligomerization can be detected in vitro by size exclusion
chromatography (Sondermann et al., 2003), it is likely that this region mediates SOS self-
association. Functionally, the N-terminus has been implicated as an autoinhibitory region which
may interfere with the function of the Dbl homology (DH) and Pleckstrin Homology (PH)
domains that directly follow (Das et al., 2000). Regulation of this autoinhibitory function may
be mediated by signaling events, as inhibition appears to be relieved by tyrosine phosphorylation
(Das et al., 2000). The role of SOS self-association in mediating these events is currently not
known.
The DH domain is a catalytic guanine nucleotide exchange factor motif for
Rho/Rac/cdc42-family GTPases (RhoGEF), and this domain in mammalian SOS1 specifically
catalyzes exchange on RAC (Nimnual et al., 1998). RAC function has been linked to many
important cellular processes, including motility, invasion, and axon pathfinding (Hall, 1998).
DH domains are invariably followed by PH domains, which mediate protein-protein and protein-
lipid interaction. In the case of SOS, the PH domain may be a point of protein-protein
interaction, auto-inhibition (Das et al., 2000) and lipid binding (Chen et al., 1997).
The DH and PH motifs of SOS are followed by the domains important for RasGEF
activity (Figure 4A). The RAS exchanger motif (REM) is important for full RasGEF function
(Chen et al., 2000), and recently has been shown to enable an allosteric interaction between
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Figure 1:
SOS encodes a 1600 amino acid protein with a diverse domain structure.
'The SOS protein contains two types of GEF domain, one specific for catalysis of guanine
nucleotide exchange on the small GTPase RAC, and the other specific for exchange on the small
GTPase RAS. There are also many protein-protein interaction motifs in SOS, including the PH
domain, REM, and PXXP motifs.
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activated RAS and SOS which stimulates SOS to be a more potent RasGEF for a second RAS
molecule (Margarit et al., 2003). Following the REM, the Cdc25 homology region encodes the
catalytic RasGEF activity (Lai et al., 1993; Liu et al., 1993). Structural modeling and affinity
studies have suggested a model whereby SOS binding to RAS through the Cdc25 homology
region leads to distortion of the RAS nucleotide binding site, thus promoting release of guanine
nucleotide (Boriack-Sjodin et al., 1998; Lai et al., 1993).
The C-terminus of SOS regulates SOS localization and perhaps even function. Signaling
through RTKs recruits SOS to the plasma membrane through binding of the SH3 domains of the
adaptor protein GRB2/DRK (Buday and Downward, 1993; Olivier et al., 1993) to the C-terminal
PXXP motifs of SOS (Figure 4A). Recruitment of SOS to the membrane allows it to catalyze
GDP,/GTP exchange to stimulate RAS. In a parallel mechanism, SOS appears to be targeted to
actin filaments by interaction of the C-terminal PXXP motifs with the SH3 domains of ABI- 1 in
an ABI-1/EPS-8 complex, where SOS may then act as a RacGEF (Scita et al., 1999; Scita et al.,
2001).
A third possible role for the C-terminus of SOS as an autoinhibitory domain (Corbalan-
Garcia et al., 1998) stems from observations of MAPK hyperactivation in response to ligand
after transfection with a Sos C-term truncation (Byrne et al., 1996), and from phenotypic analysis
of overexpression of a SOS C-term truncation in the fly eye (Karlovich et al., 1995). This
autoinhibition may be regulated by a negative feedback loop whereby activated MAPK
phosphorylates SOS leading to its downregulation. Supporting this idea, ERK-1 MAPK
phosphorylates mammalian SOS I in vitro and EGF stimulation of cultured fibroblasts induces a
SOS I mobility shift consistent with phosphorylation (Buday et al., 1995). Although the
phosphorylated residues have yet to be mapped, the C-terminus of Drosophila SOS contains five
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putative MAPK phosphorylation sites, while the C-terminus of mammalian SOS contains six
putative MAPK phosphorylation sites (defined as P-X-S/T-P, Supplementary Figure 1).
Although SOS is ubiquitously expressed, it is tightly regulated by signaling events and
unable to activate RAS or RAC without proper targeting to specific subcellular locations
(Corbalan-Garcia et al., 1998; Scita et al., 1999). For example, studies constitutively targeting
mouse and human SOS 1 to the cell membrane observe a higher transforming potential of these
constructs (Quilliam et al., 1994). SOS function also may be limited by availability of binding
partners, as has been shown for ABI-1, where that protein is the limiting factor in targeting SOS
to sites where it may activate RAC (Innocenti et al., 2002). Thus SOS function appears to be
regulated both by heterologous protein-protein associations and by autoinhibitory interactions. A
recent study has implicated phosphorylation of SOS by the non-receptor tyrosine kinase Abl as a
mechanism for activation of SOS RacGEF activity (Sini et al., 2004). While phosphorylation of
the various functional domains provides a potential mechanism for signal dependent activation or
repression of SOS function, much remains unknown about the complex interactions of the
different SOS domains, and how these different regulatory elements are coordinated in vivo.
Here we present the characterization of a novel class of Sos alleles isolated as dominant
enhancers of eye specific expression ofyan a'', a constitutively active allele that is no longer
subject to downregulation via MAPK (Rebay et al., 2000). These Sos alleles, referred to
collectively as SosE 2-3, comprise a series of point and deletion mutations throughout the Sos
locus that individually disrupt many of the different domains important for SOS function. We
have used these new alleles, together with previously characterized null alleles, to explore SOS
function during development and have found defects in both gastrulation and later development.
Sequencing and further in vivo characterization of the SosEY 2 -3 alleles has shown that they are not
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null alleles and that at least one, SosM 9 , acts as a dominant negative. The amino acids and
functional motifs affected by these mutations are all conserved from Drosophila to human SOS 1,
suggesting that our findings may have implications for SOS regulation and function in higher
eukaryotes.
Results and Discussion
Isolation of new Sos alleles
Previously, we isolated eleven alleles of Sos as dominant enhancers of the phenotype
induced by eye specific expression of yan"'ct, a dominant active allele of the transcriptional
repressor yan (Rebay et al., 2000). Enhancement of the yan"t phenotype suggests that these
mutations, referred to as SosEY2-3 alleles, impair endogenous RTK signaling, consistent with Sos
functioning as a positive component of the pathway. However, as described below, subsequent
genetic and molecular analyses suggest that the SosEY2 - 3 alleles behave differently than
previously characterized null mutations, Sose2h and Sose4G, which contain early termination
codons at amino acids 579 and 421, respectively (Simon et al., 1991).
For example, while the SosEY 2-3 complementation group contains many strong enhancers
of sev- YanaC' (Figure 2C, compare to Figure 2B, and wildtype in Figure 2A), Sos n"ll alleles do not
enhance the phenotype (Figure 2D). Further discrepancies emerge when genetic interactions
with a sev-Ras V12 (activated Ras) transgene were examined. Sos mnUl alleles strongly suppress the
sev-Ras V2 rough eye phenotype (Figure 2H, compare to Figure 2E), while SosEY2-3 alleles only
weakly suppress (Figure 2F-G, (Rebay et al., 2000). Transverse sections revealed that the extra
R7 photoreceptors produced by sev-RasV12, on average 2.6 per ommatidia, (Figure 3B-C,
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Figure 2:
SosEY 2-3 alleles are strong enhancers of sev-yana t
Scanning electron micrographs (SEM) of Drosophila eyes show the wildtype (A) compared to
the screen starting phenotype with sev-yanact (B), and a Sos allele isolated by the screen which
dominantly enhances this phenotype (C). In contrast, a null allele of Sos does not enhance the
sev-yanact phenotype (D). The sev-Ras V 2 phenotype is shown in (E). The rough eye is only
mildly suppressed by SosEY2-3 alleles (F,G), unlike null alleles of Sos which strongly suppress
sev-Ras V2 (H).
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compare to wildtype in Figure 3A) are dominantly suppressed by Sos"u alleles to only 1.4 R7
cells per ommatidia and to a lesser extent, to 1.9 R7 cells, by SosEY2 - 3 (Figure 3D). Moreover, the
overall disorganization of ommatidia observed in the sev-RasV12 (Figure 3B) background is
suppressed by the null allele of Sos (Figure 3C) but not SosEY2-3 (Figure 3D). Thus our screen for
modifiers of yan"tc isolated a distinct class of Sos alleles, illustrating the potential of different
genetic modifier screens to isolate different subsets of alleles of a given gene.
Molecular Characterization of SosEY2 -3 alleles
To investigate whether the SosE Y2-3 alleles might provide useful tools for analyzing Sos
regulation and function, we determined the molecular nature of these mutations (for details, see
Materials and Methods). Sequencing of eight SoEY2-3 alleles revealed mutations in conserved
domains that would be predicted to specifically affect activity levels of Sos (Figure 4A).
SosM9 8 (D296N), a point mutation in the DH domain, disrupts a highly charged surface
(Soisson et al., 1998), that may be a point of protein-protein interaction. The DH domain of SOS
is the site of RacGEF activity (Nimnual et al., 1998), and a disruption of protein-protein
interaction there might interfere with or promote GEF activity. Strikingly, the residue affected
by SosM98 is conserved not only amongst SOS homologs from Drosophila to humans, but also in
the DH domains of distantly related GEFs such as TIAM-1 and TRIO (Figure 4B). Another
mutation that maps to the DH domain, Sos X Q41, is a small in frame deletion that replaces K385
and L386 with a single Methionine (Figure 4A). As this region of SOS forms an alpha-helix
(Soisson et al., 1998), loss of an amino acid likely disrupts the remainder of the helix.
Five SosEY2 - 3 alleles appear likely to impair RasGEF function based on their molecular
lesions. SosEK1069 and SosXER 5 2 2 have early termination codons, before and after the Pleckstrin
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Figure 3:
SosEY2- 3 alleles mildly suppress sev-Ras Vl2
sev-Ras V2 flies have disorganized ommatidia and extra R7 photoreceptors (B, 2.6 per ommatidia,
versus 1.0 per ommatidia in wildtype eyes (arrow indicates R7, A). This phenotype is strongly
suppressed by heterozygosity for Sos (C), with greater organization and fewer R7s (1.3 per
ommatidia). In contrast, heterozygosity for SosM98 leads to some suppression of extra R7s (1.9
per ommatidia) but the eye remains disorganized.
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R7 = 1.0 per ommatidia R7 = 2.6 per ommatidia
n=553 n=607
R7 = 1.30 per ommatidia R7 = 1.91 per ommatidia
n=633 n=558

Homology (PH) domain, respectively (Figure 4A), leaving both without the RasGEF domains.
Sos5 XMN1°25 and Sos VW3 49 both have missense mutations in the REM of SOS, an integral domain for
RasGEF function (Chen et al., 2000) and a point of SOS-RAS interaction (Margarit et al., 2003).
The most direct lesion to the RasGEF catalytic domain is in SosXB0", where a six base pair
deletion removes two conserved residues, V1011 and A1012 (Figure 4A).
SosYF9 is a small deletion near the C-terminus that leads to truncation of the PXXP motifs
(Figure 4A). These motifs, which appear multiple times in the last several hundred amino acids
of SOS, are important for SOS binding to the SH3 motif of DRK/GRB2 (Chardin et al., 1993),
and for SOS binding to the SH3 domain of ABI-1, which may target SOS to RAC (Innocenti et
al., 2002; Scita et al., 1999). Our finding that this allele contains intact catalytic domains yet
displays defects in RTK signaling, indicates the importance of the full complement of PXXP
motifs for SOS function in vivo.
Emphasizing their relevance to understanding SOS function in higher eukaryotes, each of
our alleles map to residues conserved in SOS homologs from Drosophila to humans
(Supplementary Figure 1). Our alleles span the SOS protein, suggesting that multiple domains
are necessary for proper function, and that mutations enhancing sev-yan"et are not specific to any
particular domain. In addition, the alleles that lack the RasGEF domain, SosEK0 6 9 and SOSXER522,
but still do not suppress the sev-Ras V'2 eye phenotype are of particular note as they indicate that
the genetic suppression of sev-RasV12 by Sos requires inactivation of both the RAS and RAC
GEF domains (Figure 1). This may reflect the complex interactions between RAS and RAC
signaling, where RAS activation has often been linked to activation of RAC (Scita et al., 2000),
and may indicate that activation of RAC contributes to the sev-Ras V 2 phenotype.
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Figure 4:
Molecular characterization of SosEY2 3 alleles
SoSEY 2-3 alleles map to discrete domains along the SOS protein (A). Allele name is in italics and
the molecular lesion is indicated below. The residue affected in the SosM9 8 allele is conserved
amongst SOS homologs and in DH domains from unrelated proteins TIAM-I and TRIO (B).
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Analysis of Sos mutant phenotypes in the eye and wing
In order to understand how these mutations affect SOS function, we analyzed the mutant
phenotype of our SosEY2-3 alleles, focusing on tissues in which RTK signaling plays well-
documented roles. For example, RTK signaling has been shown to be crucial for proper
recruitment and survival of photoreceptors in the Drosophila eye (Freeman, 1997) and for
growth, patterning and specification of vein fate in the wing (Diaz-Benjumea and Hafen, 1994);
(Nagaraj et al., 1999). Although all of the Sos alleles identified by our screen are homozygous
lethal, several viable or partially viable transheterozygote combinations allowed us to examine
phenotypes in the adult animal. In the wing, transheterozygotes exhibit wing size reduction and
loss of wing vein material (Figure 5B, compare to wildtype in 5A). In addition, the SosEY 2 - 3
transheterozygotes have small rough eyes with missing photoreceptors (Figure 5D, compare to
wildtype in 5C). Photoreceptor R7 appears most severely affected and is lost in 60% of
ommatidia. Both the eye and wing phenotypes are consistent with reduced RTK/RAS/MAPK
signaling and with the SosEY 2-3 alleles behaving as partial loss-of-function mutations.
Because interallelic complementation in the transheterozygous combinations might
partially mask SosEY2-3 phenotypes, the FLP-FRT system (Xu and Rubin, 1993) was used to
produce marked clonal patches of homozygous mutant tissue in the eye. For this analysis, two
>s'"u ll alleles, Sose2H and Sose4G (Simon et al., 1991), and two EY2-3 alleles, SosM98 , a mutation
in the DH domain, and SosAI ° 25, a mutation in the REM, were examined. For these analyses,
only one representative of each class is shown, as the same results were observed for both.
Sos" ul l cells do not survive to become part of the adult eye, resulting in ommatidia with
fewer than the normal complement of photoreceptors (Figure 6A). In contrast, SosEY2-3 mutant
tissue survives to form large clones in which many ommatidia are missing photoreceptors, with
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Figure 5:
SosEY 2 -3 mutant tissue displays defects in wing vein fate and photoreceptor recruitment
Transheterozygotes of SosEY2-3 alleles have shortened wing veins (arrow, B), and lack R7
photoreceptors in 60% of ommatidia (D). Wild type controls are shown in (A, C).
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R7 lost at a comparable frequency to that seen in transheterozygotes (Figure 6B). The lower
penetrance of photoreceptor loss observed in SosEY2-3 mutant tissue compared with complete
penetrance of photoreceptor loss observed in null alleles suggests that, consistent with the
molecular nature of these alleles and with the transheterozygote phenotypes, SosM9 8 and
,SosxMNO025 represent hypomorphic mutations in the Sos gene.
To ask whether photoreceptor recruitment occurs in the complete absence of Sos
function, Sos"u1 clones were analyzed earlier in eye development by examining elav expression
in the 3rd instar eye discs. As shown in Figure 6C, Sos " " tissue does not support specification of
photoreceptor neurons. The lack of Sos ""1 tissue in the adult eye suggests the undifferentiated
mutant tissue is removed by cell death, consistent with RAS signaling being required for cell
survival in the eye (Bergmann et al., 2002).
A role for SOS in early embryonic patterning
Zygotic mutant embryos of Sos, EY2-3 or null, have no obvious defects associated with
their lethality. Many survive embryonic development, presumably due to high levels of maternal
Sos, but die as 1 St instar larvae. To examine the phenotype of Sos mutants without maternal
contribution, we used the FLP-FRT ovoDI system (Chou and Perrimon, 1996) to produce
homozygous mutant germline clones. Embryos which lack maternal and zygotic Sos"11 show a
striking twisted or "u-shaped" phenotype, which is readily observed using the segmentally
patterned marker anti-ENGRAILED (Figure 6E, compared to wildtype in 6D). This phenotype
is similar to that seen in corkscrew mutants (Perkins et al., 1996; Perkins et al., 1992), a
component of the RTK signaling pathway, and is likely to result from defects in gastrulation and
germband retraction. Interestingly, the patterning defects but not the lethality of Sos maternal
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Figure 6:
Sos"" tissue displays defects in photoreceptor specification and gastrulation
Sosn" ll clones do not contain any mutant photoreceptors (A), while Sos M 9 8 clones contain some
photoreceptors (clone marked by lack of pigment, B). In third instar larvae, Sos"u lclones are
larger than seen in the adult but cannot specify photoreceptor cell fate (clones marked by lack of
GFP, C). Sos maternal and zygotic null embryos have striking "corkscrew" phenotypes, shown
by anti-engrailed staining in E; compare to wildtype embryo in (D). These patterning defects are
rescued by zygotic contribution of wildtype SOS (F). Maternal and zygotic SosEY2 -3 embryos are
homozygous lethal but do not display obvious patterning defects (G). Embryo shown is SosM98;
similar results were observed for So XM l1025 germline clones.
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and zygotic null embryos can be rescued by zygotic contributions of Sos (Figure 6F), indicating
that maternal Sos is not essential for early embryonic patterning. The striking "corkscrew"
phenotype has not previously been reported for Sos mutant embryos, and reveals the importance
of maternally derived stores of SOS during embryogenesis. In contrast, germline clones of
SosE K2-3 alleles are grossly normal (Figure 6G), though lethal late in embryogenesis/early 1St
larval stages. This lethality can be rescued by zygotic Sos, suggesting again that the SosE Y2 -3
mutations are partial loss of function alleles.
Overexpression of SOSM 98 produces dominant negative phenotypes
In order to explore further the function of the SOSEY2-3 mutant protein compared to
wildtype SOS, transgenic flies carrying full length Sosw t and SosM 98 cDNA under the control of
the UAS promoter were used to misexpress SOS in the wing and eye. Among the EY2-3 alleles,
SosM g5 was chosen for overexpression because it is the strongest enhancer of sev- Yan" .
Moreover the residue affected by this mutation is conserved not only between SOS homologs but
also in DH domains such as those found in Trio and Tiam 1 (Figure 4B), suggesting that this
mutation may affect a conserved aspect of DH domain function. Both immunofluorescence and
western blot analyses indicated no difference in the subcellular localization, expression level or
size of SosM98 compared to SosWv (Figure 7).
To examine the effect of overexpressing SOS in the wing, we used a GAL4 driver highly
activated in the wing disc, dpp-GAL4, to induce expression of the two transgenes.
Overexpression of Sosw t leads to a thickening of the L3 wing vein (Figure 8B, 8E, compare with
wildtype in 8A), consistent with increased RTK signaling leading to ectopic wing vein tissue
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Figure 7:
SOSM98 is localized normally and expressed at similar levels to wildtype SOS
Antibody staining of SOS in transfected S2 cells shows cytoplasmic localization for wildtype
SOS (A) and SOSM98 (B). Analysis by western blot (C) shows that wildtype and mutant protein
are the same size and expressed at similar levels.
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(Diaz-Benjumea and Hafen, 1994). Overexpression of SosM9 8 yields a range of small, blistered
wings (Figure 8C, 8D), some with ectopic wing margin bristles, shown at higher magnification
in Figure 8F. The small size of these wings may be indicative of a growth defect, a phenotype
often associated with loss of RTK signaling (Schweitzer and Shilo, 1997).
We used sev-GAL4, which is activated in a subset of photoreceptor cells (R3, 4 and 7)
and in cone cells, to drive expression of Sos w t and SosM98 in the eye. Overexpression of Sos" has
no observable effects on eye development, and does not affect the number of photoreceptors
specified (Figure 8G), indicating tight controls on the activity of SOS protein. Strikingly,
overexpression of SosM9 8 leads to disorganization of the ommatidial structure, missing
ommatidia, and loss of photoreceptors, particularly of R7, which is missing in about half the
ommatidia (Figure 8H, compare to driver alone in Figure 8F). This loss of photoreceptor
phenotype is consistent with defects in RAS pathway activation and with the size and patterning
defects observed upon overexpression in the wing.
This leads us to propose that SOSM98 may function as a dominant negative when
overexpressed, perhaps by sequestering fully active SOS into less active complexes, thus
reducing the available pool of active SOS. Although SosM9 8 behaves in certain respects as a
hypomorphic allele, it also exhibits some dominant negative characteristics. For example, while
SosM9/SosM 98 flies die at late embryonic or early larval stages, SosM98/Deficiency animals
survive to adulthood. Similarly, if Sos M 9 8 were simply a hypomorph, one would expect it to
display more deleterious phenotypes in trans to a deficiency than in trans to a hypomorphic
allele, whereas in fact comparable defects are observed (Figure 5 and data not shown).
241
Figure 8:
Overexpression of SOSM98 disrupts RTK signaling
Ectopic expression of wildtype SOS in the wing leads to thickening of wing veins (B and higher
magnification, E, relative to wild type, A). In contrast, overexpression of SOS M 98 is associated
with smaller wings, disruption of wing veins and induction of ectopic margin bristles (C, D, and
higher magnification in F). In the eye, overexpression of wildtype SOS has no effect (F, G),
while overexpression of SOSM9wcauses disorganization of ommatidia and loss of photoreceptors,
particularly R7 (H).
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Concluding Remarks
Our screen for enhancers of yana"' has isolated a collection of new alleles in the RasGEF
SOS affecting multiple conserved domains in this complex multidomain protein. These alleles
impair but do not abolish SOS activity and thus may provide unique and useful means for
dissecting the complexities of SOS function and regulation. Of particular interest is SOSM98,
which as discussed above contains a single amino acid change in the DH domain and may
function as a dominant negative. This allele may prove an important tool for dissecting the dual
roles of SOS in the activation of RAS and RAC, particularly in understanding the mechanism by
which these activities of SOS are coordinated.
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Supplementary Figure
Supplementary Figure 1:
SosEY2-3 alleles disrupt conserved residues in SOS
Alignment of Drosophila, mouse, and human SOS proteins shows that all SosEY 2 -3 alleles cause
molecular changes in conserved residues (each allele shown by arrow). Analysis of the C-
terminus of SOS reveals 5 putative MAPK phosphorylation sites (defined as P-X-S/T-P) in
Drosophila SOS (indicated by magenta stars) and 6 putative MAPK phosphorylation sites in
mammalian SOS (indicated by green stars), one of which is conserved from Drosophila to
human (indicated by a red star).
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Materials and Methods
Molecular Biology and Genetics
The Sos coding region was subcloned from the plasmid sE-Sos kindly provided by U. Banerjee
(Karlovich et al., 1995). Stratagene's Quick-Change mutagenesis scheme was used to alter the
affected residue in SosM98 , using primer pairs: M98S 5'-
ccgatattctccaacataatgaacatttacgaggtgacggtc-3' and M98 A 5'-
gaccgtcacctcgtaaatgttcattatgttggagaatatcgg-3'. Sos constructs were shuttled into pUAST (Brand
and Perrimon, 1993), and transgenic lines were generated as previously described (Rebay et al.,
1993). All overexpression data was confirmed by use of at least three independent transgenes. In
all cases, the data were consistent with the example shown.
For sequencing, SosM9 8 and SosXMVw °2 5 were isolated in trans to a deficiency uncovering the Sos
locus, genomic DNA isolated and sequenced. The remainder of the SosEY 2 - 3 alleles were
balanced over CyOact-GFP, embryos were collected, allowed to hatch, and then homozygous
mutant larvae identified by lack of GFP expression. Genomic DNA was purified and sequenced
using an ABI 373 DNA Sequencer.
To remove any unlinked secondary lethals, Sos alleles were recombined onto the multiply
marked second chromosome b pr cu pI s. The markers were then removed by recombination with
a wild-type chromosome. All experiments described here were performed with "cleaned" alleles.
For the examination of clones in adult eyes, Sos FRT40A/CyO males were crossed to w ~ 8
eyeless-FLP; FRT40A P{w+}/CyO. Mutant tissue was recognizable by the absence of red eye
pigment. For larval eye disc clones Sos FRT40A/CyO was crossed to w"' s eyeless-FLP; P{Ubi-
GFP], FRT40A. Mutant clones were recognizable by the absence of green fluorescent protein
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fluorescence.
Fly stocks used: dpp-GAL4 (57A1); sev-GALA (K24); sev-RasV 2 (CR2); Df(2L)b87e25/CyO
(Deficiency uncovering the Sos locus).
Immunohistochemistry
Mouse polyclonal antibody to SOS was raised against a GST-SOS antigen consisting of amino
acids 1722-2863, purified as described (Rebay and Fehon, 2000). Fixation and staining of S2
cells and embryos were performed as previously described (Fehon et al., 1991; Fehon et al.,
1990). S2 cells staining was performed using mouse polyclonal antibody to SOS 1:1000, with
CY3-conjugated goat anti-mouse secondary (1:10000). Embryo stainings were performed using
mouse anti-ENGRAILED (monoclonal antibody 4D9, Developmental Studies Hybridoma Bank
(DSHB)), followed by CY3 conjugated goat anti-mouse (1:1000). Fixation and antibody
staining of larval eye discs were performed essentially as described (Wolff, 2000). Larval eye
discs were stained with mouse anti-ELAV (9F8A9, 1:100; DSHB), followed by CY3 conjugated
goat anti-mouse (1:1000, all secondary antibodies from Jackson ImmunoResearch, West Grove,
PA)
Histology
Adult flies were prepared for scanning electron microscopy as described in (Tootle et al., 2003).
Fixation and tangential sections of adult eyes was performed as previously described (Tomlinson
et al., 1987).
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Bioinformatics
All alignments were performed using ClustalX (Thompson et al., 1997). SOS protein sequences
from Drosophila (DmSOS, gi: 24584199), mouse (MmSOS, gi:6678062), human (HsSOS),
gi: 15529995), were aligned with each other and with the DH domains of Human TRIO
(HsTRIO, gi:3522969), and Human TIAMI (HsTIAM-1, gi:4507500).
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Appendix B
Generation of Mouse and Guinea Pig antisera for SINE OCULIS
Serena J. Silver, Ishara Mills, and Ilaria Rebay
I.M. made the GST-SO fusion protein construct
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In order to study the RD gene network member SINE OCULIS more effectively, we
generated a set of polyclonal antibodies raised against the full length SO protein fused to GST.
GST-SO was grown in BL21 E. coli and, as it is highly insoluble, we used the protocol for
insoluble GST fusion proteins using Urea following by dialysis (Rebay and Fehon, 2000). This
produced a protein yield of approximately 1 mg/ml, which was then used as antigen for antibody
production in mice and guinea pigs by Curagen. Three mice were used and two guinea pigs,
with 50ug of antigen per injection for each mouse and 100ug of antigen per injection for each
guinea pig. Each animal underwent five rounds of injections with an injection schedule as
previously described (Rebay and Fehon, 2000).
Antibody from the first two bleeds was not useful, but serum from the third bleed until
exsanguinations produced good quality antibody from both guinea pigs and mice, although the
GP antibody is somewhat better.
These antibodies can be used for tissue and western blots (Figure 1), and nicely
recapitulate the mRNA expression pattern of SO previously reported (Seimiya and Gehring,
2000). In embryos, use the guinea pig antibody 1:10000, and the mouse antibody 1:2000-5000.
In eye discs, use the guinea pig antibody 1:5000, and on western blots use the guinea pig
antibody 1:10000, and the mouse antibody 1:5000. It is particularly useful to have antibodies
from two different species for SO when performing immunoprecipitation experiments, as the
size of SO is similar to heavy chain. Thus for clear results, immunoblotting should be performed
with antibody from an organism different from that used for immunoprecipitation.
Perhaps most interestingly, the SO antibody recognizes a triplet of protein via western
blotting (Figure 1), similar to the triplet observed upon western blot analysis of human SIX1,
which is hyperphosphorylated in mitosis (Ford et al., 2000). It remains to be determined whether
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the SO triplet corresponds to a similar phosphorylation event and how this phosphorylation
might affect SO function.
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F G
Figure 1: The SO antibody works well in tissue and on western blots.
Wildtype embyros at early and late stages stained with GP anti-SO antibody, a-d;
third instar larval eye disc stained with GP anti-SO antibody, protein is also visible
in MF but out of focus, e; western blot showing the SO protein runs as a triplet, as
visualized using GP anti-SO, f, and Mouse anti-SO, g (note: gels run for different
lengths of time).
v
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Appendix C
Analysis of phosphatase activity of human BOR and
fly loss of function EYA domain mutations
Serena J. Silver, Tina Tootle, Mousumi Mutsuddi,
Ben Chaffee, Justin Cassidy and Ilaria Rebay
M.M., B.C., and J.C. recapitulated the BOR and fly ED mutants in Mouse EYA3 EYA
DOMAIN GST fusion expression constructs. S.J.S. and T.T. purified GST fusion proteins and
performed phosphatase assays.
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Results
We and others have recently identified a novel function for the EYA DOMAIN of EYES
ABSENT as a protein tyrosine phosphatase (Li et al., 2003; Rayapureddi et al., 2003; Tootle et
al., 2003). As several identified mutations in Drosophila EYA (Bui et al., 2000), and more
intriguingly, in human patients suffering from Branchio-oto-renal syndrome (BOR) or Ocular
Defects (OD) (Azuma et al., 2000), map to the EYA DOMAIN (Table 1), we asked whether any
of those molecular lesions affect the phosphatase activity of EYA.
Phosphatase assays were performed to analyze the ability of MmEYA3 EYA DOMAIN
containing the mutations listed on Table 1 to dephosphorylate the peptide I(pY)GEF as
previously described (Tootle et al., 2003). We found that most ED were not able to
dephosphorylate peptide, except for the fly allele, T250M, and the complex BOR/OD allele
G344S , and one of the OD alleles K465G (Table 2). Thus at least some aspect of the BOR
phenotype may be associated with loss of phosphatase activity.
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Table 1 - EYA amino acid substitutions
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Dm EYA Mm Eya3 Hs Eyal Source of mutation
T497M T250M T332M Fly
E528K E281K E363K OD
G594S G344S G426S Complex type with OD & BOR
T6431 T3931 T4751 Fly
S655P L405P S487P BOR
L673R L423R L505R BOR
R715G K465G R547G OD
G723E G473E G555E Fly- in conserved HAD motif
Table 2: Phosphatase activity of EYA DOMAIN mutations
Mm Eya3 Results
T250M normal ptpase activity - km= 220uM, kcat =.0008
E281K no ptpase activity
G344S good ptpase activity - km = 871 uM, kcat = 4.7 * 1 OA-7
T3931 no ptpase activity
L405P no ptpase activity
L423R no ptpase activity
K465G Some ptpase activity
G473E no ptpase activity
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Appendix C
EYA protein protocols
273
Purification of EYA DOMAIN GST fusion proteins with French Press
1. Grow two overnight cultures (100 ml) of BL21 E. coli containing an IPTG inducible GST
construct of interest
2. Dilute cultures 50ml in 500ml of LB in the morning, grow to an OD6 0 0 of 1.0 (2 liters of
LB is considered one prep, and all volumes below assume 2 Liters). Once you dilute the
cultures, make sure the water bath shaker in the cold room is set to 16-18 degrees.
3. Move flasks to shaker in the cold room and let equilibrate to 18 degrees (about 10-15
minutes)
4. Add 500ul .8M IPTG to each flask and induce for 2.5 - 3 hours
5. Centrifuge at 3500rpm in Beckman, and resuspend in 7.5ml of Tris buffer for French
press (in cold room - 50mM Tris buffer pH 8.0, mM EDTA and 100mM NaCl plus protease
inhibitor cocktail (1 tablet per 10 mls, Roche)).
6. KEEP EVERYTHING ON ICE! Put resuspended stuff into Sorvall centrifuge tube. The
bacteria from 2 Liters will fit into one tube (-40mls)
7. Take your ice bucket with your prep and a small beaker over to the Baker lab to use the
cold room French press (dress warmly and cover your ears!! also, bring at least two pairs of
gloves)
8. Lyse by three passes through the French press at 1000psi.
9. Clarify lysate by spinning at 16K in sorvall SS-34 rotor for 15-20 minutes.
10. Transfer supernatant to a fresh tube (50ml Falcon tube works well) and add lml of 50:50
glutathione-agarose slurry
11. Incubate overnight, rocking at 4 degrees
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1 2. Use the Beckman to spin down beads gently (1000rpm for 30 seconds), and wash 5 times
with 50mM HEPES, 300mM NaCl. Leave in a 1:1 slurry of beads and buffer, and transfer to an
eppendorf tube. (Make sure that the small centrifuge is cold!)
13. Wash once with elution buffer (50mM Tris pH 7.0, 150mM NaCl) - spin eppendorfs at
3500 for 1 minute to gently pellet beads.
14. Elute in 10mM reduced glutathione in elution buffer (1 ml per elution) 15 minutes is
generally good for the 1 st elution. Three elutions will get most of the protein off of the beads. If
the protein is being troublesome sometimes a higher pH (between 8.0-9.0) will work better.
GLUTATHIONE can go bad over time!!! If your elutions aren't working and your bottle is old,
order a new bottle.
15. Determine the protein concentration by microplate Bradford Assay, using a BSA standard
curve (see Biorad protocol). You should get between 0.4 - 1.0 mg/ml protein from a 2 Liter prep.
16. Protein can be stored at 4 degrees in a covered ice bucket, but is best used fresh for
phosphatase assays.
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Protocol for EYA DOMAIN phosphatase assays
Phosphatase assays are performed with fresh GST-ED fusion protein.
Assays with pNPP
1. Make a 2x buffer mix: 400mM PIPES pH 7.0, 5mM EDTA, and 20mM MgCl 2 - use this
2x buffer to dissolve pNPP.
2. Make a 200 mM stock solution of pNPP - I find it easiest to weigh out approximately the
right amount of pNPP and then add the appropriate volume of liquid for 200mM - use the
molecular weight printed on the bottle - it is sold in anhydrous and regular forms - don't
use the tablets, as they don't dissolve in our buffer.
3. Don't forget to set up buffer alone controls!! Perform each timepoint in duplicate or
triplicate. Do 6 timepoints and 6 substrate concentrations if possible.
4. Dilute enzyme in ddH2 0 such that you are adding about 5ug of enzyme per reaction in a
volume of 40 ul; total reaction volume 80ul. Final buffer conditions: 200mM PIPES pH
7.0, 5mM EDTA and 10mM MgC12
5. Allow reaction to procede at 30 degrees for different time intervals, quench reaction at
each timepoint using 40ul of 10M NaOH.
6. Mix by inverting tube, spin down briefly in centrifuge and pipet into plate for Tecan
GENios plate reader (be careful - solution is now VERY basic)
7. PNP anion is detected at 405 nm (extinction coefficient £M= 1.78 x 10 4 /cm M). Data
from platereader can be copied directly into Microsoft Excel. Use Excel to analyze
results - subtract background, average replicates, and correct for Moles of Enzyme in
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reaction and Moles of substrate in reaction compared to Moles of product formed (use
appropriate conversion based on extinction coefficient)
8. Plot on a Lineweaver Burke or Eadie-Hofstee graph to determine Km and Vma,.
Assays with Peptide substrate: I(pY)GEF
1. Reactions are performed in a 50ul volume with a final buffer concentration of 200mM
HEPES pH7.0, 10mM MgC12, 5mM EDTA. Make a 4x buffer mix of 800mM HEPES
pH 7.0, 40mM MgC12, 20mM EDTA - MAKE SURE TO USE PHOSPHATE FREE
WATER FOR EVERYTHING.
2. Perform assays for 6 timepoints and 6 substrate concentrations if possible.
3. Make 4x dilutions of substrate using phosphate free water - good starting substrate
concentrations are 70, 80, 90, 100, 110, 120 mM final concentration - mix equal parts 4x
substrate and 4x buffer to 25ul
4. Dilute enzyme in phosphate free water so that by adding 25ul you add 5ug enzyme per
tube.
5. Set up assays such that each timepoint is a separate rack - pipette appropriate substrate
concentrations into appropriate tubes so that each timepoint has the full complement
6. Add enzyme to each rack, mixing after rack is complete and put at 25 degrees. Repeat
for all timepoints
7. Make a standard curve using the free phosphate and instructions given with the BIOMOL
green kit. Aliquot out BIOMOL green needed for the day's experiments using a tissue
culture sterile pipette to avoid contamination of the entire bottle.
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8. Quench reactions by addition of 100 ul BIOMOL green, which contains Malachite
Green/Ammonium Molybdate dye, which will form a complex with free phosphate and
color develops over 30 minutes.
9. Detect at 595 nm in the plate reader, copy to excel, and convert to moles of free
phosphate using the standard curve.
10. Normalize to background, average points, make sure to account for Moles enzyme used
in each reaction.
Note: as the reactions are performed in eppendorfs and transferred, we only read 100ul of the
reaction on the plate reader, including the phosphatase standard, to avoid errors due to missed
liquid.
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Protocol for Immunoprecipitation of EYA from Eye discs and Embryos
EYE DISCS
1. Dissect 100 discs from 3 rd instar larvae in S2 cell media - should wind up with 50-75ul of
discs when they settle. Transfer with a wide mouth pipet tip into an eppendorf. Pipet off the
extra media.
2. Add 100ul whole cell lysis buffer (100 mM NaCl; 50 mM Tris, pH7.5; 2 mM EDTA; 2
mM EGTA; 1% NP-40) and grind with blue pestle. Add 400ul more buffer and rock for 30
minutes. After rocking, grind again (you may want to remove some liquid and put it aside while
grinding).
3. Spin at 14K for lmin at 4 degrees. Move supernatant to a fresh tube (KEEP OUT 40ul
FOR PRE-IP, add 40ul 2X SDS buffer to PRE-IP), and add GP anti-EYA 1:1000
4. Rock at 4 degrees for 1 /2 hours. Meanwhile, wash Protein G sepharose beads in lysis
buffer at least 3 times (one of these times rock for a while). After final wash add an equal
volume of lysis buffer to beads to make 1:1 slurry.
5. Add 30ul of Protein G slurry to lysate - rock for another 1 /2 hours
6. Wash beads 3x in lysis buffer (spin at 3000K I minute in between washes)
7. Add equal volume of 2X SDS buffer to the beads.
EMBRYOS
I. Collect wildtype embryos overnight in the stinky room
2. Dechorionate embryos.
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3. Put embryos into an eppendorf and add some lysis buffer to grind. Add extra lysis buffer
and rock at 4 degrees for 30 minutes. After rocking, grind again (you may want to remove some
liquid and put it aside while grinding).
4. Follow above from step 3.
280
XB10
VA1011-1012l
DmnSOS QE tIPP PF RY I
MmSOS r PPF ZY I
HsSOS ZA I PF I I
DmSOS
MmSOS
HsSOS
I PNT F SD-EL - PL LSFPWE iPSIL  P
DmSOS ATIAASAAP LHA*PB IM&APPP LEQS PHNPHAFSVFAPVI
Mm SOS ----------------------------------------------- : p ___
HsSOS ----------------------------------------------- WAS
DmSOS I R S PQH PAPHLPKKPAVW TL FSPALPILPPQSLPSPF A
MmSOS I :- P ------------------------
HsSOS I rPPL. PPP
*
DmSOS
MmSOS
HsSOS
*
TEAPPSPLPILVVBPRHE RSPFHRMQ PTHS F VPISPV
iS ...-- - -------P..l.VFIQLPHI---------------
DmSOS PMATNMYRAVPPPLP PER ESCADMA RQAPDAPLPP PPIPPIPPML I8Y FV's
Mmsos --- VPPPVP P P --------- PPAIPP -----------------------
HsSOS --- V PVPPPVP P --------- PPAIPP-----------------------
DmSOS SLLLPN IMIRRNSAIEK SQPNQAA4NPISTTL VAV DEPLPLPISPAASSTTTSPLTPAMSP MPN
MmSOS- P PPLLP PUPL aPP ---- AFP Po
HsSOS ------P IW PN~ZatmI IP PPLLPPUP P- - PLI PPP ----AFFPP
DmSOS
MmSOS
HsSOS
DmSOS
MmSOS
HsSOS
IP HPVESIS SYAQ QQTHPAIYSQ HQHAHLPIHPH HH P PEFFPAS LP
PFPPPPP -. P P ppp-- ---- .LPPP.IPVP P --------------- PPr PPPPP_ - . ..-PWPP IAPPVP T------------------- ,QH P
PSLSAN FYNNPDTMFLYPSZNEE
'u P ' P
1596
1336
1333
013
983
966
1091
1059
1042
1171
1084
1067
1251
1125
1108
1331
1144
1141
1411
1189
1186
1491
1257
1254
1571
1311
1308
1T 
--------------------------
-------------------------- 
--m-m -
--------------------------
Dual functions of the Retinal Determination Gene Network member
EYES ABSENT as a transcription factor and protein phosphatase
by
Serena Jean Silver Brown
B.A. Biology
B.A. English and American Literature
New York University, 1999
SUBMITTED TO THE DEPARTMENT OF BIOLOGY IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
AT THE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Ctef kreer 004-1
© 2004 Serena Jean Silver Brown. All rights reserved.
The author hereby grants to MIT permission to reproduce and to
distribute publicly paper and electronic copies of this thesis document in
whole or in part.
Signature of Author: _ (J Serena J. Silver Brown
Certified by:
Ilaria Rebay
Associate Professor of Biology
Thesis Supervisor
Accepted by:
Stephen Bell
Professor of Biology
Chairman of the Graduate Committee
IMASSACHUSETTS INSRTrE
OF TECHNOLOGY
JUN Is 2004
*AiCHlVES
LIBRARIES 1
_ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ - I- - - -- - - - I- - - - - - - - - - - -

Dual functions of the Retinal Determination Gene Network member EYES ABSENT as a
transcription factor and protein phosphatase
Serena J. Silver Brown
submitted to the Biology Department on June 10, 2004 in partial fulfillment of the
Requirements for the degree of Doctor of Philosophy in Biology
Proper development of cell types and tissues requires the integration of extracellular
signals to provide context specific information that insures appropriate differentiation. The
Drosophila eye is an excellent model for the study of this signal integration, as its development is
orchestrated by the interactions of common signal transduction pathways in conjunction with
organ specific gene expression. Signaling through these pathways sets the stage for appropriate
deployment of the Retinal Determination (RD) gene network members to direct formation of the
eye and other organs.
Our studies have focused on the RD gene network member EYES ABSENT as a point of
signal integration necessary for the formation of the Drosophila eye. We have examined two
functions for EYA, the first as a transcriptional co-activator, and the second, more novel function
as a protein tyrosine phosphatase.
Previous work suggested that EYA functions as a transcriptional co-activator, particularly
in a complex with the DNA binding domain containing RD network member SINE OCULIS
(SO). In order to better understand RD network regulation, we performed a structure-function
analysis of the EYA protein, which defined the P/S/T rich region of EYA as crucial for EYA
transactivation potential. This region is also necessary for EYA mediated ectopic eye induction
and rescue of the eya2 mutant phenotype. We showed that RAS/MAPK signaling potentiates
EYA transactivation, providing a mechanism for previously described in vivo activation of EYA
by MAPK. We have also demonstrated roles for GROUCHO and DACHSHUND in negative
and positive regulation of the EYA-SO transcription factor, respectively.
Recently we have begun to study a novel function of EYA suggested by the homology of
the highly conserved EYA domain (ED) to the Haloacid dehalogenase (HAD) family. Using the
substrate analog para-nitrophenyl phosphate (pNPP), we showed that recombinant ED possesses
phosphatase activity, which is affected by tyrosine phosphatase inhibitors but not
serine/threonine phosphatase inhibitors. To determine whether this activity is important for EYA
function in vivo, mutants that reduce or abrogate phosphatase activity, as shown by lower
specific activity or higher Km in pNPP assays, were tested for their ability to induce ectopic eyes
or rescue the EYA mutant phenotype. These mutants, which we refer to collectively as EYA AD,
are unable to induce ectopic eyes or rescue the eya2 phenotype to the degree of wildtype EYA.
As the EYAHAD mutants are all within the ED, which is known to bind to SO, we tested whether
these mutants are competent transcriptional coactivators with SO, and found that they retain this
activity. Thus the phosphatase and transactivation functions of EYA may represent two distinct
essential functions of EYA.
As EYA represents one of the first transcription factors found to possess phosphatase
activity, and modulation of phosphorylation state represents a common mode of transcriptional
regulation, it will be of particular interest to elucidate the role of EYA phosphatase function in
vi'vo, studies which will require identification of transcriptional targets and phosphatase
substrates.
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